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CV 
Birgith Pedersen graduated as a nurse in 1980. She has a clinical background in 
radiology, cardiology, intensive care and oncology. In 1987 she became a specialist 
in intensive care, but she soon switched to the field of oncology nursing. Working as 
an assistant ward sister in an oncology unit she completed her diploma in leadership 
in 1995. This stimulated her interest in developing an academic career, which was 
further deepened by her employment as a teacher at a nursing school during the 
period 1996-2002 and her acquisition of a Master of Science in Nursing from 
Aarhus University in 2001. As a developmental nurse at the Department of 
Oncology she has focussed on further developing the area of clinical nursing 
through research and development with a special view to increasing our 
understanding of living with side effects of cancer treatment. For a decade she has 
among other things been responsible for in-house course activities for trained nurses, 
the development of tools to support observations and documentation and organising 
network meetings. Focus has especially been on a) stimulating clinical nurses in 
evidence-based practice by organising journal clubs and projects days and providing 
support in connection with writing papers for nursing journals, and b) conducting 
research on how patients experience and cope with side effects from cancer 
treatment. Birgith has also participated in developing the curriculum for the 
bachelor’s programme in nursing, in competency development (how to advance 
from novice to proficient nurse) and in describing possible career directions. In 
October 2012 she was enrolled as a PhD student at Aalborg University, where she 
has studied experiences with changes in weight and body composition among 
women during and after adjuvant treatment for breast cancer. 
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ENGLISH SUMMARY 
The side effects of antineoplastic adjuvant treatment for breast cancer include 
changes in weight and body composition. These changes can influence women’s 
general health and survival rate and may affect their perception of their body and 
their self. However, research findings on the factual changes are diverse and 
sometimes contrasting, and existing studies on the effects of weight changes on 
body and self perception among women during and after breast cancer treatment 
seem to be insufficiently explored. No studies have combined quantitative and 
qualitative data to expand the knowledge of the complex human phenomena and 
take into account the inseparable body-subject. 
This study aims to increase our knowledge on how changes in weight and body 
composition influence women’s experience of their body and self during and after 
adjuvant antineoplastic treatment for breast cancer to identify women with a special 
need for healthcare. The following research questions are scrutinised: 
 What characterises changes in weight and body composition during 18 
month from diagnosis, and how is the risk of weight changes associated 
with current antineoplastic treatment? 
 
 What is the essential meaning of the phenomenon of changes in weight and 
body shape among women treated for breast cancer, and how do these 
changes influence the women’s perception of body and self? 
 
 How can an understanding of the women as unified body-subjects expand 
our knowledge of factual bodily changes and their influence on the 
women’s perception of body and self? 
 
Guided by existential phenomenology and a lifeworld perspective, this study applies 
a multi-stage mixed methods design consisting of two studies in three phases, which 
are integrated and illustrated in joint displays. Study I (Paper 3) utilises data 
collected among 95 women after surgery for breast cancer in stages I-III followed by 
endocrine treatment and/or chemotherapy. Baseline data are summarised by 
descriptive statistics. By means of bioelectric impedance analysis, data of weight 
and body composition were obtained 4 times during 18 months after breast cancer 
surgery. Estimated changes of repeated measurements and odds ratio were 
calculated using a linear mixed model and logistic regression. Study II (Paper 1 and 
2) is a qualitative study consisting of two phases. To improve the data collection 
process for study II, an interview guide was been developed based on a focus group 
consisting of five women experiencing weight changes (phase one). Approximately 
12 months after diagnosis 12 women from the initial sample were invited for 
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individual interviews (phase two). The interviews were analysed within the frame of 
existential phenomenology and reflective lifeworld research. 
Study I showed modest average changes in weight, fat mass and waist. However, 
changes in body composition and an increased risk of developing changes were 
mainly observed over time among women treated with chemotherapy whereas 
women in endocrine therapy increased their waist circumference. Independent of 
treatment regimes, Study II showed that changes in weight and body composition 
influenced the women’s perception of body and self. The essential meaning of the 
ambiguous transforming body was continuously associated with fear of recurrence 
and perceived as a demanding stranger. Occasionally the unified body-subject 
divided into subject and object. Even though some women managed to control the 
changes, showing great willpower, others had to realise that they were unable to do 
so and thus had to accept them. 
Integrating the two studies and illustrating them in joint displays showed that even 
minor changes in weight combined with an extended waist circumference influenced 
the women’s perception of body and self extensively (Paper 4). Weight gain 
triggered fear of recurrence, shame and self-blame and affected the women’s view of 
themselves as a unified body-subject. Weight loss, on the other hand, supported a 
positive body perception, making the women feel capable of taking care of their 
body and self as autonomous agents.   
In conclusion, changes analysed using statistical tools in a pooled sample neither 
explained nor corresponded to the perceived changes. All women are potentially in 
risk of changes in weight and body composition and deserve continuous attention 
from health professionals. Not paying attention to the women’s experiences may 
prolong the illness and suffering and prevent the women from regaining the sense of 
a unifying body-subject.  To support women in the transition to a new habitual body, 
health professionals must enter into a narrative work with the women. In addition, 
tailored interventions in the form of weight management, nutrition and physical 
activities must be offered to these women as prevention across sectors in the 
healthcare system.  
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DANSK RESUME 
Vægtændringer hos kvinder i forbindelse med adjuvant behandling efter brystkræft 
er en kendt bivirkning, der kan påvirke langtidsoverlevelse og livskvalitet samt føre 
til livsstilssygdomme. På trods af disse konsekvenser er der i Danmark ikke forsket 
i, hvorledes vægtændringerne er fordelt på fedt og fedtfri masse – parametre, der kan 
belyse den sundhedsmæssige risiko. Kun sparsom forskning belyser, hvordan 
vægtændringerne påvirker kvindernes selv- og kropsopfattelse og ingen studier 
kombinerer kvantitative og kvalitative data for at belyse faktuelle ændringers 
påvirkning af opfattelse af krop og selv som et forenet subjekt - objekt. 
Formålet med dette studie er at udvikle viden om kropslige forandringer i 
forbindelse med adjuvant antineoplastisk behandling for brystkræft og om hvorledes 
disse forandringer påvirker kvinderne opfattelse af krop og selv med henblik på at 
kunne identificere kvinder, der har brug for en særlig sundhedsfaglig indsats. 
Følgende forskningsspørgsmål er belyst: 
 Hvad karakteriserer forandringer i vægt og kroppens sammensætning af 
fedt, fedtfri masse og kropsvæske gennem 18 måneder fra 
diagnosetidspunkt hos kvinder under og efter adjuvant antineoplastisk 
behandling for bryst kræft og hvordan er risikoen for ændringer relateret til 
denne behandling? 
 
 Hvad kendetegner den essentielle mening af fænomenet ’ændringer i vægt 
og kropsfacon’ blandt kvinder behandlet for brystkræft, og hvordan 
påvirker forandringerne kvindernes opfattelse af krop og selv? 
 
 Hvordan kan en forståelse af kvinder som et forenet subjekt - objekt 
uddybe viden om betydningen af faktuelle kropslige forandringer for 
kvindernes opfattelse af sig selv og deres krop ved adjuvant behandling for 
brystkræft? 
 
Med udgangspunkt i eksistentiel fænomenologi og et livsverdensperspektiv er der 
udført to studier i et ’multistage mixed methods design’ bestående af tre faser. 
Resultaterne er integreret og illustreret i joint displays. Studie I (artikel 3) anvender 
data indsamlet blandt 95 kvinder opereret for brystkræft i stadie I-III med 
efterfølgende endokrin behandling og/eller kemoterapi. Baselinedata er 
sammenfattet ved hjælp af deskriptiv statistik. Gentagne målinger gennem 18 
måneder er foretaget ved hjælp af bioelektrisk impedansanalyse. De gentagne 
målinger og odds ratioer er beregnet ved hjælp af en lineær mixed model og 
logistisk regression. Studie II (artikel 1 og 2) er et kvalitativt studie i to faser. Som 
udgangspunkt for dataindsamlingen er der udviklet en interviewguide på baggrund 
af en fokusgruppe bestående af kvinder, der har oplevet vægtforandringer efter 
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kræftbehandling (fase 1). Guiden er efterfølgende anvendt i individuelle interview 
med 12 kvinder fra studie I 12-18 måneder fra diagnosetidspunktet (fase 2). 
Interviewene er analyseret på baggrund af fænomenologisk refleksion og 
livsverdensanalyse. 
Studie I viste, at de gennemsnitlige vægtforandringer er små, men at der sker 
forandringer i vægt, fedtmasse og livvidde over tid.  Forandringen i disse parametre 
var primært relateret til kvinder behandlet med kemoterapi, mens kvinder i endokrin 
behandling alene øgede deres livvidde.  
Studie II viste, at kvinder uagtet typen af behandling var optaget af kropslige 
forandringer. Den essentielle betydning af kroppens tvetydige forandringer var 
knyttet til frygt for tilbagefald relateret til vægtøgning, øget fedtmasse og forandret 
kropsfacon. Forandringerne fik betydning for kvindernes oplevelse af sig selv som et 
forenet subjekt. Kroppen forandrede sig under behandlingsforløbet og blev oplevet 
som et objekt, der var ude af kontrol eller skulle kontrolleres. Selvom det lykkedes 
nogle af kvinderne at kontrollere forandringerne med stor viljestyrke, måtte andre 
indse, at de kropslige forandringer var uden for deres kontrol, hvorfor accept heraf 
var den eneste løsning. 
Integration og illustration af de to studier i joint displays viste, at de målte 
forandringer ikke var i samsvar med de oplevede forandringer (artikel 4). Selv 
mindre vægtændringer og forandringer i taljemål påvirkede kvindernes opfattelse af 
krop og selv betydeligt. Vægtøgning skabte frygt for tilbagefald, skam og skyld i 
modsætning til vægttab, der understøttede en positiv kropsfornemmelse og en 
følelse af at kunne tage ansvar for egen sundhed.  
Det kan konkluderes, at målte kropslige forandringer ikke kan stå alene, men må 
komplementeres med kvindernes oplevelse heraf. Kvinder i adjuvant antineoplastisk 
behandling for brystkræft er potentielt i risiko for ændring i vægt og kroppens 
sammensætning af fedt, fedt fri masse og væske. Hvis ikke oplevelsen af disse 
forandringer tages alvorligt kan det forlænge og forstærke kvindernes lidelse. Med 
udgangspunkt i en narrativ tilgang og med skræddersyede interventioner på tværs af 
sektorer kan sundhedsprofessionelle støtte kvinderne i erkendelsen af en ny krops og 
selvopfattelse. 
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PREFACE 
In conducting a mixed methods study I acknowledge the challenges pointed out by 
researcher Janice Morse. Morse compares mixed methods research with serving 
two masters (1). She stresses the need to be a highly versatile researcher, adept in 
different research paradigms and being familiar with many different research 
methods. Accepting the challenges in this PhD project has enabled me to extend my 
knowledge of different methods and analytical strategies. Although Brinkman and 
Kvale (2) are mainly occupied with interviewing, borrowing their metaphor I have 
felt like a miner trying to reflect on the facts of a small part of the world – and like a 
traveller into unknown land, filled with choices.  
A mixed methods study can contribute with understanding a complex phenomenon 
by using the best suited methods and analytical strategies to explore the attributes of 
the phenomenon, including considerations of the consistency between ontology, 
epistemology and method (3). One can also look at mixed methods as one method 
(4).  
However, participating in courses on body and embodiment lead me to the world of 
phenomenology. Sharing my questions and arguments with a multidisciplinary 
phenomenology network made me consider the option of leaning on philosophical 
and epistemological assumptions from the position of existential phenomenology, 
as described by the French philosopher Maurice Merleau-Ponty. This position is not 
just in accordance with the healthcare perspective, but also significant from a 
nursing perspective. 
Thus, by means of existential phenomenology and multiple methods the bodily 
changes in weight and body figure experienced by women with breast cancer during 
and after cancer treatment turned out to be a complex matter. Combining and 
integrating different forms of data inspired by mixed methods methodology 
contributed to a deeper understanding of the problem. The choices I have had to 
make during the research process have involved a series of scientific challenges, as 
this thesis uses a variety of mixed methods concepts to explain the study on the 
design level. On the data collection level multiple methods have been used to 
illuminate the bodily changes and their influence on the women from different 
perspectives. Finally, the use of different analytical tools has ensured that no stone 
was left unturned. 
During the entire learning process, I developed awareness on different levels of 
what it can mean to exist in the world as an embodied human being. Conducting a 
scientific, comprehensive study and writing a thesis has been challenging. As a 
body-subject, I have been forced to sit down or stand up throughout the writing 
process. Thus, my body changed into a stiff body that impelled me to move, to go 
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outside or to just perform ordinary everyday tasks (displacement activities perhaps). 
Thinking, reading, and understanding the wholeness changed from a fluent process, 
which normally went unnoticed, to a fragmented, slow, always conscious process 
striving to understand and reveal coherent patterns that were meaningful to me and 
others.  
The four papers and this thesis are the results of this effort. I invite you to join me 
on a travel into methodologies and philosophical thoughts to learn about the 
experience of changes in weight and body composition among women with breast 
cancer to get a glimpse of an unknown world, which, at the same time is familiar, 
because we are all embodied human beings. 
The structure of the thesis is inspired by recommendations by the highly estimated 
scholar John W. Creswell (4,5). The thesis builds on articles. When writing 
empirical articles for mixed methods research it is recommended to write: ‘a 
quantitative article, a qualitative article, an overall mixed methods article. These 
articles could go out to different journals’ (4, p.92). Four papers are generated from 
this study: two qualitative, one quantitative and one mixed methods article, which 
were submitted for publication after completion of each analysis. Although the data 
collection for study I was initiated first, data collection and analysis for study II was 
completed before study I. Thus, the orders of the papers on the next page reflects 
when the papers were published or submitted for publication.  
 
Birgith Pedersen 
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CHAPTER 1. INTRODUCTION  
Being a nurse for several years in the field of oncology I have listened to my own 
and others’ prejudices regarding weight gain among women in adjuvant treatment 
for breast cancer. Weight changes were considered an inevitable effect of normal 
ageing, a female issue only related to appearance and nothing to worry about in 
proportion to the risk of dying from cancer. However, turning my attention to what 
these women actually said, a new understanding emerged along with an incentive to 
conducting a research project with a view to increasing the knowledge, and 
understanding the issue, and giving a voice to the women concerned. The following 
quote illustrates a core issue of living with weight changes during and after 
treatment for breast cancer. 
People might think: why do I moan about my two-three kilos when I 
am not too fat. But it concerns my self-perception and the fact that 
you cannot decide for yourself. You lose control when you start 
taking the pills. I am simply not able to make any impact on my 
weight. Suddenly, it is me gaining weight. I cannot stand it, but I do 
not talk about it. I feel like it is embarrassing, because I am 
certainly not too fat. But it means a lot to me and my body 
perception. (Quote from a participant) 
The changes gave rise to embarrassment, lack of comfort, silent suffering, and fear 
of losing control of one’s weight. These serious feelings were suppressed, as the 
women did not expect others to understand the effect weight gain had on them. In 
addition, the changes were understood as a consequence of medication. So what do 
weight changes among women treated for breast cancer have to do with nursing and 
healthcare? This question will be considered in the following chapters. 
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CHAPTER 2. BODY WEIGHT, HEALTH, 
AND NURSING 
This chapter deals with bodily changes as issues for nursing and healthcare. First, 
there is an elaboration on the body in nursing, followed by reflections on the 
relationships between breast cancer, weight changes and health. 
2.1. BODILY CHANGES IN NURSING  
Since Florence Nightingale, the founder of modern nursing, wrote her bedside 
observations and stressed the need for nurses to be able to observe the sick and 
make judgements based on adequate information, a central issue in nursing has 
been observation and prevention for the ‘sake of saving life and increasing health 
and comfort’ (6, p.125). Nightingale aimed to decrease risk and prevent disease and 
is referred to as an epidemiologist who opened up for nursing interventions on the 
organisational, population and individual level. Although Nightingale was 
concerned with giving patients the best conditions for nature to act (6, p.133), she 
also highlighted the urgency of taking the patients’ experiences of illness seriously 
(6, pp. 95-104).  
In addition to caring for patients’ basic needs and creating nursing plans, her 
successors followed her example and turned the focus of nursing in the direction of 
care. Understanding the meaning of illness on everyday life became a central aspect 
of and a precondition for providing nursing care (7, p.28). In this endeavour the 
philosophy of science and nursing, including epistemological and ontological issues 
as natural ingredients in human- and care-oriented nursing, was brought to light 
(8,9). Favouring a focus on illness and care, it was stressed that the patient was not 
only a body to care for, but a person who might need assistance in finding meaning 
in the experience of illness and suffering (8,10, p.74). 
In Denmark the Norwegian nurse and philosopher Kari Martinsen has influenced 
our understanding of care as a fundamental precondition in human lives and in 
nursing.  From a caring perspective the aim is to strengthen the life courage of 
patients, to recognise the need of the suffering person and to act accordingly in the 
clinical encounter. Caring for the ill person requires that the body is recognised and 
clinical judgements made on the basis of structured professional knowledge and an 
open and sensitive approach that embraces the patients’ subjective experiences of 
illness (11).  
Although caring is a central value in nursing and a precondition for practicing good 
nursing, the Australian-American scientist Janice Morse stresses that comfort - or 
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well-being - is a central concept in nursing. Comfort is situated in a continuum that 
moves from serious discomfort that occupies the mind and influences everyday life 
where the body is no longer silent or taken for granted to a high level of relieving 
comfort (12,13). While nursing aims to provide comfort, recognise the need of 
others, save lives and increase health and life courage, it is pivotal to understand the 
experience of the injured body in serious illness conditions. To support the patient 
through caring practice the professional may apply knowledge that is based both on 
natural sciences and human and social sciences (14).   
Building on these theorists this thesis takes a care-oriented nursing perspective. 
Consistent with a lifeworld perspective that acknowledges the individual’s 
experience, it takes the individual’s self-understanding, lived body and the meaning 
of suffering and well-being into account (13,15,16). A lifeworld perspective on 
weight changes associated with treatment for breast cancer involves focussing 
attention on the body as an essential unity for understanding how patients 
experience their illness (17-19). From an existential phenomenological point of 
view - as outlined by the French philosopher Maurice Merleau-Ponty - one does not 
possess the body as an object. Instead, the body is understood as an inseparable 
unity of body, mind, and soul as ‘one’s own body’ or the body-subject in an attempt 
to overcome the dualistic understanding of a separate body and mind (20). 
Applying existential phenomenology as an overriding approach thus seems to be 
useful in exploring bodily changes related to weight changes among women with 
breast cancer. The next section will explain why weight changes associated with 
breast cancer is an important topic to explore. 
2.2. BREAST CANCER – HEALTH AND SURVIVAL 
Breast cancer is the main cancer disease among women in Denmark, and over the 
past decades the incidence has increased (21). By the end of 2013 the incidence was 
4.897 and the prevalence 60.197 with a five-year survival rate of 85 % (22). One of 
the main reasons for this increase in the incidence of breast cancer is suggested to 
be exposure to estrogen from fat tissue, especially in postmenopausal women (23). 
Overweight and obesity are considered as an expanding problem in Denmark and 
worldwide (24), and this may lead to an increasing incidence of breast cancer. 
Although weight gains in general stagnated from 2010 to 2013, the proportion of 
overweight and obese women in the population remains 40-50 % from age of 35 
and up (25); this number doubled during the period 1990-2000 (23).  
In addition to the association between breast cancer and overweight, weight gain 
may increase the risk of all-cause mortality (26,27) and the development of lifestyle 
diseases such as cardiovascular diseases, diabetes, joint and muscle diseases, and 
respiratory diseases (24,28). To prevent breast cancer and increase long-term 
survival, women are advised to avoid weight gain in adult life, particularly after 
menopause (23,29,30). However, such recommendations may be seen as a ‘double-
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edged sword’, as studies have demonstrated that weight changes and especially 
weight gain is considered a side effect of cancer treatment. Furthermore, due to 
long-term survival, there has been increasing focus on how these women are living 
with side effects after cancer treatment. Thus, an exploration of the extent and 
meaning of weight changes seems essential. 
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CHAPTER 3. BACKGROUND AND 
OVERVIEW OF LITERATURE 
This chapter provides the background for the present study. A comprehensive 
literature review is conducted to identify knowledge gaps regarding factual changes 
in weight and body composition and how the changes influence breast cancer 
stricken women’s perception of their body and self. 
3.1. BACKGROUND 
Weight changes in breast cancer women have been investigated for decades, due to 
the expected association between fat tissue and breast cancer development and the 
increased risk of both recurrence and early death (31-39). The duration of adjuvant 
chemotherapy is suggested to be a main contributor to weight gain (34,36,37,39,40). 
It is currently being discussed whether premenopausal status is a predictor for 
weight gain in association with treatment for breast cancer, though it has been 
observed that premenopausal women gain more weight than postmenopausal women 
(37,41). Reviewing studies, which applied imagining technology to determine 
changes in body composition over time, Sheean et al. (42) found that body weight 
did not increase consistently. Neither did weight gain depict changes in lean and 
adipose tissue, which are of concern for survival and health. 
Adjuvant cancer treatment consists primarily of surgery, radiotherapy, 
chemotherapy, and endocrine treatment - alone or in combination (43).  
Acknowledging weight changes as a side effect of cancer treatment, there has been 
specific focus on the influence of endocrine treatment and chemotherapy.  Kumar et 
al. (44) compared weight development in women allocated to radiotherapy or 
tamoxifen and found no difference. Studies by Ganz et al. and Goodwin et al. 
(32,40) confirmed these findings. They found it was the onset of menopause and 
treatment with chemotherapy that caused weight gain. Subsequently, a study 
demonstrated that premenopausal women were found to gain more weight than 
postmenopausal women in adjuvant chemotherapy in combination with tamoxifen 
(31). In line with this, it is documented that women in current adjuvant 
chemotherapy on average gain 2.0 kg during and after adjuvant treatment, although 
gaining as much as 10 kg is not uncommon (33).  
As cancer treatment changes, a continuous evaluation of weight patterns following 
breast cancer diagnosis is needed. Recently, the effect of anastrozole (aromatase 
inhibitor) on weight change in postmenopausal women at high risk of developing 
breast cancer was compared with tamoxifen (estrogens receptor antagonist) or 
placebo (45). In this preventive setting, body weight increased by 0.9 kg at 12 
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months follow-up in women receiving tamoxifen as opposed to placebo. Weight 
gain associated with anastrozole versus placebo was 1.4 kg. None of the results were 
statistically significant but as no body composition data was included, it is unclear if 
the gain is related to increased fat mass. Comparing tamoxifen and anastrozole 
showed no statistically significant difference. However, severe weight gains > 5 kg 
were found in both groups.  
In another study, Sedjo et al. (46) demonstrated that women receiving aromatase 
inhibitors as opposed to estrogen receptor antagonists during follow-up treatment 
were 46 % less likely to gain weight (ORadj = 0.54, 95 % CI 0.31 – 0.93). Still, the 
findings are inconclusive in that some studies have found premenopausal status to be 
a predictor (31,37,38), while others claim that women’s menopausal status does not 
influence their weight gain (23,26,33). Menopause status in estrogen receptor- 
sensitive breast cancer predicts the choice of follow-up endocrine treatment, and 
significant factors influencing weight have been observed in connection with 
estrogen receptor antagonist treatment (38). This is in line with Sedjo et al. (46) who 
found that the risk of weight gain decreased among women given aromatase 
antagonists, which are normally given adjuvant to postmenopausal women. Also 
alcohol consumption (23,26) and decreased physical activity (37,38) may influence 
the weight.  
In addition to these divergent findings, weight changes are depicted as distressing 
side effects in quality of life questionnaires (31,47-49). Quality of life can be 
affected by for example fatigue, weight gain and altered sexuality (50). However, 
distressing side effects are not discussed with the professionals, because the 
professionals seem to be more focussed on recovery than everyday life problems 
(51). Neglecting the individual’s self-understanding of suffering and well-being may 
contrast fundamental values and preconditions for providing care in nursing (14-16). 
Thus, understanding and recognising the experience of suffering and illness, 
including side effects from cancer treatment, is essential. Loss of hair and breast 
may lead to a sense of losing parts of one’s identity (52-54), and distressing 
symptoms in the years after active cancer treatment are reported to induce a feeling 
of losing one’s pre-cancer being (55). Furthermore, a meta-analysis showed that 
breast cancer survivors experience changes in self-perception, which are not only 
related to breast cancer surgery and hair loss, but also to weight changes (56).  
These studies demonstrate that body weight changes may fluctuate over time and be 
associated with treatment modality and menopause status. Despite the impact on the 
women’s health, overall survival, and self-perception, some argue that the problem 
is overestimated, because treatment with current antineoplastic agents, e.g. 
anthracycline based chemotherapy, minimises the changes (57).   
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3.2. LITERATURE REVIEW 
To investigate factual changes associated with contemporary anti-cancer medication 
and how weight changes may influence the women, a comprehensive literature 
search was conducted in collaboration with a librarian from Aalborg University 
Hospital. By means of PICO diagrams, the search was carried out in two phases. In 
order to find  studies on bodily changes as well as the women’s experiences of the 
changes, literature focusing on studies 1) reporting quantitative body changes and 2) 
reporting how the changes influence the women from a qualitatively point of view, 
were reviewed. Initially the searches were rather specific and provided very few hits. 
Subsequently the searches were broadened and repeated. The last search was 
conducted November 2015.  
The quantitative literature search was conducted in the databases PubMed, CINAHL 
and Embase using MeSH terms, CINAHL terms and Emtree as well as free text 
(Appendix A). As the search in PubMed provided most of the selected papers, the 
search string from this database is shown. The search was broad not to exclude any 
important articles and the papers were selected as described in appendix A. The 
qualitative literature search was performed in the databases PubMed, CINAHL, and 
PsycINFO using MeSH terms, CINAHL terms and thesaurus as well as free text - 
with the PubMed search sting as displayed in appendix B. Subsequently, the search 
underwent a selection (Appendix B).  
The literature review is described in the next sections. Given the adverse association 
between fat tissue and breast cancer development, the papers selected from the 
quantitative search provide an overview of changes in weight and body composition 
during and after treatment with current adjuvant treatment regimes for breast cancer. 
This is followed by papers selected from the qualitative search that are described 
and critically assessed for the purpose of getting acquainted with the contemporary 
research regarding the experience of weight changes. The overall aim of the 
literature review is to determine knowledge gaps for further investigations.  
3.2.1. WEIGHT CHANGES – SIDE EFFECTS OF CANCER TREATMENT 
This paragraph aims to provide an overview of changes in weight and body 
composition during and after treatment with current antineoplastic treatment regimes 
for breast cancer. The review focuses on breast cancer treatment with current 
chemotherapy and/or endocrine treatment and reports findings from 19 studies. 
Assessing studies published from 2004 and forward, one study was found which 
reported changes in weight associated with endocrine treatment as the main focus 
(58). However, the effect of endocrine treatment is also depicted in some studies 
reporting findings on chemotherapy. 
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3.2.2. STUDY DESIGN AND DATA COLLECTION 
The majority of the studies had a retrospective design (30,34,35,39,46,59-66) and 
examined breast cancer stages I-III (30,34,35,39,46,61,63,66). Most of the studies 
included between 100 and to 350 participants and one included more than 3000 
women. Data was primarily extracted from records, and in several studies the 
methods used to estimate weight changes were not described (39,60,62-65) or did 
not specify the chemotherapy regimens (39,46,59-61). If the regimes were specified, 
the women received various regimes (30,34,35,64-67). Moreover, the descriptions of 
endocrine treatment differed. In most studies, endocrine treatment followed 
chemotherapy, but was given as a standalone treatment and reported separately in 
two studies (34,64). Cut-off points for assessing weight changes were either missing 
(30,66,67) or defined as absolute weight changes ranging from 1 to 5 kg 
(39,60,63,64), relative weight changes of ± 5 % (34,46,62), or as the difference 
between the first and last measurements (65). One study that applied a retro– and 
prospective design included approx. 6000 women, but had lost about 2000 women at 
the three-year follow-up (60). 
Of  six studies with a prospective design (36,57,58,67-69), three included women 
with breast cancer in stages I-III (67-69), two included women in stage I-II (36,57), 
and one did not describe the stages (58). The samples consisted of 20 to 272 women 
and follow-up time varied from completed chemotherapy (~ 4 to 6 months) and up 
to two years. Most studies ended measurement after one year (36,58,68,69).  
Chemotherapy regimens were specified in five studies (36,57,67-69). If cut-off 
points for assessing weight changes were described, they were defined as absolute 
weight changes of ± 2.5 kg (57) or relative changes of ± 5 % (69).  
In general, the studies provide a picture of how the studies differ regarding 
heterogeneous sample sizes, treatment regimes and follow-up time including 
different cut-offs, which make them difficult to compare. Most studies measured 
short-term and up to one year (57,58,63,65,66,68). Other studies measured up to 24 
months (30,62,67), and a few extended the weight measure time. Saquib et al. 
measured for three years (34), whereas Sedjo et al. and Heideman et al. provided 
follow-up for five years (46,64). However, Heideman et al. categorised their 
measure points widely with a mean follow-up of 3.5 years. The different time spans 
and measurement times make it difficult to get a clear picture of the context in 
which the studies took place. 
3.2.3. RESULTS QUANTITATIVE LITERATURE REVIEW 
In addition to the described differences, also the extent of the changes and the 
description of the changes differed, which prevented a common pattern. Although 
the studies investigated modern/third generation chemotherapy (57,65), they 
involved different chemotherapy regimens without specification. Some studies with 
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small sample sizes between 20 to 76 reported changes in body composition in 
addition to reporting weight changes (36,57,58,68).  
In the following, an attempt will be made to discriminate findings related to 
anthracycline based chemotherapy (hereafter abbreviated ACCT) and the effect of 
endocrine treatment as these anticancer agents have been considered as adjuvant 
standard breast cancer treatment in Denmark recently (43). The findings will be 
reported in terms of changes in the short-term, after one year, after two years and 
after more than two years. 
3.2.3.1. Short-term studies 
Ingram et al. (57) investigated 76 premenopausal women for up to seven months. Of 
these, 39 received ACCT were measured until completed chemotherapy. With a cut-
off of 2.5 kg, 55 % displayed stable weight, 34 % weight gain, and 10.5% weight 
loss, with the mean weight gain being 1 kg. Examining changes in body 
composition, they found that both fat mass and fat free mass increased during weight 
gain and decreased during weight loss. These findings showed that women receiving 
other regimes than ACCT were more exposed to changes. The opposite was shown 
in the study by Ricci et al. (66). An investigation of 172 women given ACCT, where 
129 received AC-T1, showed that women receiving ACCT and specifically AC-T 
regimes had the highest risk of weight gain one month after completed 
chemotherapy. The exposed women were younger (54.2 ± 11 years) than the women 
in the other regimes (59.3 ± 11.2 years), p = 0.007. In addition, their BMI increased 
from 27.4 kg/m2 at baseline to 28.3 kg/m2. These women were thus overweight in 
advance when assessed by the WHO BMI scale.   
With a cut-off of ± 1 kg and after completed chemotherapy, Wang et al. found an 
even distribution in weight groups as approx. one third remained stable, one third 
gained weight, and one third lost weight in their study of 98 women, of whom 56 
received ACCT. A different cut-off of 2.5 kg, as suggested in the study by Ingram et 
al., would probably have changed the distribution with more women in the stable 
group. However, the range of changes was –11 kg to +9 kg. Thus, some women are 
exposed to extensive weight changes in the short term.  The authors conclude that 
age ≤40 years and weight ≥ 60 kg at diagnosis, numbers of chemotherapy ≥ 4 cycles, 
and antiemetic hormone dosage ≥ 200 mg increased risk of weight gain after 
chemotherapy (57,64). One kilo weight change in a 60 kg body weight corresponds 
to 1.6 % changes, while 2.5 kg correspond to approx. 4 %. This is more in line with 
the 5 % cut-off suggested by Saquib (34), which was found important for long-term 
survival in a study of Thivat et al. investigating 111 women, all treated with ACCT 
(35). In this study, 31 % presented a weight variation of more than 5 % from 
diagnosis to completed chemotherapy. In addition, the study demonstrated that the 
                                                          
1 Doxorubicin, cyclophosphamide and paclitaxel 
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exposure to relative weight variations of 5 % had a negative impact on recurrence 
and survival assessed during a 20 years follow-up. 
3.2.3.2. One year follow-up  
Freedman et al (68) investigated 20 women in ACCT treatment baseline, for six and 
12 months. They found no changes between baseline and six months (after 
completed chemotherapy), however, statistically the weight at one year was 
significantly increased (p = 0.05). The decrease in fat free mass was also statistically 
significant. As the sample was small, the findings must be assessed in association 
with the findings following completed chemotherapy in Ricci’s (66) and Wang’s 
(63) studies. Between baseline and one year, Gordon et al. (36) investigated 43 
premenopausal women for body composition changes. Only 15 of these women 
received ACCT, and although they found increased fat mass especially in the trunk 
at 12 months, which may be clinically important for cardiovascular diseases, 
diabetes and breast cancer outcome, the data were unified and calculated in just one 
group. Thus, this analysis does not account specifically for changes in women given 
ACCT who only provided one third of the data for analysis. Nevertheless, 
interpreting the findings from the total group, the authors argue that premenopausal 
women at risk of premature menopause are more exposed to body changes. 
Chaudhary et al.(65) reviewed 246 charts and found non-significantly mean weight 
gain of 0.39 % at one year compared to baseline. Premenopausal status was 
associated with significant weight gain. Out of this large sample only 40 received 
ACCT, and the findings from this group were not reported separately. However, 
pointing at premenopausal women at being at special risk of changes is in line with 
Gordon’s and Wang’s studies. Tredan et al. (69) measured in total 272 women, of 
whom 233 were given ACCT. Measurements took place  at baseline, nine months 
and 15 months (~ one year), with a 5 % cut-off . At nine months, more than half the 
women (126) had gained weight, with the mean weight gain being 3.2 kg. 60 % of 
these women gained less the 5 %, 33 % between 5 -10 % and 7 % gained more than 
10 %. At 15 months ~ one year, 60 % of the cohort had gained weight, with a mean 
increase of 3.9 kg. Forty-five percent gained less than 5 %, 32 percent between 5 
and 10 %, and 14 percent gained more than 10 %. Nine patients dropped out 
corresponding to less than 10 %, which is a reasonable and accepted drop-out in a 
sample of this size. The findings demonstrated that 40 % of the weight gainers 
increased their weight by more than 5 % at nine months, increasing to 45 % of the 
women at 15 months. These relative weight changes depict a serious problem as 
Tivat et al. (35)  found these relative weight changes essential for recurrence and 
survival.  
Only one study examined the effect of endocrine treatment alone. Francini et al.(58) 
investigated 55 postmenopausal women randomised into an estrogens receptor 
antagonist group (27 women) and an aromatase inhibitor group (28 women) 
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baseline, six and 12 months. At 12 months the weight remained stable in the 
estrogen receptor antagonist group and fat mass and weight decreased in the 
aromatase inhibitor group. These findings do not correspond with the findings of 
Sestak et al. (45) that showed increasing body weight of 0.9 kg at 12 months follow 
up in women receiving estrogen receptor antagonist versus placebo. Weight gain 
associated with anastrozole versus placebo was 1.4 kg.  
3.2.3.3. Two-year follow-up 
Although Han et al. (30) investigated 260 breast cancer-stricken women, of whom 
165 received ACCT, and described measurements at three, six, 12, and 24 months 
from baseline, the study suffers from a drop-out of approx. 30 %. Thus, the 
conclusion pointing at no weight changes during this follow-up has to be evaluated 
cautiously as we do not know whether these drop-outs were weight gainers. 
However, it is interesting that 23 women from the remaining group gained more 
than 5 %. 
In line with Han et al. (30), Jeon et al. (62) conclude that there are no changes at 
two-year follow-up. However, investigating 108 women after completed ACCT 
(TAC) - equalling six months - showed a mean weight change of 3.64 kg, 
statistically significant with p < 0.0001). At 12 months, the mean weight slightly 
decreased to –0.19 kg. At 24 months the mean weight decreased to –0.2 kg, and 72 
% displayed a stable weight calculated with a 5 % cut-off.  
Also Liu et al. (67) who investigated 147 women, of whom 80 were given ACCT, 
found the highest weight changes after completed chemotherapy, assessed at eight 
months following baseline. After eight months, the mean gain was 2.5 kg, and at 24 
months the mean weight was still 1.7 kg higher than baseline. Treatment with ACCT 
showed a slower and milder increase than in 67 women who were given other 
chemotherapeutic (CMF). Thus it seems that changes after completed chemotherapy 
demand further investigation, and although Han et al. (30) and Jeon et al. (62) 
demonstrate no changes at one year, this is contradictory to the findings of Liu et al. 
(67) and Tredan et al. (69). 
3.2.3.4. Long-term follow-up – more than two years 
Out of 2972 eligible women, data from 2859 participants aimed at examining the 
association between different chemotherapy regimes, estrogen receptor antagonist 
use, and weight gain. In this study, Saquib et al. (34) found that all types of 
chemotherapy were significantly associated with weight gain (OR = 1.65, 95% CI = 
1.12, 2.43) as opposed to estrogen receptor inhibitors (OR = 1.03, 95 CI = 0.71, 
1.51). In contrast to the study by Liu et al. (67), the regimes containing ACCT did 
not differ from other regimes. With a 5 % cut-off, 1031 women gained weight 
during chemotherapy. From this group, 868 women were followed for six years. The 
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weight gain occurred initially before the one-year measurement and for all women it 
they were unlikely to return to pre-cancer weight.  
Heideman et al. (64) analysed data from 271 women, of whom 93 received ACCT. 
Out of the total group, only 68 women were given endocrine therapy, and 87 
received combination therapy. The result from the ACCT group alone was not 
shown, but the study reported that 26 % of all women gained 5 kg or more during 
the first year following diagnosis. Women treated with chemotherapy gained a mean 
weight of 2.2 kg (SD ± 4.3) and women given combination therapy with 
chemotherapy and endocrine treatment gained  a mean weight of 2.6 kg (SD ± 6.0; p 
< 0.05). The last group of women gained further weight after the first year and 
displayed the highest weight gain at five years. No significant changes in weight 
were found among women receiving endocrine treatment alone. Although the 
findings were analysed at diagnosis, after one year and after five years, the reliability 
of the findings must be discussed as time ‘at diagnosis’ included measurements one 
to three months following diagnosis, the one-year measurement included three to 15 
months, and the five years measurement included 15 months to six years following 
diagnosis. These choices make variations over time unclear. 
3.2.4. SUMMARY OF THE QUANTITATIVE LITERATURE REVIEW 
Reviewing the quantitative literature demonstrated findings from most of the world 
as the studies were conducted in Asia, Europe, North and South America, and 
Australia. This indicates that weight changes as a side effect of cancer treatment are 
a worldwide issue for women with breast cancer. Although the studies report 
divergent findings and disagree concerning the amount and patterns of changes, it is 
demonstrated that some women suffer from severe changes that need further 
investigation.   
Although several studies have investigated changes in weight involving different 
measure points, cut-offs, etc., only few studies have depicted changes in lean or 
adipose tissue relevant to the women’s health. Research has mainly focussed on 
weight gain as a contributing factor for recurrence and decreased survival among 
women treated for breast cancer. However, weight variations > 5 % are found to be 
a prognostic factor for decreased survival in breast cancer (35). In addition, a 
relative weight loss of 2.4 % is also found to influence the survival rate among a 
mixed group of cancer patients, including women with breast cancer (70). In both 
studies, women with stage I-IV breast cancer participated. Stage IV breast cancer is 
characterised by distant metastases and thus a severe prognosis that may have 
influenced the findings.  
The findings reveal several contradictions, and it seems that further investigations 
are needed at least for six to 12 months following diagnosis to examine whether the 
changes are overestimated as claimed by Ingram et al. (57). Besides, recognising 
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needs and providing comfort for women exposed to distressing side effects 
associated with cancer treatment demand further investigation of how this body 
change is experienced. 
3.3. THE EXPERIENCES OF CHANGES IN WEIGHT AND BODY 
SHAPE 
The literature search was conducted in three databases but only six studies appeared 
relevant for the topic under investigation. The literature review revealed that 
although weight changes may influence women’s self-esteem and quality of life 
(56), their experiences of their altered bodies seem to be inadequately explored.  
3.3.1. DESIGNS, DATA COLLECTION AND FINDINGS 
The six studies used data from individual interviews (71-74) and focus groups 
(71,75,76). The sample size of individual interviews consisted of 11 (72), 12 (73), 
15 (71), and 20 women (74). The women in the interview studies were mainly 
Caucasian, whereas the women in the focus group studies by Halbert et al. (75) and 
Weathers et al. (75) included African-American women. This group of women was 
claimed to be more exposed to overweight and obesity than Caucasian women. 
However, as the fat epidemic is spreading worldwide - from USA to Europe and 
now also appearing in Asian countries (77,78) - the breast cancer incidence is 
expected to be influenced in general (79) and to demand attention to weight changes 
among all ethnicities. The studies from the quantitative literature review covered 
four continents and disclosed a variation in weight changes over time. The studies in 
the qualitative review originate from USA and Canada. The experience of changes 
in weight and body composition has thus not been given the same attention as the 
factual changes. This may be essential for a caring practice that involves knowledge 
and understanding based on natural as well as human and social sciences (14).  
Reviewing the quantitative literature, weight changes fluctuated over time and 
measurements were undertaken from months to years. The studies reviewed for the 
qualitative phase are conducted during different time spans after diagnosis and apply 
different analytical methods. Maley et al. (71) included women more than one year 
from diagnosis and analysed their interviews with constant comparative methods. In 
a transparent research process, they showed how the perception of body weight 
changes moved between vulnerability and control, stress and living well, uncertainty 
and confidence (71).  
Halbert et al. (75) and Weathers et al. (76) illustrated how weight changes resulted 
in psychological stress and concerns about health. Weight changes appeared 
unexpected, and weight gain and weight loss could promote discomfort. Although 
weight loss could be perceived as an illness, it might induce a positive body 
perception, if the women had been heavy before the diagnosis. These qualitative 
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data were obtained from focus groups, and data were collected after completed 
cancer treatment less than five years and more than five years from diagnosis. The 
authors claimed a grounded theory approach with data analysed by constant 
comparative methods in one study (75), and the other study analysed data by a 
transactional model of stress and coping (76). However, the findings were described 
with brief textual quotes indicating a basic step in the analysis which does not seem 
to be performed on a theoretical level (75,76). It was unclear how 34 women 
participated in ten focus groups (75), and how 16 women were involved in focus 
groups to explore data from questionnaires (76). Given the delimited literature 
addressing the experiences of weight changes, these two studies may - despite their 
weaknesses - provide a sense of what may be at stake for these women. 
In the studies by Brunet (72) and Thomas-MacLean (73), a transparent data analysis 
was described from a phenomenological point of view (72,73). According to Brunet 
et al., weight gain was perceived as a visible change that affected the overall self-
worth and induced negative emotions about not being able to control weight. The 
interview referred to experiences from two to 31 years from diagnosis (72). In the 
study by Thomas Maclean et al., weight loss was interpreted as an illness whereas 
weight gain was associated with a feeling of undergoing a treatment without end. 
These findings were related to experiences from one to 24 years after completed 
treatment (73). One study used semi-structured interviews that contained questions 
about well-known side effects from cancer treatment. Weight changes appeared as 
unexpected and distressing, and changed weight distribution was a concern for the 
women. None of these experiences were unfolded as most of the data were 
transformed into numbers (74).  
In general, the studies revealed that the women wanted to gain control over their 
health, which was deeply associated with both weight gain and weight loss 
(71,72,75). Related to disease and fear of possible death, the changes were 
associated with existential treats (72-75). The body weight changes were visible for 
the women themselves and others and had to be camouflaged by clothes (72,75). 
Besides appearing unexpectedly, the changes could be a constant reminder of the 
breast cancer diagnosis (76) and induce a feeling of never-ending treatment (73,75). 
In some cases, the changes were expressed as ‘rather die than look like this’ (75): p. 
184). Although these changes seem to inflict women broadly, one study revealed 
that professionals did not take weight gain seriously in outpatient follow-up visits 
(71).  
3.3.2. SUMMARY OF THE QUALITATIVE LITERATURE REVIEW 
These findings demonstrate that the changes may be intertwined in a field of bodily 
changes and emotions that greatly influence the women. Although changes in body 
and weight were central elements in the studies, the participants were included from 
one to 31 years from diagnosis. As the influence of the changes may be relative and 
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dynamic during the cancer trajectory, findings from these studies can provide a 
sense of what may be at stake for these women during this varying time span.  
However, it may be questioned whether these findings can provide specific and 
individualised support to the individual women during 12 months following 
diagnosis where weight changes seem to be increasing. Furthermore, the influence 
of changed body distribution was not explored. Valuable information about the 
women’s experiences of changed body distribution may thus be missing.  
Finally, losing one’s pre-cancer being or parts of one’s identity is reported in other 
studies associated with the consequences of cancer treatment such as loss of breast 
and hair (52-54), but is not specifically linked to changes in weight and body shape. 
Although Halbert et al. (75) reported an average weight gain of eight kilos among 47 
% of 34 women, and Cappiello et al. (74) reported that half of the interviewed 
women (n = 20) experienced persistent weight gain, the literature review did not 
depict how the influence of changes of the women’s perception of body and self 
could be associated with factual changes.  
3.3.3. SUMMARISING THE LITERATURE 
Changes in weight and body composition seem to be a complex multi-factorial 
phenomenon associated with bodily changes and long-term survival which 
influences quality of life, body perception, and self-esteem. The phenomenon of 
changes in weight and body composition is observable, measurable, felt, and sensed. 
Research on the factual changes caused by breast cancer treatment is diverse and 
sometimes contradictory. It seems that changes fluctuate over time and as a 
minimum have to be examined until one year following diagnosis. It is also argued 
that the problem of bodily changes may be overestimated. However, we cannot 
determine whether weight changes are over- or underestimated without taking the 
women’s experiences of their altered body into account.  
Current research on the experiences of weight changes on body perception is limited 
and reports experiences that cover a long time span. How these changes influence 
women’s perception of body and self and the essential meaning of the bodily 
changes during and after initial cancer treatment short-term to approx. one year 
following treatment seems to be insufficiently explored and needs further 
investigation. Without understanding the essential meaning of the changes, health 
professionals risk ignoring a demanding discomfort that may influence the everyday 
life of women whose bodies have changed and are no longer silent and taken for 
granted.  
Given the adverse effects of weight changes on breast cancer survival and the 
general health as well as the women’s experiences, it is vital that health staff pays 
attention to how these serious consequences during and after adjuvant therapy are a 
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concern for the women as unified body-subjects. In addition to studies on factual 
changes in weight and body composition and the experiences of changes, the 
development of new knowledge of this complex topic requires further exploration.  
Separate research on factual bodily changes or research about the experiences of 
bodily changes does not seem to provide a sufficient understanding of the 
relationship between the two perspectives. Neither does the research ensure a 
perspective that takes the unified body-subject into account. Thus, there is a risk of 
employing a dualistic understanding of a separate body and mind, which is 
inconsistent with fundamental assumptions in nursing. On the other hand, combining 
quantitative and qualitative methods and integrating findings may provide insight 
into the ways in which bodily changes influence the women’s experiences in a more 
profound way. 
3.4. PURPOSE AND RESEARCH QUESTIONS 
The purpose of this study is to investigate the complexity of changes in weight and 
body composition among women during and after adjuvant antineoplastic treatment 
for breast cancer and to increase our knowledge on how changes in weight and body 
composition influence women’s experience of their body and self as unified body-
subjects. This leads to the following research questions: 
 
 What characterises changes in weight and body composition during 18 
month from diagnosis among women during and after adjuvant 
anitneoplastic treatment for breast cancer? 
 
 How is the risk of weight changes associated with current adjuvant 
antineoplastic treatment? 
 
 What is the essential meaning of the phenomenon of changes in weight and 
body shape among women treated for breast cancer? 
 
 How do these changes influence the women’s perception of body and self? 
 
 How can an understanding of the women as unified body-subjects expand 
our knowledge of factual bodily changes and their influence on the 
women’s perception of body and self? 
The above mentioned research questions indicate the fundamental assumption that 
bodily changes cannot be understood without considering the individual’s self-
understanding and the meaning of suffering (13,15,16).  This is consistent with a 
caring practice, where understanding the experience of an injured body in a state of 
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illness demands application of knowledge based on natural, human and social 
sciences (14).  
As it is not the body as an object or the subject’s experience, but rather the 
inseparable body-subject which must be taken into account, understanding complex 
human phenomena may demand complex research processes and explication of an 
overriding/underlying philosophy that acknowledges a unified body. In addition to 
clarifying research processes, the researchers are obliged to reflecting on and 
articulating these fundamental assumptions for their study (4).  
This study demands a basic attitude that takes the unified body-subject into account. 
In addition, to overcome dualism when focussing on physical changes and the 
patient’s experiences, the study must also be philosophically driven by a 
fundamental wish to understand the wholeness of bodily changes and the experience 
hereof. Framing this study with the philosophy of existential phenomenology 
acknowledges a unified body. This philosophy transcends dualism on the 
ontological and epistemological level and points towards a mixed methods research 
design that provides opportunity for this transcendence.  
The next chapter elaborates on the philosophical perspective in existential 
phenomenology as an overriding framework and guidance for obtaining a 
phenomenological attitude.  
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CHAPTER 4. PHILOSOPHICAL 
PERSPECTIVE 
In this study, fundamental assumptions on the ontological, epistemological, and 
methodological levels are unified by existential phenomenology as developed by 
Maurice Merleau-Ponty. In this chapter, the philosophical perspective is presented 
and link between the philosophy, the mixed methods methodology and fundamental 
assumption in nursing are provided, followed by a guidance for obtaining a 
phenomenological attitude.   
4.1. EXISTENTIAL PHENOMENOLOGY AS AN OVERRIDING 
FRAMEWORK 
Phenomenology is described as ontology and epistemology, an approach, and a 
method (80,81). It is also described as a scientific lifeworld approach that can serve 
as a methodological tool in revealing knowledge embedded in an intersubjective 
world that is unique to each human being and, at the same time, shared (15). From 
the perspective of Merleau-Ponty, the gap between the body as an object and the 
perceiving subject is changed into a unifying understanding of the lived body that 
aims at overcoming the dualistic mind-body notion (17,18). Being a body rather than 
having a body is consistent with a nursing philosophy focussing on the unified, 
inseparable body. Thus, existential phenomenology provides fundamental values 
and a manner of thinking that spans the philosophical and methodological levels.  
To address patients’ experience of health-related bodily changes within a frame of 
existential phenomenology, the human being is understood as essentially embodied, 
an inseparable body-subject (15,82,83). The body: 
[…] is a physical thing, an object that can be weighed, measured 
and described using purely physical or naturalistic terms. But it is 
also the source of subjective feelings, perceptions and sensations; it 
is the seat of subjectivity, the place where consciousness occurs. As 
such the body is a subject-object, a unique being that can be 
experienced both from a first and a third person point of view (83, 
p.37). 
The first person point of view may in this case be understood as the immediate 
experience of bodily perceptions and embodied activities as they appear in the 
consciousness.  This is a first-hand experience that may provide an account of what 
it is to suffer from a particular illness. This perspective can for example be explored 
by means of qualitative methods. The third person point of view refers to the body 
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as an object that can be observed and examined in a detached manner. This 
perspective may be investigated by means of quantitative methods.  
Focussing on physical and biomedical changes and paying attention to the patients’ 
experiences and environment by application of multiple theories and methods is in 
accordance with the inclusion of different mental models (3,4,14). Bodily 
perceptions contain meanings and due to the inseparable body-subject, changes in 
body can lead to far-reaching changes in one’s sense of self as everything exists 
through the body (83). Illness and suffering are thus experienced as a disruption of 
previously lived experiences, including bodily alienations, altered experiences of 
time and space, challenges to self-identity and integrity, etc. When perceiving 
patients as body- subjects, it is therefore not sufficient to examine the physical body 
and the subjective experience side by side, which leads us further into the realm of 
existential phenomenology. 
The thoughts of Merleau-Ponty regarding the unified body-subject and how being in 
the world may appear for the perceiving subject are unfolded. This investigation 
provides the basis for understanding how existential phenomenology may direct 
values and tools for reflection throughout the study, focussing on the influence on 
body and self-perception caused by changes in weight and body composition. The 
following section provides an understanding of how Merleau-Ponty overcomes 
dualism by unifying idealism and realism and by combining Husserl’s epistemology 
with Heidegger’s ontology.  
4.1.1.  ‘BEING-IN-THE-WORLD-AS-IT-APPEAR-FOR-US’ 
Building on the thoughts of Husserl and Heidegger, Merleau-Ponty strives to 
overcome the dualism between body and mind inherited from Descartes. Merleau-
Ponty acknowledges that human beings exist as biological bodies (Körper), which, 
in some cases can be identified as objects. However, his concern is the lived body 
(Leib) and the human being as a historical person engaged and living in a shared 
world, a meaningful community with other persons.  
Acknowledging that phenomenology is empirically driven, Merleau-Ponty argues 
that the world exists as a fact, representing real objects. However, the world exists 
for us, which means that the world consists of intersubjectively constructed 
meanings. Merleau-Ponty also acknowledges scientific knowledge, but discusses 
‘whether it is entitled to deny or rule as illusory all forms of inquiry that do not start 
out from measurements and comparisons’ (84, pp.34-35). Within this form of 
science important aspects of reality that are manifest within the perceived world risk 
being overlooked (84). To explore existential dimensions perceived by human 
beings in the lifeworld, Merleau-Ponty suggests phenomenology as a science that 
links realism and idealism. From this perspective it seems that Merleau-Ponty avoids 
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‘either or’ and highlight ‘both and’ in what is claimed to be a realist stance, a way of 
‘being-in-the-world’.  
This realist stance draws both on empiricism, logical positivism and rationalism (84) 
as Merleau-Ponty stresses that things are not to be understood as existing solely in 
themselves, nor are they reduced to mere aspects of the subject’s conceptual world 
(18). In other words, ‘being-in-the-world’ or being embodied means that all 
knowledge or ideas derive from experiencing ‘the-world-in-itself’. This world 
becomes innate in the mind, ‘the-world-for-us’, and by combining ontology with 
epistemology, as a third option in existential phenomenology, ‘the-world-in-itself-
for-us’ appears. The real world exists, but it exists for the individual human being in 
a perceiving act – i.e. it is subjective and constructed (Figure 1).  
Figure 1. Existential phenomenology as a realist stance  
     
‘The-world-in-it-self’
Knowledge a posteriori with sense perception 
as the source of knowledge. The reality is 
confirmed  through experiences and experiments. 
Empirism
Phenomenology - ontological focus
– the nature of existence
Heidegger
“Dasein” – the meaning of being in the world. 
Tied to temporality it is not possible to bracket pre-
understanding. Lived experiences are interpreted.
Phenomenology - epistemological  focus
– theory of knowledge
Husserl
“Zu dem sachen selbst”. 
By eidetic reduction and pure consciousness pure 
description of a phenomenon is possible.
Existential phenomenology
Knowledge is embodied obtained through perception
The existing world with multiple meanings –A realist stance
‘The-world-in-itself-for-us’
‘The-world-for-us’ 
Knowledge a priori through use of 
reason and independent of senses. 
The reality is what appears in mind. 
Rationalism
 
Combining the ontological and epistemological levels in existential phenomenology, 
the women in this study are consequently considered as persons and human beings 
who experience physical changes and give meaning to these changes, 
psychologically, spiritually, and socially. Being a unity consisting of a biological, 
physical body and an animate organism with mental acts and processes, the 
perception of the body and world changes if the physical body changes.  
In this study, it was taken for granted that knowledge is not purely objective, but 
always contains subjective elements. All knowledge in the world, even scientific 
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knowledge, is built upon the world as directly experienced from human beings’ 
point of view. Knowledge is embodied when we perceive the world around us 
through our senses. Although knowledge derives from the empirical world, it is not 
identical with the real world. Rather, it is a map of a landscape and thus constructed 
by the researcher. 
Depending on the context, phenomena may change, and thus the phenomenal 
‘world-in-itself-for-us’ can never be exhaustively described. When all knowledge is 
based on the world as directly experienced from human beings’ points of view, our 
senses can teach us to see the world by returning to the things themselves, ‘zu den 
Sachen selbst’ (84, p.53). Revealing factual bodily changes from the women’s point 
of view may thus be a question of ‘the-world-in-itself-for-them’.   
4.1.2. THE BODY IN THE WORLD 
According to Merleau-Ponty, the real world is perceived through the body. 
Searching for this third way of ‘being-in-the-world’ in the attempt to overcome 
dualism, he introduces ‘one’s own body’ (84). This refers to the lived body or the 
unified, inseparable body-subject that functions as an anchor in an already existing 
world, the natural setting of and field for thoughts and explicit perceptions (20). 
‘Being-in-the-world’ - or embodiment - is thus a central concept that acknowledges 
human beings physical ties to the world. Human beings think, see, hear, feel and are 
conscious through their body’s interaction with the world. Being an object and 
subject, nature and culture in an always dialectic relationship, the body-subject 
perceives the world through perception, language, emotion and movement in time 
and space, creating pre-reflective embodied knowledge (20).  
It is important to note that humans not only see, hear, feel etc. They see the sunset; 
hear music and voices, love a beloved, etc. It is through our senses that we perceive 
the world, and it is the body that embraces and constitutes the world (84). Thus, all 
perceived phenomena and meanings are interconnected as flesh in a mutual relation 
with the world, culture and the environment. This interconnectedness which also 
includes the perception of bodily changes, serves as a horizon that is always 
implicitly present as shifting backgrounds for what stands out as figures or the 
significant element in a situation (20).  
According to Merleau-Ponty the body comprises two distinct layers that always 
infiltrate each other. Normally the two layers adjust to each other effortlessly but in 
illness this effortless connection may be hindered. The one layer refers to the 
habitual body, which is a general and pre-reflexive existence, situated in taken-for- 
granted everyday living. The second layer is the present body that refers to a 
reflexive existence. The habitual body acts as a reference for the present body.  With 
the present body in focus for the unified body-subject, the past, future and present 
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are tied together (20, pp.84, 287. Thus past and future exist for the present and as the 
present always exists as ‘nows’ the meaning of bodily changes are infinite.   
Acknowledging that the human being exists as a biological body (Körper), the body 
may be identified as an object by others and by the perceiving subject. The 
perceiving subject is further more a historical person engaged and living in a shared 
world, a meaningful community with other persons. As it is the body-subject that 
perceives, if the biological body changes, so does that person’s perception of body 
and world. Thus, the meaning of illness and suffering can never be understood 
without reference to the surroundings and the life project of the body-subject (20, 
pp.312-18, 346).  
As existential phenomenology is claimed to be a science of phenomena (15), 
phenomenology as methodology and method also demands considerations.  
4.2. PHENOMENOLOGY: A METHODOLOGY AND METHOD 
Methodology is prior to method as methodology points towards the concrete 
methods that are to be used and implicitly contains the researcher’s philosophical 
perspective, which is described in the former sections. Empirically driven, 
examining the life-world as a tacit ground for science, phenomenology is 
acknowledged as a methodology and a scientific life-world approach that can reveal 
knowledge embedded in an inter-subjective world, unique for every human being 
and at the same time shared (15).  
Phenomenology is not restricted by a certain method. To reveal essences and 
explore meanings as they unfold for human beings, some conditions for obtaining 
scientific rigor have been described (15,80,85). Understanding the person's 
experience of the world and returning to the things themselves, the research methods 
are the methods of philosophy, accessible through a phenomenological method or 
attitude.  
Going ‘zu den Sachen selbst’ without preconceived expectations and 
presuppositions, phenomenological investigations are looking for how the 
phenomenon is established or takes shapes and appears in typical structures or 
essentials and relationships (80). According to Merleau-Ponty, we shall consider 
things naively, try to forget what we find natural because of their familiarity (84, 
p.61), and ‘look at ourselves in an un-familiar gaze’ (84, p.68). However, even 
though Merleau-Ponty wants to return to the prior knowledge, pure description is 
not possible because during the process an immediate interpretation takes place. To 
understand how this structure manifest requires a focus on the relationship between 
subject (researcher) and object (that which is being studied) a presentation of two 
essential concepts - phenomenological intentionality and reduction - are needed.  
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Intentionality refers to the directedness of consciousness towards objects or events, 
to something in an inseparable connection with the world. As people are ‘always in 
move […] in a coming-into-being of possibilities’ (17,p.286), the world is 
continuously transforming and thus infinite. What appears meaningful in this world 
emerges in an interaction between figure and background in the life-world context 
(15).  
In this study, the intention is to put into words the essential meaning of factual 
changes in weight and body composition that may be tacit, pre-reflexive and 
embodied. Thus the researcher may be in a double position. On the one hand, the 
researcher endeavours to reveal what is essential for the women in a shift between 
figure and background from the women’s perspectives. On the other hand, the 
researcher has to be aware of own intentionality, in the attempt to go ‘zu den Sachen 
selbst’ through phenomenological reflections.  
Reduction is concerned with phenomenological reflection that aims to bring 
different perspectives into view (81). To perform phenomenological reduction, the 
researcher must recognise that she influences the situation with her pre-
understanding and her research design. Instead of bracketing one’s natural attitude, 
bridling is suggested as a means of attaining phenomenological reduction (15,16). 
Bridling means to be aware of our natural attitude and replace it by a 
phenomenological attitude by questioning a presumed reality in data gathering as 
well as in the analysis and interpretation of data.  
In summary, phenomenology is a science that may explore existential dimensions 
perceived by human beings in the lifeworld, and for scientific reasons some 
requirements must be met. Scientific rigor and perpetual, critical self-reflection must 
be obtained during the research processes, irrespectively of whether the researcher is 
dealing with quantitative or qualitative data. This critical self-reflection is performed 
through a phenomenological attitude. 
4.2.1. PHENOMENOLOGICAL ATTITUDE 
Existential phenomenology as a science is performed through perpetual critical self- 
reflection and focuses on how the reality is presented to us through experience 
without taking anything for granted. Thus, the research process must take the natural 
attitude into account, the taken-for-granted assumptions. As researchers we should 
position ourselves in such a way as to allow things to reveal themselves to us as 
phenomena, ‘that which shows itself in itself’ (15, p.32). To provide a direct 
description of experiences without psychological or causal explanation, researchers 
must be aware of their own dogmatic attitude towards reality as well as their 
constitutive contribution to the reality given (20, pp. xxiv, xxix).  
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The phenomenological reflections of this study demand that the researchers adopt a 
phenomenological attitude, bridling one’s taken-for-granted assumptions (86). Thus, 
bridling is a means of scrutinising the researchers’ involvement with the investigated 
phenomenon, not to suspend this involvement.  
The first step is to recognise how researchers enter into the research situation with a 
specific pre-understanding and research design, and thus how they may influence the 
situation through data collection, analysis, and interpretation (2,15,87). Practicing a 
phenomenological attitude may thus imply a consideration of how one can position 
oneself and apply the multiple methods used in a trustworthy and transparent way. 
Being engaged as a researcher with data collection and being acquainted with the 
women behind the measurements and statements provided a unique opportunity to 
remain faithful and faithless throughout the process (88). However, to maintain such 
phenomenological attitude it is important to scrutinise one’s pre-understanding.   
4.2.2. PRE-UNDERSTANDING 
The researcher’s pre-understanding may prevent her from exploring what seems 
familiar or contributes to flavouring the data by making her look for supportive 
trends in datasets and interview statements. Therefore, I have conducted an 
investigation of my own pre-understanding. First, literature studies, discussions with 
colleagues in general, nurses at the outpatient clinic, breast cancer survivors, and 
friends became part of my pre-understanding. On the one hand, the literature and 
discussions confirmed that weight changes were perceived as a problem that was 
relevant to investigate. On the other hand, weight changes were considered as a 
minor problem related to a normal female perspective on the body, a wish to be 
attractive, and thus a matter of vanity. Another important issue was the contradiction 
between weight gain as a side effect of cancer treatment and lifestyle diseases 
caused by excess body fat. These serious implications and lack of understanding of 
the women’s perspective urged me to commence the project. 
Conducting a focus group (Paper 1) in preparation of the individual interviews 
revealed how the women struggled with changes in weight and body shape. Their 
thoughts, feelings, and opinions became part of my pre-understanding. This became 
obvious when I was interviewed by a clinical nurse consultant before conducting the 
individual interviews. This interview revealed that my driving force in researching 
the women’s experiences was a feeling of solidarity, a wish to give the women a 
voice and acknowledge their concerns. Conducting the first individual interview, I 
was hit by a discouraging feeling, as it seemed to reveal nothing of importance. 
Reflecting on this I acknowledged that this could be a sign that I had fallen into the 
familiar trap: the taken-for-granted. My solidarity with the women and attempt not 
to downplay their feelings might prevent me from maintaining a phenomenological 
attitude. This insight emphasised the need for me to be more open, to wonder, and to 
be more conscious of applying a ‘phenomenological method or attitude’. In the 
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following interviews, this remained a challenge, but I strove to stay more open and 
curious, and I consequently caught a glimpse of what might be at stake.   
In this chapter, fundamental ideas which often serve as an orientation to the world 
when unarticulated and silent are explicated for research purposes. With existential 
phenomenology as an overriding philosophical perspective that prevails, the next 
section will provide the link to the mixed methods design used in this study, 
including descriptions of the further methodical steps. 
4.2.3. THE LINK BETWEEN EXISTENTIAL PHENOMENOLOGY AND 
MIXED METHODS 
Existential phenomenology is suggested to be an overriding philosophy for health 
care practice (19,82,83). Taking the stance of existential phenomenology also at the 
methodological level, including guidance by reflective life-world research, requires 
methods that follow the attempt to explore the unified body-subject. Thus, the 
methods must contribute to a deeper understanding of the women as unified body-
subjects and expand our knowledge of the relationship between factual bodily 
changes and their influence on the women’s perception of body and self. For this 
purpose, the attention is turned toward mixed methods in the next chapter, but first 
the link between mixed methods and the philosophical level will be provided. 
In mixed methods literature, pragmatism is recommended as a philosophical stance 
for mixed methods studies because it allows the gathering of all types of data in 
order to best answer the research question (5). However, combining a framework 
that encompasses the human being as a unified body-subject with mixed methods 
may also be plausible by bringing in critical realism, which is another philosophical 
stance discussed in mixed methods literature.  
In a former section it is shown how Merleau-Ponty combines Husserl’s 
epistemology with Heidegger’s ontology and thus idealism and realism in his ‘third 
way’, although pure realism and idealism/constructivism traditionally are said to be 
incompatible (Figure 1). This perspective is also prominent in critical realism. 
Integrating realist ontology with constructivist epistemology, critical realism is 
consequently claimed to be compatible with methodological characteristics of both 
qualitative and quantitative research (3,89,90). Thus, talking about alternative 
mental models in dialogue, Greene argues that critical realism can constitute a 
productive stance for mixed methods studies (89).  
There seems to be some ontological and epistemological agreement between critical 
realism and phenomenology, which may suffice as the link to mixed methods 
methodology. Agreeing with existential phenomenology on the existence of a 
physical world independent of consciousness and the meaning of experiences 
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constructed by the individual, a critical realist perspective also advocates a moderate 
position between realism and idealism/constructivism (3,89,90).   
Risjord (9) is a proponent of this moderate position for nursing enquiry and health 
professionals. In accordance with Merleau-Ponty, Risjord stresses that reality 
consists of meaningful objects and events, not multiple realities, because ‘there is a 
difference between a person’s health and his or her experience of health’ (9, p.205). 
What is multiple is not reality, but the significance of events and experiences for the 
human being (9). The exposition of existential phenomenology as an overriding 
frame for the study - by combining realism and idealism on the ontological and 
epistemological levels - thus gives rise to a perspective on the unified body-subject.  
In this study, fundamental assumptions on the ontological, epistemological, and 
methodological levels are unified by existential phenomenology as developed by 
Merleau-Ponty. In this chapter, the philosophical perspective is presented and links 
between the philosophical perspective, mixed methods methodology, and 
fundamental assumption in nursing are provided. Finally, guidance for obtaining a 
phenomenological attitude is elaborated.    
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CHAPTER 5. MIXED METHODS 
When complex research processes are required to capture the complexity of human 
phenomena, there has been an emerging focus on conducting mixed methods studies 
in health sciences and other professional domains (3,4,91,92). In this chapter ‘mixed 
methods’ for this study are described and applied to provide knowledge of changes 
in weight and body composition related to the unified body, essential for nursing 
practice. 
5.1. MIXED METHODS 
Mixed methods is still in a stage of development (93) and considered as an 
innovative process that draws on the strengths and overcomes the limitations of 
qualitative and quantitative research processes (4,91,94,95). By using a mixed 
methods design it is possible to integrate qualitative and quantitative research 
questions, methods, techniques and findings with a view to better understand a 
phenomenon and measure its magnitude, trends, causes and effects (89,93,95,96, 
p.56). Thus, it is not sufficient to use different forms of data, methods etc. To 
provide a comprehensive understanding of the phenomenon under study, the 
research process must involve some degree of integration (91,97).  
There are various ways to represent integration in a study: in creating the design, in 
data collection, in data analysis, or in a discussion or conclusion section at the end of 
a study (4). The objective behind the integration of qualitative and quantitative 
methods is to reveal complementary aspects of the phenomenon in question and to 
elaborate, expand, and reveal nuances hereof (91,94). In addition to being a means 
of bridging different parts of a study, integration thus provides synergy and adds 
value to a mixed methods study. In our case, integrating throughout the study 
process aims to expand the understanding of weight changes among women during 
and after adjuvant treatment for breast cancer, contributing to a deeper 
understanding of the meaning of factual changes.  
Independently of design, the study must basically satisfy three conditions: 
Qualitative and quantitative methods must be combined; the methods must be used 
rigorously; the study must involve integration of data collection and/or data analysis 
and/or results (4,91,95). Integration can take several forms such as merging, 
explaining, building, and embedding, depending on the type of design (4, p.7). To 
claim a mixed methods design, integration on different levels during the research 
process is thus essential. According to Fetters and Freshwater, the integration of 
qualitative and quantitative research procedure and data can be implemented at the 
design, methods, interpretation, and reporting levels of research (91, p.2135). 
Integration does not necessarily take place on all these levels.   
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Depending on the research question and clinical conditions for empirical studies, it 
is possible to use various combinations of sequential and convergent approaches and 
combine them in multistage mixed methods designs (91): p. 2137). In the following 
sections, the mixed methods design applied in this work will be elaborated in 
relation to feasibility in a clinical practice and time limits for a PhD project. 
5.2. DESIGN AND INTEGRATION ON THE DESIGN LEVEL 
Mixed methods designs consist of three basic designs: a convergent design where 
data collection takes place concurrently, an explanatory sequential design where the 
analysis of quantitative data collection informs the qualitative phase, and finally an 
exploratory, sequential design where analysis of qualitative data informs the 
quantitative phase (4,5,91). For example, in convergent designs, both datasets are 
analysed independently, and the results are merged for the purpose of comparing or 
validating. Explanatory sequential designs aim to explain, elaborate, and expand the 
understanding of a complex phenomenon and usually, findings from the quantitative 
phase are built into the qualitative phase (4,5). If applying one of these basic designs 
is insufficient, combinations of basic designs can be included in a multistage mixed 
methods framework defined as two or more phases in convergent design and three 
or more when sequential designs are involved.   
Initially, an explanatory, sequential design was planned for this study. However, as 
the data collection for the quantitative phase took place longitudinally and required 
measurements over 18 months from inclusion, the design had to use a convergent 
design as well.  Thus, the design was not wholly convergent or sequential, but aimed 
to provide depth and breadth, displaying a multistage design in two stages and a 
total of three phases (Figure 2).  Following a convergent design, the quantitative 
data collection (Study I) proceeded alongside the development of a focus group-
based interview guide in preparation of conducting individual interviews (Study II). 
Subsequently, the study followed a sequential design in which participants were 
selected for individual interviews on the basis of preliminary results from the 
quantitative component, and findings from the focus group were built into the 
thematic and dynamic dimensions of the individual interviews.  
The convergent design thus consisted of three phases. One phase was associated 
with Study I, and two phases were associated with Study II as displayed in the two 
figures (Figures 2 and 3). In the three phases, a sequential component was applied. 
Application of three phases and the use of convergent and sequential design justify 
the multistage design. The models of the mixed methods design and processes show 
that integration takes place at the study design level. 
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Figure 2. Mixed methods study design  
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Creating a study design is thus a process in progression that evolves from simple to 
more complex figures (4). Figure 2 displays the results of the final project with the 
contents of each stage visualised except for the development of the interview guide 
that is explained in depth in the methods section (Chapter 6). Acknowledging that a 
timeline may provide additional understanding of the study course, a figure showing 
the study process was added (Figure 3). In this figure, the integration on different 
levels during the study is visualised and described by the concepts: connecting, 
building, merging, and joint display.  In addition to integration on the study design 
level, Fetters, Curry and Creswell (91) consider integration on the methods level and 
finally on the interpretation and reporting levels. The integration in this study is 
further explained and discussed below. 
5.3. INTEGRATION ON THE METHODS LEVEL    
The integration on the method level follows the design and may take place by 
building, connecting and merging quantitative and qualitative data collection and the 
subsequent analysis (91). As the design in this study was partly convergent and 
partly explanatory sequential, data collection was integrated through connecting and 
building (Figure 3). 
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Figure 3. The study process 
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Connecting occurs when one type of data links with another through sampling. 
Building occurs when results from one data collection procedure informs the data 
collection approach of another procedure. Finally, merging occurs when the 
quantitative and qualitative databases are brought together for analysis (91).  
According to the literature review, changes in weight and body composition were 
particularly reported after completed chemotherapy and at least 12 months following 
diagnosis. In the present study, we wanted to extend this limit to 18 months to 
follow the changes further on. To deal with the time limits of a PhD study we 
therefore decided to proceed with the qualitative component before the quantitative 
data analysis was complete and thus also applied a partly convergent design. 
Following a partly sequential design, a preliminary analysis of the quantitative data 
informed eligible women of the qualitative interview study (91,94). This ensured a 
purposeful sampling for the qualitative interview that displayed various experiences 
regarding their weight and thus also represented the quantitative cohort, which is 
further described in the methods chapter. Study II is thus connected with Study I 
(integrated) on the sample level (Figures 2 and 3).   
In a convergent design, samples do not need to be linked to each other, as data 
collection and analysis are carried out in parallel (91). In parallel with the 
quantitative data collection, women who had experienced changes in weight and 
body shape were invited to a focus group session (Study II, Phase 1). The purpose of 
the focus group was to provide content and form for an interview guide. The results 
from the focus group informed data collection of the individual interviews. Thus 
results from the focus group (Study II, Phase 1) were built (integrated) into the 
interview study (Study II, Phase 2).  As the study is a multistage mixed methods 
study, integration of findings appears later in the study process. This is explained in 
the next section.  
5.4. INTEGRATION AT THE INTERPRETATION AND REPORTING 
LEVELS 
Fetters, Curry and Creswell (91) introduce the stage approach to integration on the 
interpretation and reporting levels. The stage approach is used in multistage mixed 
methods. Using this approach, the results of each step are reported in stages as the 
data are analysed and published separately. The papers may briefly refer to each 
other. For convergent designs, a popular way to represent integration is in a 
discussion or conclusion section at the end of a study by arraying quantitative and 
qualitative findings in parallel (4). Another way of integration on this level is 
through joint displays. Using joint displays, data are integrated by bringing the data 
together in figures, tables, etc. to visualise new insight and generate new inferences. 
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Interpreting and reporting a multistage mixed methods study using a partly 
convergent, explanatory, sequential design bring these integration forms together. 
Initially, the results of each step are reported separately as the analysis was 
completed individually for each part of the study (Paper 1, Paper 2 and Paper 3). 
Paper 2 refers to Paper 1, but no connection is made in regard to Paper 3. However, 
Paper 4, the mixed methods paper, demonstrates how the phases of the whole study 
are integrated. In Paper 4, an integrative analysis/interpretation is structured around 
joint displays that give birth to new inferences. The assessment of how the 
quantitative and qualitative findings cohere can - according Fetters, Curry and 
Creswell (91) - lead to three outcomes. The integration can provide confirmation, 
expansion, or discordance. In the present study, expansion was sought as the aim 
was to elaborate, expand, and reveal nuances of complementary aspects of the 
phenomenon in question. Searching for expansion and complementarities through 
convergence and sequences provided breadth and depth. This is elaborated on in 
Paper 4. 
In summary, integration has taken place on several levels during this multistage 
mixed methods study, which provides a strong structure for the relationship between 
the various parts of the study and is consistent with the perspective of a unified 
body-subject. Combining a convergent design with an explanatory, sequential 
design in a multistage mixed methods design provided integration at the design 
level. At the methods level, data were connected through sampling and results from 
a focus group built into individual interviews. At the interpretation and reporting 
levels, every phase was initially analysed and reported separately. Findings were 
subsequently integrated through a unifying analysis and interpretation that was 
reported in a mixed methods paper.  
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CHAPTER 6. METHODS 
In this chapter, participants, data collections and analytical strategies applied in the 
two studies will be presented. In line with the phenomenological framework, the 
research questions are all explorative and point towards descriptions, which 
facilitate an open approach to gaining knowledge of bodily changes, including 
investigating subjective experiences. As the data must be analysed in their frame of 
logic (98), the studies are presented one by one. However, keeping quantitative data 
and qualitative data apart may be inconsistent with fundamental assumptions in 
nursing and existential phenomenology as the overall framework. To ensure a 
perspective on the unified body-subject, an integrative mixed methods interpretation 
is described in chapter 7. 
6.1. STUDY I: THE QUANTITATIVE COMPONENT – CHANGES IN 
WEIGHT AND BODY COMPOSITION 
Study I aimed to investigate characteristics of changes in weight and body 
composition during 18 months following diagnosis associated with current adjuvant 
antineoplastic treatment for breast cancer and to examine how the risk of weight 
changes are associated with this current treatment. The study is described in the 
paper ‘Changes in weight and body composition among women with breast cancer 
during and after adjuvant treatment – A prospective follow-up study’ (Paper 3). 
Providing quantitative findings regarding bodily changes associated with weight, 
Study I takes a third person perspective and focuses on the biological body (Körper) 
(83,84). Although the analysis of data was performed with statistical models 
consistent with the features of data in this study, a phenomenological attitude was 
adopted not to take anything for granted. Becoming part of my pre-understanding, 
the diverse findings from the literature review stimulated curiosity that was put into 
play during the data collection process. Collecting the majority of the data, my 
familiarity with the data became extensive and created an immediate perception of 
the findings. This sharpened my critical assessment of the statistical analysis. Thus, 
the taken-for-granted was continuously scrutinised during the analysis, and the 
interpretation of quantitative data was made with an open mind to allow unexpected 
findings to be reveal. 
6.1.1. PARTICIPANTS 
Participants in Study I were included consecutively when they attended the out-
patient clinic for information of adjuvant treatment after surgery. Before that, the 
staff at the surgery clinic gave all eligible women written information along with 
brief verbal information after the initial surgery (Appendix C). Eligibility was 
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initially surgery and subsequently allocation to adjuvant treatment for stage I-III 
breast cancer, following the Danish Breast Cancer Group’s recommendations for 
women at low or high risk of recurrence (43). In addition, the women should be able 
to read and speak Danish. Women with pacemakers or other electric devices 
implanted were not eligible. Furthermore, women suffering from psychiatric 
diseases in an unstable phase, cognitive impairment, severe co-morbidity, or other 
malign diseases, including disseminated breast cancer, were excluded. The clinical 
nurses at the out-patient clinic subsequently acted as gatekeepers and assessed the 
exclusion criteria in advance to minimise the inconvenience for these women.  
When attending the oncology out-patient clinic, the women were already acquainted 
with the study, and the gatekeepers asked the women permission for the PhD student 
to present the project verbally. The women who accepted were subsequently 
informed about the study and the requirements for gaining valid data (See appendix 
C). Some wanted to be enrolled immediately. Others wanted time for further 
reflection and were enrolled afterwards. All measures were planned for a regularly 
scheduled clinic visit for minimal inconvenience for the participants.  
A total of 192 women were screened. Of these, 61 women did not meet the inclusion 
criteria and 30 women who met the inclusion criteria refused to participate. Thus, 
101 women were included, of which six women were lost to follow-up after the first 
measurement (Figure 4).  
Figure 4. Consort diagram – inclusion process Study I 
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The eligible, but not included women were older than the included women and 
differed with regard to menopause status and cancer stage (Appendix D). The final 
sample of 95 women represented 75 % of the eligible women. All 95 women 
completed the study, and only five (1.3 %) data collections out of 380 scheduled 
appointments were missed. 
6.1.2. INSTRUMENTS AND DATA COLLECTION 
The study examined changes in weight and body composition through 
longitudinally, repeated measurements. Patient characteristics, selected lifestyle, and 
comorbidity factors were collected at baseline. Body composition data were 
collected repeatedly for 18 months. Clinical variables included menopause status, 
type of surgery, tumour stage, receptor status, histology, and adjuvant medication. 
Lifestyle included smoking and alcohol consumption, and comorbidity variables that 
might influence changes in weight and body composition were cardiovascular, 
muscular-skeletal, lung, and neurological diseases. These data were stored in 
EpiData prior to being subjected to analysis. Body composition data included age, 
weight, height, fat mass, fat free mass, total body water, and waist measurements.  
Data on changes in weight and body composition such as body fat mass, fat free 
mass, and total body water were measured by means of an bioelectrical impedance 
analysis on a Tanita BC-418 Segmental Body Composition Analyzer (selected 
standard body type) (99,100). The device was calibrated regularly, and a comparison 
with BioScan 920-II using supine measurements (wrist-ankle measurements) 
showed no significant difference in comparable variables (Appendix E). The data 
were obtained when the women attended the oncology outpatient clinic for treatment 
or follow-up with a time schedule of 6 months ± 2 months, four times in total. The 
data were stored in a Tanita database and transferred to Excel prior to being 
subjected to statistical analysis.  
Since relative weight changes are clinically more relevant than weight changes 
measured as a number of kilograms (34), a clinical cut-off with relative weight 
changes of ± 2.4 % was chosen (70). This limit takes diurnal variations into account 
(70) and is chosen as a reasonable way of assessing weight loss, stable weight, and 
weight gain.   
6.1.3. ANALYSIS 
For the sake of the analysis and to minimise subgroups, the variables were 
transferred into categorical variables in the final analysis. For comorbidity factors, 
the categories were ‘yes’ and ‘no’. Smoking and alcohol were displayed in two 
groups as current or non-smoker and alcohol consumption as less than seven units 
per week or more than seven units per week.  Clinical characteristics were chosen to 
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give an overview of the distribution of disease-related factors, leaving out 
medication doses as these followed existing recommendations.  
Baseline demographic and clinical characteristics were summarised using 
descriptive statistics, including mean, standard deviations and number of patients in 
the total sample and in subgroups. Fisher’s exact test was used to determine the 
distribution in the two subgroups except for age distribution that was estimated by 
t
2
-test (Chi
2
). Linear mixed models using time as a fixed effect and person as a 
random effect were applied to estimate patterns of changes in weight and body 
composition over time. The outcome measures for these models were weight, fat 
mass, fat free mass, total body water, and waist circumference, respectively. The 
flexibility of linear mixed models allows for handling of repeated measurements and 
missing observations within subjects (101).      
Associations between patient characteristics and weight changes from baseline to 18 
months were examined through logistic regression. Stratified into three weight 
categories – weight loss below 2.4 %, weight gain above 2.4 %, and stable weight 
between ± 2.4 % - descriptive statistics provided an overview of the distribution of 
weight and waist circumference. Odds ratios (OR) were estimated for weight gain 
versus stable weight and for weight loss versus stable weight with respect to the 
characteristics of interest. Thus, the calculated odds ratios quantify the relation 
between patient characteristics and weight loss or weight gain, respectively. 
Statistical analyses were performed using the statistical package Stata 13.1 
(StataCorp, Texas, USA). All P values reported in the analyses are two-sided values 
with a significance level of 0.05. 
6.2. STUDY II: THE QUALITATIVE COMPONENT – THE 
ESSENTIAL MEANING OF CHANGES IN WEIGHT AND BODY 
COMPOSITION 
Study II aimed to explore the essential meaning of the phenomenon of changes in 
weight and body shape among women treated for breast cancer and how the changes 
influence the women’s perception of body and self? The study is described in two 
papers. Paper 1: ‘Bridging the gap between interviewer and interviewee: developing 
an interview guide for individual interviews by means of a focus group’. Paper 2: 
‘The ambiguous transforming body – A phenomenological study of the meaning of 
weight changes among women treated for breast cancer’.  
Paper 1 demonstrates findings that followed the partly convergent design as data 
was collected alongside the quantitative data collection in Study I with no 
connections between the two samples. Inviting women experiencing changes in 
weight and body shape aimed to contribute in developing an interview guide and 
thus to prepare the next step: the individual interviews. Developing the interview 
guide contributed to theory development regarding the use of focus groups as a basis 
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for subsequent, individual interviews. To provide the reader with an understanding 
of the whole study process, findings from the focus group are described in this 
method chapter. 
Paper 2 illustrates how individual interviews aimed to explore the essential meaning 
of the phenomenon of changes in weight and body shape from the perspective of 
women belonging to the same cohort as Study I. Thus, a partly explanatory, 
sequential design was followed and the two studies (Studies I and II) became 
connected at sample level. The findings from this part are described in the findings 
section as they present the main findings of the qualitative part of the study. 
The focus group and the individual interviews in Study II take a first person 
perspective and focus on the lived body (Leib) (83,84). Being part of a mixed 
methods study, this qualitative component provided important knowledge of the 
experiences of bodily changes and their influence on the women’s perception of 
their body and self. In terms of lifeworld descriptions, this study thus provides an 
essential contribution to the final integration. 
6.3. DEVELOPING AN INTERVIEW GUIDE (PAPER 1) 
Studying people’s experiences and collecting qualitative data requires a basic 
familiarity with the topic and a language that bridges the gap between the researcher 
and the study participants (2). The findings on the women’s experiences were 
limited as described in the literature review. Although the papers contained quotes 
and thus gave insight into the women’s language, the findings were mainly 
described in unifying concepts or themes.  
A focus group may provide a platform for sharing and comparing experiences and 
opinions among the participants (102-106). Furthermore, discussions and 
interactions in a focus group may reveal important issues and provide insight into 
the interviewees’ language (107). Thus, a focus group was conducted to extend 
knowledge of the topic, the ‘what’, but also to further extend my familiarity with the 
‘how’. The focus group aimed to provide the thematic and dynamic dimensions of 
the subsequent interview guide and support a natural conversation in an everyday 
language during the interview (2).   
6.3.1. PARTICIPANTS, SETTING, AND DATA COLLECTION 
We anticipated that one group was sufficient to cover the core elements as the aim of 
the focus group was not primarily to generate research data, but to use the data and 
analysis process in the development of an interview guide. Purposeful selection of 
women aimed to ensure a balance between homogeneity and variation, allowing for 
contrasting opinions (104,108). A team leader at a rehabilitation centre gave 
potential participants from a group of women with breast cancer written information 
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of the mixed methods project and the aim of the focus group (Appendix F). The 
women were expected to have experienced changes in weight (gain or loss) and/or 
changes in their body shape. Seven women with perceived changes were interested 
in sharing their experiences.  
The team leader provided the women’s telephone numbers to the researcher who 
subsequently contacted the women and gave them verbal information. All seven 
women consented to participate.  As two of the women cancelled the appointment a 
few days before the scheduled day, the focus group was carried out with five 
participants, during spring 2013. These women demonstrated homogeneity and 
variation in age, treatment and body changes (Table 1).  
Table 1.  Participants, focus group 
Participant  
pseudonym  
Age  Treatment and 
year initiated 
Weight 
changes 
Comments  
Bea 62 Mastectomy, 
endocrine 
treatment 2006 
Gain  5-6 
kg 
 
Changed body 
composition to male 
figure. Feeling lack of 
control 
Joan 63 Lumpectomy, 
chemotherapy, 
radiotherapy, 
endocrine 
treatment 2008 
Gain  4-5 
kg 
 
No changes in body 
composition but overall 
weight gain 
Feeling lack of control 
Eliza 
 
62 Lumpectomy, 
chemotherapy, 
radio therapy, 
endocrine 
treatment 2008 
Gain 5 kg 
 
Weight gain on waist 
Feeling lack of control 
Anne 51 Lumpectomy, 
chemotherapy,  
radio therapy, 
endocrine 
treatment 2010 
Gain 2-3 
kg 
 
Weight gain on waist 
and hips 
Feeling lack of control 
Christy 
 
50 
 
Mastectomy, 
chemotherapy 
2008 
Loss 4 kg 
 
Controlling weight loss 
 
The focus group took place at the hospital in a meeting room that was convenient for 
the purpose. The women were situated around a square table to signal that 
everybody’s contribution was equally important (102). The interview lasted one 
hour and 11 minutes and was recorded using a digital recorder. The women had in 
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advance received four questions to consider and were asked to think about further 
topics concerning weight and body changes (Appendix F). During the focus group, 
the women were encouraged to share their experiences regarding changes in weight 
and body composition, and the meeting was moderated with only a small degree of 
control to ensure equal participation (102).  
6.3.2. DATA ANALYSIS 
The focus group data were scrutinised through content and conversation analysis. 
The content analysis was inspired by Graneheim and Lundman who developed a 
model of analysis that is widely used in nursing contexts. Using this model provides 
concrete analytical strategies, demonstrated in examples, and combines how 
manifest and latent content may reveal and be described in an analysis (109).  In 
addition to defining concept analysis as a means of organising the content in themes 
and concepts displaying the manifest content, the authors claim that both manifest 
and latent content involves interpretation. However, searching the latent content, the 
underlying meaning of the text leads a step further into interpretation on a deeper 
and more abstract level (109). 
Initially, the text data were structured and organised in subthemes and main themes 
and analysed for manifest and latent content. The themes served as a preliminary 
framework for structuring the conversation analysis. The conversation analysis was 
inspired by an understanding that language cannot be extracted from the linguistic 
and non-linguistic context in which it appears. Production of talk is thus not defined 
by a single participant, but co-constructed in the relationships among participants 
(110). Analysing ‘talk-in-action’, using tools such as turn-taking, sequences, and 
repair, revealed how the talking was organised in sequences with preferred and non-
preferred adjacency pairs, and how the participants dealt with problems that arose in 
the conversation, producing repair (110, pp.208, 333 – 334).  
Analysing the focus group with both content analysis and conversation analysis thus 
provided insight into the ‘what’ and the ‘how’. Although I proceeded with content 
and conversation analyses, the phenomenological attitude was intentional to allow 
the women’s experiences and stories to come forward in the discussion and stay 
close to their statements in the analysis. Discussions with co-authors and a conscious 
effort not to make hasty conclusions contributed to challenging and bridling the 
taken-for-granted. 
6.3.3. THE THEMATIC AND DYNAMIC DIMENSIONS OF THE INTERVIEW 
GUIDE 
Studying the text data through content analysis revealed four main themes as 
presented in Paper 1: a) experiencing the body with weight changes, b) being out of 
or in control, c) being afraid of recurrence, and d) helping nature. These themes 
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provided the thematic dimension of the interview guide. Subsequently, the 
conversation analysis showed examples of the dynamic dimension in an everyday 
language. Thus, focussing on what the participants said and how they said it, three 
dynamic areas were revealed as significant: a) using words, images and metaphors – 
a shield and self-protection, b) exploring multiple meanings, c) maintaining 
everyday language.  
6.3.3.1. Using words, images and metaphors – a shield and self-protection 
The women expressed their body as ‘being significantly changed’, literally, in 
images and metaphors, using terms such as ‘male distribution’ and ‘large beer 
belly’. Struggling with weight changes and being survivors of breast cancer, the 
women also used the words ‘being here’ for being alive. When one woman 
concluded that it ‘is better to be fat and alive’, this open reference to the potential of 
death triggered the group and made everyone speak at the same time. Metaphorical 
and symbolic language makes strong emotions more bearable and is a creative 
means of expressing personal meanings and feelings and to make sense of 
experiences (111). The reaction caused by changing the gentle ‘being here’ into the 
confronting ‘staying alive’ may thus rely on a disturbance of the shield of self-
protection offered by metaphors.  
6.3.3.2. Exploring multiple meanings  
The meaning of weight changes appeared to be multiple and related to general 
prejudice concerning potential alcohol addiction and advice from other people which 
was inconsistent with the women’s body perception. As a matter of different 
opinions and a question of autonomous and competent choices, without being 
harmful to oneself, the term control appeared central. Lack of control and autonomy 
were found to be intertwined with responsibility and guilt (112) and may promote 
uncertainty about cancer recurrence (71) as well as influence one’s self-perception 
and ability to cope with an altered body (113). In addition to these former findings, 
lack of control was associated with strong feelings of embarrassment and silent 
suffering, as the women did not expect other people to understand how much losing 
control of one’s weight could influence one’s self-perception.  
6.3.3.3. Maintaining everyday language 
The women’s everyday language was filled with images and metaphors. They 
helped nature with haircuts, looked into friendly mirrors pretending to be slim and 
used makeup to cope on days when they felt grey. Presenting themselves by helping 
nature through different means helped them feel comfortable and come closer to a 
body image that corresponded with their self-image (114). This form of self-
presentation can also be seen as an investment in feeling satisfied, happy or well 
(47,114), or as protection against painful or difficult topics like cancer and death 
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(115). These images and metaphors were occasionally combined with humour, 
which may contribute to increased comfort levels and reduced anxiety and 
discomfort (116,117). Use of humour and laughter may thus contain key information 
on sensitive topics.  
6.3.4. FOCUS GROUP – A BASIS FOR INDIVIDUAL INTERVIEWS 
Assigned to facilitate the women in telling their stories and produce a narrative in 
collaboration, Dahlberg et al. talk about interviews as open dialogue (15). The 
crucial point is what and in which way the interviewee expresses her experience of a 
certain phenomenon, and how the dialogue supports further reflections on the topic. 
Furthermore, it is essential to balance between being unstructured and structured as 
the researcher is obliged to keep focus in the interview on why questions and 
comments during the interview should be led by the phenomenon (15). First, the 
focus group provided content for the dynamic and thematic dimension of the 
interview guide and pointed at topics that might be relevant to explore without 
preventing the interviewee in revealing new aspects of the phenomenon (Figure 5).  
Figure 5. An open interview frame 
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Second, to follow the overriding philosophical perspective and let the women’s 
perspective come forward in the subsequent interviews, explorative questions were 
formulated in line with Dahlberg, Dahlberg and Nyström’s open lifeworld approach 
(15, pp.184 - 187). Inspired by the interview guide, the women were encouraged to 
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reflect on their experiences and provide lived examples. Thus, this open lifeworld 
approach enabled an emphasis on the individual’s experiences and endeavoured to 
come close to the patient’s lifeworld acknowledging the patient as the main expert 
on herself. An extract from the interview guide is shown in Table 2. 
To grasp the essential meaning of changes in weight and body shape among women 
treated for breast cancer, the aim of subsequent individual interviews was to reveal 
lifeworld experiences of the informant. Although interviews are considered 
collaborative narratives, it is important to minimise the interviewer’s impact on the 
informants’ expressions and responses.  
Providing inspiration for the thematic and dynamic dimensions of the individual 
interviews (2), the analysis increased my familiarity with the topic and became part 
of my pre-understanding. Being a part of my pre-understanding, the attention to the 
use of images, metaphors, and humour made me aware of protective elements in the 
language (102). Furthermore, listening to how the women spoke about their 
experiences sharpened the awareness on my own and the women’s vocabulary and 
supported an open approach in the following interviews. Focus group findings thus 
became integrated (built) into the individual interviews as an extended 
understanding of the topic that enabled a broader perspective from the interviewer. 
Table 2. Extract from interview guide 
 
The thematic dimension 
Exploring the experience of changes in weight, body shape and body perception. 
 
Opening question 
‘Please tell me about the weight changes you have experienced during and after 
your cancer treatment, and how the weight changes have influenced your body 
perception’ 
 
Suggestions for questions to be asked in the dynamic dimension 
How did you experience the changes of your body?  
Tell me when you first recognised the changes. What happened?  
What thoughts/feelings occurred when you recognised the changes?  
How were the weight changes (gain/loss) distributed?  
How did it influence your image of yourself?  
How did it influence your perception of yourself? 
What do the changes mean to you?  
Did the changes influence your sense of womanhood/your perception of yourself 
as a woman? Under which circumstances do you experiences this influence? How 
did you recognise the influence? 
What did you feel/think? What induced these feelings/thoughts?   
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6.4. THE EXPERIENCE AND INFLUENCE OF WEIGHT CHANGES 
ON BODY AND SELF 
Seeing the body as an essential unity for understanding, lived experience is central 
in the philosophy of existential phenomenology. In accordance with the 
philosophical perspective, revealing the women’s embodied experiences is guided 
by means of an inductive, descriptive research method – ‘reflective lifeworld 
research’ as described by Dahlberg, Dahlberg and Nyström (15). Using this method, 
the qualitative data are analysed in their frame of logic (98) to answer the qualitative 
research questions. Thus, the perspective of phenomenology is more explicit and 
recurring at the method level in this part of the study.  
Embodied knowledge is pre-reflective, created through inter-relatedness with the 
world, culture, environment - a horizon always implicitly present as shifting 
backgrounds for what stands out as figures or the significant in a situation (20). 
Factual changes in body and shape may provide changed, embodied knowledge. 
Verbally expressed, this embodied knowledge cannot be extracted from the 
linguistic and non-linguistic context in which it appears. Thus, the meaning of the 
changed body is closely tied to the actual context that provides a fundamental 
understanding of how changes of phenomena may influence and disturb the 
women’s relationship with the world. Connecting Studies I and II at sample level 
contributes to this contextualisation. Lessons drawn from the focus group analysis 
enhanced attention on verbal expressions. The individual interviews conducted in 
Study II are consequently associated with Study I, Phase 1, and Study II, Phase 1, in 
the mixed methods design. 
6.4.1. PARTICIPANTS, SETTING, AND DATA COLLECTION 
In Study II, 12 women were purposefully sampled for interviews from the Study I 
cohort. As variation is more important than numbers (15), women were included if 
they displayed changes in weight and shape or felt essentially changed. In addition 
to including a homogenous sample of women treated for breast cancer approx. one 
year from diagnosis, heterogeneous variations were sought by means of different 
ages, treatment modalities, and body changes (Table 3).  
Mean age was 57 years (range 35 to 83), which reflects the total cohort with a mean, 
measured baseline of 58 years (range 28 to 82). Treatment modalities covered a 
wide range that reflected the cohort except for surgery (mastectomy) which was 
over-represented in the interview study compared to the cohort. Finally, the women 
represented stable weight, weight gain, and weight loss.  
Regardless of the importance of variation, 15 ± 10 participants are recommended in 
interview studies (2), whereas sample size in phenomenological studies is typically 
fewer than 10 (4,118). The inclusion of 12 women who had experienced the 
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phenomenon under study and was able to articulate their experiences provided rich 
data with a wealth of variations on the investigated topic. As these rich data enabled 
patterns that structured the essential meaning of the phenomenon to reveal, the 
sample size was deemed sufficient.   
Table 3. Participants in individual interviews 
Partici-
pant 
(P) 
Age  Menopausal  
status 
Treatment  Changes 
weight/waist 
P1  70 Postmenopausal  Mastectomy, endocrine 
treatment  
+ 0.6 kg/ 
+ 10.5 cm 
P2  64 Postmenopausal Mastectomy, radiation, 
endocrine therapy  
+ 1.7 kg/ 
+ 5 cm 
P3  50 Premenopausal Lumpectomy, chemo- and 
endocrine therapy, 
radiation 
 -5.7 kg/ 
 -3.5 cm 
P4  65 Postmenopausal Mastectomy, endocrine 
therapy, radiation  
+ 1.1 kg/ 
+ 6 cm 
P5 54 Postmenopausal Mastectomy, chemo- and 
endocrine therapy, 
radiation  
+ 4.4 kg/ 
+ 9 cm 
P6  39 Pre-menopausal Lumpectomy, chemo- and 
endocrine therapy  
+ 5.4 kg/ 
+ 7 cm 
P7 55 
 
Postmenopausal Mastectomy, chemo- and 
endocrine therapy   
 -9.4 kg/ 
 -5.5 cm 
P8  35 Premenopausal Lumpectomy, 
chemotherapy, radiation 
+ 2.6 kg/ 
+ 2 cm 
P9  83 
 
Postmenopausal Mastectomy, endocrine 
therapy, radiation  
 -0.8 kg/ 
  0 cm 
P10  46 Premenopausal Mastectomy, chemo- and 
endocrine therapy, 
radiation 
+10.4 kg/ 
+ 4 cm 
P11  61 
 
Postmenopausal Lumpectomy, chemo- and 
endocrine therapy, 
radiation  
+ 1.7 kg/ 
+ 8.5 cm 
P12  55 Premenopausal Lumpectomy, endocrine 
therapy, radiation 
+ 1.3 kg/ 
+ 5.5 cm 
 
Approx. one year after baseline - in connection with their outpatient visit - the 
women were asked to participate and provide written information about Study II 
(Appendix G). Three days later they were phoned for their decision and further 
appointments. During the inclusion process, three women declined participation. 
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Reasons were not sought. Of the 12 women, three were interviewed during 
outpatient visits, and nine were interviewed in their own homes. All interviews took 
place in a relaxed atmosphere and lasted from 20 – 65 minutes.  
To obtain descriptions from the participants in their own words, the researcher needs 
to explore the topic of interest, posing broad and non-leading questions to provide 
opportunities for interesting and pertinent data to appear. Starting with an opening 
question (1,15), the women were encouraged to describe their experiences with 
follow-up questions from the interview guide developed in Phase 1, Study II (Table 
2). The aims of the individual interviews were not to confirm the statements from 
the focus group interview, but to extend and clarify the meaning of weight changes. 
Thus, to allow new questions to be formed during the interview, as recommended by 
Dahlberg et al. (15), the guide was used as an inspiration. This ensured focus on the 
topic and at the same time allowed the women to speak freely, to reveal unexpected 
topics and experiences to be pursued.  
6.4.2. DATA ANALYSIS 
The aim of exploring changes in weight and body composition as they appear by 
means of phenomenological reflection demands that researchers step into a 
phenomenological attitude where one’s taken-for-granted assumptions are bridled 
(86). This phenomenological attitude was performed through several steps. 
After verbatim transcription and several readings, the interviews were coded and 
organised in meanings units. In order to understand the meaning of every unit, the 
units were moved around and those that seemed to belong together were collected in 
clusters. These clustered meanings were related to each other and formed patterns 
that described the essence of the phenomenon, the structure of the meaning and 
finally, the essential meaning of the phenomenon (15, pp.241-256).  
Patterns of meanings are made up by differences and similarities, and when 
switching back and forth between figure and background by asking questions to the 
text – it reveals what is said, how is it said, and what is the contents and special 
meaning (15,86). Describing the meaning implies ‘laying out’, i.e. discovering 
explicit and implicit, visible and invisible meanings by using the visible as a point of 
departure (15). Thus, ‘laying out’ focuses on the meaning of what is already there, 
inherent in the phenomena. Laying out the detailed descriptions of bodily changes 
and questioning visible as well as invisible threads combined with self-reflection 
helped bridle my pre-understandings.  
As mentioned earlier, bridling is a reflective stance that helps us ‘slacken’ the firm 
intentional threads that tie us to the world and helps us to restrain our pre-
understanding in the form of personal beliefs and theories in order not to understand 
too quickly, too carelessly, too slovenly (86). Thus, bridling is a means of 
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scrutinising involvement with the investigated phenomenon. To distinguish the 
particular phenomenon from one’s pre-understanding and to avoid some of the 
pitfalls in conducting interviews and analysis (2,81,86), I was interviewed by a 
clinical nurse specialist to let presumptions come out into the open.  
In addition, inter-subjective discussions in the research group helped me ‘keep 
wondering’ and prevented the analysis from closing prematurely. During the 
analysis, six interviews were read and discussed with senior researchers and to 
remain open-minded, the findings were continuously discussed by means of 
questions, such as: I think the meaning is … can I be sure? How can I be sure? Are 
there other ways of understanding this?   
6.5. ETHICAL CONSIDERATIONS 
The study was registered at and approved by the Danish Data Protection Agency 
(No. 2008-58-0028) and complies with existing rules on data storage, ethical 
guidelines for nursing research (119) and the Danish Health Act (120). The project 
was discussed with the local scientific ethics committee, which found formal ethical 
registration and approval unnecessary. Participation was voluntary, and the women 
initially signed an informed consent form after receiving information orally and in 
writing about the study (119). Anonymity and confidentiality were ensured by safe-
keeping data and anonymising names.   
The ethical requirement in patient-based research urges the researcher to reflect on 
the transformative power of the encounter, when patients are confronted with and 
asked to put their experiences of suffering and vulnerability into words (121). 
Bodily changes may be considered a potentially sensitive topic, displayed in 
repeated measurements, and the interview may be the first time the interviewees 
were given an opportunity to express their experiences with these changes (15). 
With this in mind I met the women with sensitivity and awareness. If the women 
became emotionally affected, whether during measurements or the interview, room 
and space were provided for these feelings. If such feelings emerged during the 
interview, the participant was offered a break, and I only returned to the sensitive 
topic with the participant’s permission. To distract the women from the emotional 
impact of the specific topic, I closed the encounter with small talk, acknowledging 
the women’s contribution to the study as suggested by Brinkman and Kvale (2), and 
Legrand (121).   
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CHAPTER 7. FINDINGS 
In this chapter, the main findings of Studies I and II regarding the quantitative and 
qualitative research questions are reported separately, consistently with the 
multistage mixed methods design. To answer the mixed methods questions, an 
integrative mixed methods interpretation is carried out. This unifying analysis and 
interpretation meet the requirements for mixed methods integration and aim to push 
the findings to a higher level, displaying meta-inferences.  
7.1. MAIN FINDINGS OF STUDY I (PAPER 3) 
The main findings of Study I describe the characteristics of changes in weight and 
body composition during 18 months following diagnosis which are associated with 
current adjuvant antineoplastic treatment and examine the association between risk 
of changes and the current treatment. 
7.1.1. PATIENT CHARACTERISTICS 
The samples were included consecutively, and the 95 women were randomly evenly 
distributed into two groups: a) an endocrine treatment group (EG), and b) a 
chemotherapy ± endocrine treatment group (CG).  The distribution into the two 
groups showed that the women in the CG statistically were significantly younger 
and premenopausal with less comorbidity than the women in the EG (Table 4).   
Especially in the EG, comorbidity factors like hypertension (n EG = 22) and 
osteoarthritis (n EG = 13) were prominent (Figure 6). 
Figure 6. Comorbidity factors in the two groups 
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Table 4. Baseline characteristics in the total cohort and the treatment groups 
Variables Total N = 
95 
Endocrine 
N = 47 
Chemo ± endocrine 
N = 48 
p-values 
Age     
  Mean years (range) 
SD 
58 (28-82) 
11.8 
66 (47-82) 
8.8 
50 (28-68) 
8.5 
< .0001 
Menopause status     
  Postmenopausal 57 43 14  
  Premenopausal 38 4 34 < .0001 
Type of surgery     
  Mastectomy 28 12 16  
  Lumpectomy 67 35 32 .501 
Tumour stage     
  I 59 32 37  
  II 27 12 15  
  III 9 3 6 .423 
Receptor status2     
  ER2 – positive 90 47 43  
  ER – negative 5 0 5 .056 
Histology     
  Ductal 81 38 43  
  Lobular 14 9 5 .261 
Adjuvant therapy3     
  Endocrine therapy 47 47 0  
  EC+T ± endocrine etc.4 48 0 48 < .0001 
Comorbidity     
  No 51 19 32  
  Yes 44 28 16 .014 
Smoking     
  Non-smoker 75 38 37  
  Current smoker 20 9 11 .802 
Alcohol units per week     
  < 7 82 40 42  
  ≥ 7 13 7 6 .773 
                                                          
2 90 women were estrogen receptor positive, four were triple negative, and four HER-2 positive. Three of 
these women were also estrogen receptor positive. 
3 In addition to the 47 women prescribed endocrine medication at baseline, 36 women began endocrine 
treatment after completion of chemotherapy. 12 women were not assigned any endocrine therapy. 
4 Abbreviations: ER (estrogen receptor) and EC+T (epirubicin, cyclophosphamide, taxoterre). 
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7.1.2.  CHANGES IN WEIGHT AND BODY COMPOSITION OVER TIME 
Calculating changes in weight and body composition across 18 months in the total 
cohort and the two subgroups showed that factual changes belonged to the CG 
(Figure 7). 
Figure 7. Factual weight changes over time  
 
Estimating patterns of changes in weight and body composition revealed the 
importance of subgroup analysis (Appendix H). The average body weight changes in 
the total group across the four measurements showed a statistically significant, but 
small increase in weight of 0.9 kg (p = .003, 95 % CI 0.3-1.5 kg). A calculation of 
the association between changes in waist and weight in the total group showed an 
average positive association of 0.35 kg per cm increased waist (p < .001, 95 % CI 
0.29-0.42 kg). 
Examining the two groups separately the changes were mainly observed in the CG, 
with the greatest change found at six months with 1.6 kg weight gain and a small 
decrease at 12 months of 0.9 kg, increasing to 1.4 kg at 18 months. The changes 
found after six months in the CG were associated with an accumulation of body 
fluid, which during the following months returned to baseline levels. Weight, fat 
mass and waist circumference showed a statistically significant difference between 
baseline and 18 months and demonstrated that the increased weight at 18 months 
was associated with increased body fat and a small increase in waist circumference 
(Appendix H).  
In the EG, no weight changes were observed from six to 18 months, and the total 
change from baseline to 18 months was a modest 0.4 kg. However, this group 
displayed a statistically significant difference in waist circumference in all 
measurements, but there were no significant changes in weight and body 
composition (Appendix H). 
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7.1.3. RELATIVE WEIGHT, FACTUAL WAIST AND RISK CALCULATED 
IN THREE WEIGHT GROUPS 
Examining the entire cohort from baseline to 18 months in the three weight groups, 
40 women maintained a stable weight, and 54 women (one missing) experienced a 
weight change of ≥ 2.4 % either in the form of a weight loss (n = 16) or a weight 
gain (n = 38) (Table 5). Although the average changes in kilos were minor, the 
relative mean changes in weight gain were 5.5 % (range 2.5 to 20.5 %). The women, 
who lost weight, lost a mean of 5.4 % (range 12.7 to 2.5 %).   
Table 5. Distribution of relative weight changes baseline to 18 months in groups 
Weight changes (%) n Mean  SD min p25 median p75 max 
Stable weight (± 2.4 %) 40   0.2 1.4   -2.1 -0.8   0.5   1.2    2.3 
Weight gain   (≥ 2.4 %) 38   5.5 3.4    2.5  3.3   4.5   6.5  20.5 
Weight loss   (≥ 2.4 %) 16 -5.4 3.1 -12.7 -6.4  -4.1  -3.4  -2.5 
 
Stable weight was primarily related to women in the EG group, and weight changes 
between 2.5 and 5 % were almost evenly distributed in the two treatment groups (14 
in the CG group and 17 in the EG group). Major weight changes of 5-10 % and > 10 
% were especially evident among women subjected to chemotherapy, as 17 out of 
48 women receiving chemotherapy gained serious relative weight, compared to six 
out of 47 women who only received endocrine treatment (Figure 8).  
Figure 8. Distribution of relative weight changes in treatment groups 
 
Waist distribution in groups fluctuated in the groups as decreased waist 
circumference was observed in the weight gain group, and increased waist 
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Table 6. Distribution of changes in waist (cm) baseline to 18 month in groups 
Weight changes (%) n Mean  SD min p25 median p75 max 
Stable weight (± 2.4 %) 40    1.4 3.1   -5 -0.3        1 3.4   8.5 
Weight gain   (≥ 2.4 %) 38    3.8 4.3 -10     1        4    6 13.5 
Weight loss   (≥ 2.4 %) 16   -1.5 4.7 -12 -4.3  -1.75 1.3   8.5 
 
Increased OR for weight gain versus stable weight was associated with 
premenopausal status, lumpectomy, stage III breast cancer, chemotherapy, and 
smoking. Only menopausal status and chemotherapy showed a statistically 
significant difference that disappeared when adjusted for age (Appendix I). Stage II 
breast cancer decreased the odds of weight gain, compared to stage I, but with no 
statistical significance.  
Increased OR for weight loss versus stable weight was associated with 
premenopausal status, and comorbidity that adjusted for age became statistically 
significant. Although smoking and consuming more than seven units of alcohol a 
week showed increased OR, neither of these factors was statistical significant. Only 
stage III breast cancer was associated with a statistically significant risk of weight 
loss in both crude OR and adjusted for age (Appendix I). 
7.1.4. SUMMARY 
Changes in weight and body composition were modest when calculated for the 
entire group. Women who received endocrine treatment showed almost no weight 
changes, but showed statistically significant increased waist. The women who 
received chemotherapy displayed variations in weight, fat mass, total body water 
and waist during the measurement periode. The subsequent odds ratios showed a 
statistically significant increase in risk of weight gain among premenopausal women 
subjected to chemotherapy and an increased risk of weight loss among women 
suffering from stage III breast cancer. 
7.2. MAIN FINDINGS OF STUDY II (PAPER 2) 
The main findings of Study II explore the essential meaning of the phenomenon of 
changes in weight and body shape among women treated for breast cancer and how 
these changes influence the women’s perception of body and self. 
Analysing 12 interviews from a phenomenological viewpoint, guided by Dahlberg’s 
reflective lifeworld approach, the essential meaning of changes in weight and body 
shape in association with treatment for breast cancer was revealed to be: the 
ambiguous transforming body – between a luxury problem and the risk of 
recurrence. The meaning is made up of three constituents: 1) the body – a 
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demanding stranger, 2) fighting to be the master of one’s own life, and 3) accepting 
the bodily changes. In the following section, a summeray of the findings is described 
including abbreviated extracts of central quotes to provide the reader a sense of the 
context. 
7.2.1. THE BODY – A DEMANDING STRANGER 
The women experienced an unknown body that took the lead. An unrecognizable 
strange, unhealthy and unfamiliar body that inflicted a sense of: ‘I do not recognise 
myself. I look so different […] it is not how I perceive myself’ (P5). In addition to 
perceiving the body as ugly and undesirable with extended fat around the waist, the 
changed body limited the possibility of living as usual: ‘It was not my body. It used 
to be strong, enduring and active. Now, it was heavier, bigger, hurting and refused to 
do what I wanted’ (P8).  
The increased weight disturbed the relationship between body and world, which 
facilitated a need to ignore the body: ‘Instead of looking in the mirror, I focus away’ 
(P11). The unrecognisable and unfamiliar body that hindered normal life and 
functions seemed to be divided into two, articulated as ‘I’ and ‘it’, respectively. The 
expression seems to reveal a changed body perception shifting from the unified 
body-subject ‘I am my body’ to a dissociated body-subject where the body has 
become an object the women refuse to look at.  
Despite attempts to distinguish the body as an object from the unifying body-
subject, the body remained in the foreground, and influenced self perception: ‘I do 
not feel I have the right to be sad; [...] I could be dead […] so it is a luxury problem. 
[…]. Next I consider myself as having a weak and cowardly character, because I am 
unable to manage these changes’ (P11). 
Fear of recurrence and losing one’s normal sense of belonging seem to be 
underlying as invisible, but intentional threats that give these strong feelings 
meaning. It also shows how life experiences affect and are affected by embodied 
functional capacities and impact doings as well as beings. The bodily changes might 
be downplayed as luxury problems compared to the threat of death, which the 
women had just faced. However, they compared their present, embodied experience 
to their former body, hoping to return to their previous shape and agency.  
7.2.2. FIGHTING TO BE THE MASTER OF ONE’S OWN LIFE 
Awareness of the association between fat tissue and the risk of recurrence was a 
main incentive for fighting for weight maintenance or attempting to lose weight. ‘I 
want to prevent recurrence and I don’t want to look like this’ (P3). Confronted by 
bodily changes, willpower and fighter genes stepped in as means of emphasising 
oneself as a responsible agent, feeling powerful, and being familiar with one’s own 
CHAPTER 7. FINDINGS 
77 
body. ‘Even though the medicine may induce weight gain, it is my responsibility. It 
is of no use to sit down and relinquish control’ (P12).   
In addition to preventing recurrence, weight loss eased the women’s conscience and 
made it easier to be physically active and feel attractive. As the side effects faded 
away, the body changed from a body characterised by limitations to a body of 
possibilities in time, space, and mind and towards a unified body-subject able to 
decide. Thus, ‘nothing prevents me from going back to my former shape. Then I 
return to the person I was and shift attention away from the illness. Then I feel 
cured’ (P8).  
Although having to force the body might be a sign of subject-object dualism, 
referring to ‘I’ indicated that forcing the body supported self-perception and identity 
as a responsible agent in the continuum towards health (feeling cured). The space 
increased and the body-subject seemed to move towards reintegration, displayed in 
the strong focus on ‘I’ in the language of the participants. Thus, understanding 
oneself as connected with the past, present, and future, the process of transforming 
into or maintaining one’s former self, diminished the experienced distance between 
past, present, and future.  
7.2.3. ACCEPTING THE BODY CHANGES 
Being aware of the relation between fat and breast cancer development, the only 
option might be acceptance of the demanding body signals which additionally 
seemed to relieve the burden of self-blame. Acknowledging body signals as 
cooperative signs and following them deliberately, waiting for time to come to 
regain control, gave new meaning to changes in weight and body shape. For 
example, eating in order to reduce nausea during chemotherapy might be a way of 
survival. It was my way of surviving. I thought: ‘Okay it is helpful now, and then I 
must focus on it [weight gain] later’ (P10).  
Although weight gain had to be handled secondarily, the major goal of survival was 
competing with the women’s changed appearances and their attempts to make sense 
of these changes. Increasing age and vanity appeared to be a way of downplaying 
the influence of bodily changes: ‘but when you look in the mirror … ‘my God’. […] 
If the medication keeps the cancer away you have to deal with the weight and body 
changes … but still …’ (P4).   
Underneath the ambivalence between changes in weight and body shape and the risk 
of recurrence, it was continuously apparent that the women preferred returning to 
their former life and body. Acknowledging that their former life had disappeared 
and fighting to come to terms with the present situation, occasionally weight loss 
counterbalanced loss of breast as ‘people in my surroundings not only focus on my 
missing breast, but on my weight loss’ (P7). However, body appearance and weight 
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continued to be a main theme, critical to the women’s self-perception and ability to 
act.  
7.2.4. SUMMARY 
The constituents forming the essential meaning of the phenomenon of changes in 
weight and body shape contain an existential threat that binds the constituents of the 
phenomenon of the ‘ambiguous transforming body’ together. Underneath 
experiences of a demanding and strange body, attempts to become master of one’s 
own life and accepting bodily changes, fear of recurrence, and death always seemed 
to loom large in the background. Due to knowledge of the association between fat 
and the risk of recurrence, the struggle to maintain or regain a healthy weight and 
body shape inflicted self-blame, shame, and ungratefulness and influenced the 
women’s autonomy and self-perception. To deal with these feelings they felt a need 
to downplay the importance of their bodily changes. 
7.3. INTEGRATED MIXED METHODS INTERPRETATION (PAPER 
4) 
In this section, the main findings from Studies I and II are integrated with the aim to 
provide meta-inferences. The purpose of integrating the two studies is to expand the 
understanding of the phenomenon of changes in weight and body composition and 
the influence of the changes on the women’s perception of body and self from the 
perspective of the women as unified bodies. The integration is described in Paper 4 
and further developed in this thesis. After a staged reporting in Papers 1, 2 and 3, the 
findings are organised in a format that allows integration via joint displays, visual 
means of integrating and presenting mixed methods results (91). Thus, in this study 
integration is fulfilled through narrative integration via the staged reporting and 
through joint displays.  
7.3.1. THE AMBIGUOUS TRANSFORMING BODY ASSOCIATED WITH 
RELATIVE WEIGHT CHANGES 
Integration of the findings associated with relative weight changes are illustrated in 
three joint displays organised in ‘themes-by-statistics’ types where categorical data 
organise the presentation of themes and quotes (4,122). In our case, three relative 
weight groups provided the categories in which quantitative and qualitative data 
were organised. In the specific weight category, descriptive statistics illustrated in 
box plots were arranged with matching constituents and quotes (Figures 9, 10 and 
11).  The box plots aim to describe the distribution of relative weight and waist 
changes in an illustrative way that visualises outliers in addition to ranges. The 
quantitative results are further explained and elaborated by qualitative findings in 
text moving back and forth between the two datasets.  
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Organising data from Studies I and II across the individual studies takes on what 
Fetters and Freshwater call the 1 + 1 = 3 integration challenge (96). Illustrating 
findings by joint displays and further elaborating on the displays in text show how 
the understanding of the association between factual changes and the experiences of 
the transforming body may expand through integration and keep focus on the 
women as unified body-subjects.  
7.3.1.1. The ambiguous transforming body with weight changes ± 2.4 % 
Findings from Study I demonstrated weight variations between ± 2.4 % (stable 
weight) with a mean of 0.2 % (SD 1.4, range -2.1 % to 2.3 %).  The limits of ± 2.4 
% account for the diurnal variation per day and may in general be considered as 
insignificant. However, integrating the calculated weight changes with the women’s 
experiences on the individual level, it appeared that the small weight changes 
combined with extended waist circumference had a deep impact on the women’s 
perceptions of their bodies and selves. 
Illustrated in box plots, the spread of weight in the stable weight group was 
distributed around a median of 0.5 % range -2.1 to 2.3 %. The waist changes 
fluctuated around a median of 1 cm range -5 cm to 8.5 cm. The box plot illustrated 
that weight varied more below the median, while waist varied most above median. 
This indicates that even small weight variations may contribute to large waist 
increases (Figure 9).  Among the interviewed women small weight variations from   
-0.8 kg to 1.7 kg was displayed. In their statements the body appeared as a 
demanding stranger associated with sadness, feeling out of control, shame and self-
blame for being concerned about such changes when death could have been an 
option. Conversely, their waist circumference varied from 0 cm to 10.5 cm. 
The calculated association between weight changes and changes in waist 
circumference in the total cohort was - as mentioned - 0.35 kg per cm increased 
waist circumference.  Although the women in Study II were deemed representative 
for the cohort, three of the interviewed women in the stable weight group had a 
larger increase in waist than this mixed model calculation through logistic 
regression. Thus, these women provided variation and nuances beyond the 
calculated result. 
Feeling responsible, the women were unable to neglect it when the body changes 
became excessive. To cope, the women accepted the changes and interpreted them 
as side effects of cancer treatment, a necessary cost for being alive, or as an effect of 
normal ageing. However, the changed body figure insistently appeared in the 
foreground due to the increased waist circumference. 
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Figure 9. Joint display of weight changes ± 2.4 % 
              
The ambiguous transforming body with stable weight ± 2.4 % 
 
Quantitative results visualised in box plots 
                        Weight in percent                                                            Waist in cm                                      
     
 
Qualitative findings: Constituents and quotations 
The body – a demanding stranger 
‘Instead of looking in the mirror, I focus away [and compare myself with obese people] who do not 
deserve respect and display loss of control. Compared to being alive I do not feel I have the right to be 
sad, but I am so sick of the changes. I could be dead […] so it is a luxury problem. […] then I think, 
‘Am I too sensitive?’ But I feel I have changed a lot. Next I consider myself as having a weak and 
cowardly character, because I am unable to manage these changes’ (P11: 1.7 kg, 8.5 cm). 
 
Fighting to be the master of one’s own life 
‘Even though the medicine may induce weight gain, it is my responsibility. It is of no use to sit down 
and relinquish control’ (P12: 1.3 kg, 5.5 cm).   
 
Accepting the body changes 
‘The fat around the waist emerged despite eating low-fat. I know it can also be associated with my 
age, but… I know it is a question of vanity, but when you look in the mirror ... ‘my God’. […]. If the 
medication keeps the cancer away you have to deal with the weight and body changes…but still’ (P4: 
1.1 kg, 6 cm).                                    
 
Integrating the findings revealed that body distribution changes seem to contain a 
risk for pushing towards an emerging dissociation of the unified body, although the 
women talk about the changes in terms like ‘I feel sad, I focus away, I know, etc.’. A 
central issue for the women’s self-perception is to take responsibility for the bodily 
changes. Thus, not being able to control the body changes and the resulting serious 
influence on self-perception may be so harmful that further strategies such as 
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objectifying and neglecting may be applied to avoid confrontation with the changed 
body. 
7.3.1.2. The ambiguous transforming body with weight gain > 2.4 % 
Weight gain was evident among 38 women (Table 5). The interviewed women who 
gained weight > 2.4 % all belonged to the CG. Although women in the EG were also 
exposed to weight changes > 2.4 %, the majority of women in the weight gain group 
and particularly those with serious weight gains were observed in CG (Figure 8).  
Just as stable weight with extended waist affected the women’s perception of their 
body and self negatively, weight gains > 2.5 % similarly influenced the women’s 
body and self-perception. The changes interfered with their sense of identity and 
integrity as they caused alienation from the former body perception and inflicted a 
sense of womanhood and perception of oneself as an autonomous human being.  The 
changes tended to be a never-ending reminder of illness, with constant attention on 
signs and symptoms belonging to the breast cancer disease even though the women 
were considered cured. Thus, their perception of a body with increased weight and 
waist appears to be linked to loss of femininity and a body out of control which 
prevented habitual beings and doings.   
In the group of interviewed women, factual weight gain varied from 2.6 kg to 10.4 
kg. Illustrated in box plots, the spread of weight in the weight gain group was 
distributed around a median of 4.5 %. Below the median the distribution of 50 % of 
women was 2.4 % to 4.5 % (Figure 10). Above the median, the plot displayed an 
outlier of 20.5 %, and the upper whisker limit was approx. 9 %. This indicates a 
more reliable spread of relative weight gain ranging from 2.4 % to approx. 9 % 
(Figure 10).   
The calculated waist changes fluctuated around a median of 4 cm (range -10 cm to 
13.5 cm). The value -10 cm depicted an outlier most likely associated with an error 
in measurement when exploring intra-person measurements on the datasheet5.  The 
lower whisker value was approx. -3 cm, a more reasonable minimum value. The 
interviewed women in this group increased their waist from 2 cm to 9 cm, but 
visualised, the spread of weight and waist in the weight gain group indicates that a 
weight gain > 2.4 % does not necessarily trigger an extended waist. Less than 25 % 
of the values showed decreased waist circumference between -3 cm and 0 cm, 
corresponding to 75 % of the women who increased their waist from 1 to 13.5 cm. 
As all the women in this group gained weight, there is an incongruence regarding 
                                                          
5 On the datasheet it was added that the measurement was not in accordance with the participant’s experience.  
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the calculation of the association between weight and waist of 0.35 kg/cm waist 
extension. This may be a question of a changed distribution of fat and fat free mass. 
Figure 10. Joint display of weight gain > 2.4 %. 
              
The ambiguous transforming body with weight gain > 2.4 % 
 
Quantitative results visualised in box plots 
                        Weight in percent                                                            Waist in cm     
     
                                  
  
Qualitative findings: Constituents and quotations 
The body – a demanding stranger 
‘I do not recognise myself. I look so different […] it is not how I perceive myself. My weight gain is 
located in the trunk area. It is very unpleasant, and I have heard that it is very unhealthy. I am feeling 
so fat and unattractive. Fat women can look attractive and excess fat does not influence womanhood – 
if their shape is womanly. Now my belly is saggy. Looks like a sack. The distribution around the waist 
makes you look fat and unattractive.  [....]’ (P5: 4.4 kg, 9 cm). 
 
Fighting to be the master of one’s own life 
[ at a distance from chemotherapy the weight could begin to decrease] ‘Now I am able to decide. 
There is nothing that prevents me from going back to my former shape. Then I return to the person I 
was and shift attention away from the illness. Then I feel cured’ (P8: 2.6 kg, 2 cm). 
 
Accepting the body changes 
‘I do not want to have excess weight, because now I am aware of the association between breast 
cancer and body fat. [But during chemotherapy] only eating could keep a lid on the nausea, so … I 
knew it was not for my own good, but it was the only way I could endure. It was my way of surviving. 
I thought, Okay it is helpful now, and then I must focus on it [the weight gain] later. I could not do 
more at the time’ (P10: 10.4 kg, 4 cm). 
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However, integrating qualitative and quantitative findings regarding weight gain 
revealed that a changed body distribution was in foreground and influenced 
everyday life and triggered a distressing uncertainty with fear of recurrence. Self- 
and body perception fluctuated between perceiving oneself as a unified body subject 
and the body as an object with its own will. Although dissociation appeared as ‘I do 
not recognize myself’ and ‘able to decide [over the body]’ the unified body-subject 
appeared when acknowledging the inescapable body and accepting body demand as 
a way to come to terms with the present body.  
7.3.1.3. The ambiguous transforming body with weight loss > 2.4 % 
In the weight loss group, the 16 women were almost evenly distributed in the 
treatment groups with seven in CG and nine in EG. Although all women in this 
group displayed a weight loss > 2.4 %, serious weight loss was observed in CG as 
five of the seven women in this group had a weight loss > 5 %. By contrast one out 
of nine in the EG had weight loss > than 5 %. Mean weight changes in the weight 
loss group was -5.4 % (range -12.7 to - 2.5). The perceived changes - which for the 
two interviewed women varied from 5.7 kg to 9.4 kg and reduced waist from 3.5 cm 
to 5.5 cm - interfered with body and self-perception as depicted in joint displays.   
Illustrated in box plots, the spread of weight in the weight loss group was distributed 
around a median of -4.1 kg displaying a distribution of 50 % women between -4.1% 
to -2.4%. Below the median, the plot displayed two outliers with -12 % and -12.7%, 
and the lower whisker limit was approx. -7.5 %. Thus, a more reasonable spread 
below the median was -7.5 % to -4.1 %. The waist changes fluctuated around a 
median of -1.75 cm (range -12 cm to 8.5 cm). Although the calculation of the 
association of 0.35 kg per cm increased waist was statistically significant (p < .001, 
95 % CI 0.29-0.42 kg), the box plot revealed a more complex picture as more than 
25 % of the women extended their waist from 1.25 cm to 8.5 cm despite weight loss 
(Figure 11).   
Compared with increased waist and weight that inflicted alienation and dissociation 
of the unified body-subject, it seemed that a weight loss > 2.4 % strengthens one’s 
self-identity and induces a feeling of being able to act autonomously. Besides 
increasing the self-confidence, weight loss promoted the ability to be in motion and 
thus enabled an eased everyday life. It was also perceived as a successful means of 
preventing recurrence, turning the attention away from the cancer illness towards a 
positive body perception. The quotes indicate that weight loss in some cases may be 
intentional and may be a way to counterbalance negative experiences regarding loss 
of breast.  
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Figure 11. Joint display of weight loss > 2.4 %. 
              
The ambiguous transforming body with weight loss > 2.4 % 
 
Quantitative results visualised in box plots 
                           
                          Weight in percent                                                      Waist in cm 
       
 
Qualitative findings: Constituents and quotations 
To be the master of one’s own life 
‘I do not want to look like this, and I will do whatever I can to prevent recurrence. [Also incentivised 
by] my fighter gene – to be the master of my own life and knowing the increased risk of recurrence. 
With weight loss it is easier to be physically active and do good things for my body. I feel attractive 
and less anxious of recurrence and ease my conscience’ (P3: - 5.7 kg, -3.5 cm). 
 
Accepting the body changes 
‘With my weight loss I look well. It promotes a positive feeling. At the same time, I have lost my 
breast, which induces a negative feeling. Now people in my surroundings not only focus on my 
missing breast, but also on my weight loss. So now we have something positive to discuss regarding 
my body. […] I am riding on a male bike and now I get on the bike like a man. Before I was unable to 
do this, I did not have the balance and strength’ (P7: - 9.4 kg, -5.5 cm). 
 
In the quotes from this weight group, it may be noticed that both women were 
overweight at diagnosis and decreased their waist circumference. In this context, the 
changed body distribution does not seem to stand out in the foreground as an 
essential figure against the background. Instead, it seems that the eased body 
movement and the appearance in social settings prevail. Perceiving a lighter body 
may provide a sense of femininity, control, and trusting oneself as an autonomous 
agent able to improve habitual beings and doings. The counterbalance between loss 
of breast and positive attention contributes to adding distance to the cancer disease. 
However, a tendency of a dissociated self was observed when speaking of ‘do good 
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things for my body’ and ‘something to discuss regarding my body’, but there was no 
tendency to perceive the body as a stranger. Thus, the unified body-subject still 
seems to be under pressure despite the positive body perception associated with 
weight loss > 2.4 %.  
7.3.2. THE AMBIGUOUS TRANSFORMING BODY IN THE PAST, 
PRESENT, AND FUTURE 
Integration of the findings associated with changes in weight and body composition 
over time is illustrated in two joint displays (Figures 12 and 13). The categories of 
the two treatment groups, CG and EG, and the time aspect organise a condensed 
description of the women’s experiences. These joint displays are not pure ‘themes-
by-statistics’ types (4,122) as the themes are absent, but the descriptions are based 
on the essential meaning of the ambiguous transforming body. The presentation of 
the women’s bodily experiences in a time perspective demonstrated how a selected 
sample 12 – 18 months after diagnosis interpreted their bodily changes in the light of 
the past, present, and future. 
7.3.2.1. The ambiguous transforming body during and after chemotherapy  
The majority of stable weight is observed in the EG group, and although the 2.5% to 
5% changes are almost evenly distributed in the groups, the serious changes > 5% 
appear in 17 women in the CG compared to six in the EG (Figure 3). The women 
belonging to the CG (n=48) were mainly premenopausal with less comorbidity than 
the EG (Table 2). The women in the CG displayed several statistically significant 
changes in body composition variables (Appendix H). The changes fluctuated over 
time and could impact the women’s health as body fat mass increased at 18 months. 
Interviewing a selected sample between 12 – 18 months after breast cancer diagnosis 
demonstrated how they interpreted their bodily changes in the light of the past, 
present, and future (Figure 12).  
Staying in the present, but talking about the past, the women compared their body 
changes during chemotherapy with their bodies before the diagnosis. Six months 
from diagnosis the women had an average increase of 1.6 kg in total body water.  
Comparing the changed body with their initial body, the women described their 
body as extremely changed and uncomfortable. In addition, it seemed that the 
changed body obstructed their everyday being and doing as the body had changed 
from a cooperating body to a body almost perceived as an enemy. 
At 12 months from baseline, the average changes were decreasing, but now the 
weight gain of 0.9 kg was associated with excess fat mass. Despite the minor 
changes, some women experienced their present body as unfamiliar and felt 
confronted by a transformed identity, new reality, and self-perception. As the body 
had to be obeyed during chemotherapy, some women now felt responsible for taking 
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care of the bodily changes. Although the changes still obstructed their normal beings 
and doings, some women felt that the body was on its way back to the former weight 
and shape. At this time interval from chemotherapy, the women articulated how they 
wished to control their bodies in order to return to their normal weight and shape in 
the future. In their attempts to regain a friendly and effortless body, they strove to 
find a new balance between demands, desire, and energy and thus be able to perform 
activities related to everyday beings and doings.  
Figure 12. The ambiguous transforming body during and after chemotherapy. 
 
The ambiguous transforming body – during and after chemotherapy (n = 7) 
 
 
Past 
  
Present 
 
Future 
Before diagnosis Six months from 
baseline 
12 months from baseline 18 months from baseline 
 
Baseline (mean) 
 
Weight kg 71.1 
FM kg      24.4 
TBW kg   34.1 
Waist cm  92.6 
Six months difference 
 
Weight kg 1.6 (p = .002) 
FM kg   – 0.7 (p = .094) 
TBW kg     1.6 (p <.001) 
Waist cm  1.3 (p = .037) 
12 months difference 
 
Weight kg 0.9 (p = .076) 
FM kg       0.8 (p = .057) 
TBW kg    0.0 (p = .763) 
Waist cm  0.9 (p = .136) 
18 months difference 
 
Weight kg 1.4 (p = .007) 
FM kg       1.4 (p = .001) 
TBW kg    0.0 (p = .929) 
Waist cm  2.1 (p = .001) 
 
Before diagnosis the body 
used to be strong, enduring 
and active. Independently 
of either having a normal 
weight or being overweight 
in advance, some women 
expressed that they felt 
content with their weight 
and looks.  
In the past it was easier to 
lose weight or to control 
weight although the weight 
might fluctuate up and 
down. 
 
 
The body-subject seemed to 
be remembered as a unity in 
cooperation ‘I was my 
body’. 
 
 
During chemotherapy, the 
body turned into a sick 
and unknown body that 
changed uncontrollably.  
The body was no longer 
perceived as a friend, but 
as uncomfortable and 
heavy, unattractive, big, 
hurting, and fat. The body 
became an unrecognisable 
stranger that had to be 
obeyed.  
  
 
 
 
The body–subject divided 
into an object with the 
body as it as opposed to 
the subject as I expressed 
as ‘me and the body’. 
 
After chemotherapy, the 
body was still unfriendly, 
strange, sensitive, and 
fragile without power. The 
women felt responsible for 
taking care of the changes 
that still remained and for 
some increased. Unless the 
body turned back to normal 
weight and shape, the 
changes demanded the 
women to adapt to a new 
reality and a transformed 
self-perception, which was 
the hardest challenge.  
 
The body–subject still 
divided as it against the 
subject as I.  
However moving towards 
a reintegration into the 
unified body–subject  
 
Talking about the future, 
the women longed for an 
unnoticed and effortless 
body. They wished to keep 
doing well for the body by 
being active, eating healthy 
things and controlling 
hunger. Returning to the 
pre-cancer weight may 
provide distance from the 
cancer illness and induce a 
feeling of being cured.  
In addition, maintaining a 
weight loss was a means of 
preventing recurrence. 
 
Longing for the unified 
body–subject towards “I 
am my body” 
 
 
 
However, at 18 months the average weight showed an increasing tendency, with 1.4 
kg fat mass compared to baseline measurement. In addition, the waist circumference 
demonstrated a statistically significant difference compared to baseline 
measurement. Thus, it can be questioned whether the wish to regain an effortless 
and unnoticed body was fulfilled at that time. 
The experience of being a unified body-subject seems to fluctuate during the course 
of adjuvant treatment. The body changes during and after chemotherapy were 
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compared with former body perception as a unified body-subject that turned into a 
dissociated subject-object relation striving towards reconciliation. 
7.3.2.2. The ambiguous transforming body associated with endocrine therapy 
alone 
The physical changes related to women in the EG (n = 47) were minor, but 
statistically significant with respect to changes in waist circumference during all 
measurements. The body changes in these women did not fluctuate as in the CG. In 
the EG, only five women were exposed to weight changes > 5 % (Figure 8). 
However, in line with the quantitative results it was not the weight changes which 
were of concern to the women interviewed (n =5), but the extended waist 
circumference (Figure 13).  
  Figure 13. The ambiguous transforming associated with endocrine therapy. 
 
The ambiguous transforming body – associated with endocrine treatment alone (n = 5) 
 
    
Past 
Before diagnosis 
 
Six months from baseline 
Present 
12 months from baseline 
Future 
18 months from baseline 
 
Baseline (mean) 
 
Weight kg 69.1 
FM kg       24.1 
TBW kg    32.9 
Waist cm  91.8 
 
Six months difference 
 
Weight kg 0.4 (p = .197) 
FM kg       0.0 (p = .982) 
TBW kg     0.3 (p = .238) 
Waist cm   1.9 (p < .001) 
12 months difference 
 
Weight kg 0.4 (p = .212) 
FM kg      0.2 (p = .506) 
TBW kg   0.1 (p = .632) 
Waist cm  1.6 (p= .002) 
18 months difference 
 
Weight kg 0.4 (p = .171) 
FM kg       0.2 (p = .587) 
TBW kg    0.2 (p = .491) 
Waist cm  1.7 (p = .001) 
Before the diagnosis, the 
waist circumference was 
smaller, and it was suitable 
to wear clinging clothes. 
It was easier to lose weight 
or to control weight although 
the weight might fluctuate 
up and down. 
 
 
 
The body-subject seemed to 
be remembered as a 
cooperating unity ‘I was my 
body’. 
During endocrine treatment the body changed, which 
reminded the women of their cancer illness and the 
need for medication to avoid recurrence.   
The attention on maintaining a healthy body was 
enhanced and the increased waist circumference was 
associated with being unhealthy. Interpreting the 
changes as a consequence of medication and at the 
same time as a sign of ageing seems to prevent a 
strong division of the unified body-subject. 
 
 
The body–subject seems divided in it and I but 
towards reintegrating into the unified body –subject  
expressed as ‘I and my body’. 
Talking about the future the 
women still hoped the body 
would return to its former 
shape when the five years 
endocrine medication was 
finished. Meanwhile they 
maintained attention on 
minimising the changes 
through intentional actions 
(clothing and diet). 
 
Longing for the unified 
body–subject towards ‘I am 
my body’. 
 
 
Regarding their body perception in terms of the past, the women remembered that 
their body could change, but the changes were manageable. However, at the time of 
interviewing the changes were perceived as uncontrollable side effects that reminded 
them of their cancer illness and the need for medication to avoid recurrence. Waist 
circumference was statistically significantly changed at 12 months. Mean age in the 
EG was higher (66 years, range 47 - 82) compared to the CG (50 years, range 28 - 
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68) (Table 2), and the women interpreted the changes as a consequence of 
medication and also a sign of ageing.  
Talking about the future, the women were hoping to regain the former unified body-
subject, but at 18 months the increased waist circumference remained. The enlarged 
waist circumference was associated with developing an unhealthy body figure that 
could indicate increased abdominal fat. The total body fat increased by 0.2 kg during 
the 18 months which does not seem to be in accordance with the women’s 
experiences of their changed body.  
The attempt to take intentional action has seemingly not provided the expected 
result. However, collaborating with the changed body by keeping an eye on 
nutrition, being physically active, or hiding the body changes with an altered 
clothing style, the women tried to come to terms with what they perceived as 
unpreventable changes. This seems to prevent a strong division of the unified body-
subject as the body-subject changed from ‘I was my body’ to ‘I and my body’. 
7.3.3. THE ‘FIT’ OF INTEGRATION 
Although in explanatory quantitative mixed methods studies it is usual that 
qualitative findings explain quantitative results, the qualitative findings in this study 
expanded and complemented the issue under investigation. Illustrated in joint 
displays and further elaborated in text provided a deeper understanding of what can 
be at stake when women in adjuvant treatment for breast cancer are concerned with 
changes in weight and body shape. Integrating the two data sources provided new 
and interesting angles on the topic. 
Integrating relative weight changes with factual changes in waist circumference and 
the constituents and integrating findings in a time perspective expanded insight into 
how even stable weight and weight gain combined with enlarged waist influenced 
the women’s self and body perception. In these weight groups, in particular the 
changed body distribution revealed as foreground and was associated with risk of 
dissociation of the unified body-subject. In contrast, in weight loss combined with 
decreased waist, the eased movement and the opinions regarding weight prevailed in 
the foreground as figure in social settings. Integrating the two data sources in a time 
perspective provided insight into how the women could perceive their bodies as 
dissociated from self independent of belonging to the CG or the EG.  
As the two data sources provided information regarding ‘two sides of the same 
coin’, integration provided complementary aspects of the studied phenomenon and 
insight into experiences of changes connected to a body and self-perception related 
to a unified-body subject. These findings will be further discussed in the next 
chapter.
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CHAPTER 8. DISCUSSION 
In this chapter, a joint discussion of the study is presented. The joint discussion aims 
to synthesise and articulate the overarching lessons from the two studies and the 
integrative mixed methods interpretation. In addition, it contributes to illustrating 
how an understanding of the women as unified body-subjects can expand our 
knowledge of factual bodily changes and their influence on the women’s perception 
of body and self.  
8.1. EXPERIENCING THE BODY WITH CHANGES 
Diagnosed with breast cancer and receiving adjuvant therapy, the women are 
confronted by a strange and unfamiliar body, striving to maintain mastery in their 
own life and accepting bodily changes. As a changing entity, the body may become 
visible when everyday unreflective ‘being-in-the-world’ breaks down and the 
relationship between body and world is disturbed (123, p.41). Understanding the 
meaning of the ambiguous transforming body thus involves a reflection on how the 
changes appear because ‘it is impossible to separate things from their way of 
appearing’ (84, p.70). To illustrate how the bodily changes ‘appear-in-themselves-
for-the-women’, the relationship between factual changes and the meaning of the 
changes were depicted in joint displays. In the next section, a discussion based on 
existent literature aims to expand the acquired knowledge 
8.1.1. RELATIVE WEIGHT CHANGES ASSOCIATED WITH INCREASED 
WAIST – ESSENTIAL FOR BODY AND SELF PERCEPTION 
Out of 95 women, 40 women’s weight remained stable from baseline to the 
measurement at 18 months. Offhand, this might indicate that the women had been 
able to balance their energy intake (124). However, regardless of stable weight, 
weight gain, or weight loss, the women’s body and self-perception were influenced. 
Among women with stable weight ± 2.4 % or weight gain > 2.4 %, the changed 
body became a stranger that reminded the women of their illness, affected their 
sense of womanhood and self-respect and questioned their ability to maintain 
control. Particularly, it seemed that the increased waist circumference was of 
concern as these changes signalled an unhealthy body in discomfort whereas 
regaining their former figure reminded them of being cured. To move to a higher 
level of comfort when the women perceived the body as dis-eased and disobedient 
(12), they endured and found meaning in their condition by interpreting the 
discomfort as side effects of medication or normal ageing.  
Looking into treatment groups, minor weight changes were primarily seen among 
women in the EG, and major changes of 5-10 % and > 10 % were especially evident 
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among women who were given chemotherapy. This corresponds with studies that 
report chemotherapy to be the main contributor with respect to weight gain 
(33,34,58). Findings from the quantitative data analysis showed that being 
premenopausal and receiving chemotherapy and estrogen receptor antagonist 
treatment increased the odds ratio for weight gain calculated from baseline to 18 
months. Thus, it seems that these women deserve special attention. However, 
independently of treatment group, analysing the whole cohort in three weight groups 
and integrating the findings revealed that not just weight, but particularly extended 
waist deeply impacted the women’s perception of themselves as unified body-
subjects.  
Perceiving the body as an unknown stranger, the women as unified body-subjects 
were dissociated in ‘I’ and ‘it’ and were longing for their normal body and identity. 
Investigating the effect of getting a breast reconstruction to ‘feel like me again’ was 
found to be a core category in another study (54). Interpreting this core category 
with findings from our study, it seems that the influence of changes in weight and 
body composition on the women’s perception of body and self creates the same wish 
to regain former body and former self. However, as a breast reconstruction may 
support returning to the ‘pre-cancer’ being (55), it seemed that intrusive and 
unmanageable changes in weight and body composition prevented the women from 
getting that feeling. Changes in weight and body composition may thus be regarded 
as a critical factor that needs caring assistance from health professionals, equalised 
to coping with a missing breast. Acknowledging the serious impact on the women 
expands an understanding of the essential meaning of changes in weight and body 
composition and the women as unified body-subjects.  
Despite the women’s attempts to downplay the changes, the body appeared as a 
transforming ambiguous body, and even minor weight gain and slightly extended 
waist led to a negative self-perception. Although these changes seem to be 
insignificant, some of the women felt extensive changes in their body or fought to 
maintain their pre-cancer body weight and shape. However, having a disobedient 
body that hindered normal life and induced a loss of self-confidence, the women 
also feared recurrence. The women changed visibly and invisibly. Visible changes 
are found to provoke disruption between body and self (72,115), which confirms the 
findings in this mixed methods study. In addition, Brunet et al. found that visible 
weight changes like weight gain may affect overall self-worth (72). Thus, the sense 
of one’s own value or worth as a person may be in play. 
Although women are found to be concerned with a changed weight distribution (74), 
no studies in the qualitative literature review elaborated on this topic. It is confirmed 
that weight gain influences identity and impose negative attitudes towards oneself 
(71,72,75,125) contrasted by weight loss that may strengthens self-identity and 
sense of being able to act autonomously, and thus increased self-confidence (125). 
In addition, it has been demonstrated that women treated for breast cancer want to 
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gain control over their health with respect to weight gain and weight loss loss 
(71,72,75). This also plays a significant role in the present study where it was 
demonstrated that stable weight, weight gain, or weight loss seem to be continuously 
related to a fear of recurrence and death due the possible association with fat tissue 
exposure to estrogen (23). As weight loss can be associated with illness (73,75), the 
positive reaction to weight loss was particularly found among women who were 
overweight prior to breast cancer diagnosis (75). Thus, weight loss in overweight 
women may be voluntary (126), incentivised by a wish to obtain a healthier lifestyle 
(46). 
The interviewed women with weight loss were overweight at baseline. In this 
context, weight loss turned the attention away from illness, but was still connected 
with a fear of recurrence. When the attention was focused on preventing the risk of 
recurrence, the meaning of weight loss was associated with being able to take care of 
one’s body and self as an autonomous responsible agent. Seeking predictability in an 
unpredictable context during and after cancer treatment, the women tried to 
discipline their body (127) in an attempt to be master of their own lives, keep 
autonomy, personal agency, and capability to carry out certain actions. In addition, 
the changed bodies made the women feel attractive, their body movements were 
eased, and their relationship with the world was positively affected. Interpreting 
voluntary or involuntary weight loss as bodily changes towards a healthier lifestyle 
thus induced a positive reaction.  
The positive reaction may also be associated with prejudices in modern society 
where the female body is seen as an expression of one’s identity and is preferred to 
be slim and toned (52). Being heavy before, the reaction to the changes may be a 
sign of a changed relationship with the women’s lifeworld. Thus, not only concerns 
about health and recurrence, but also the social context may be of essential 
importance. Although weight loss seems to promote a positive body perception, the 
integration revealed that increased waist circumference may be experienced even 
with weight loss. Thus, we must question whether weight loss with increased waist 
induces the same positive reaction as we have already demonstrated that stable 
weight and weight gain combined with increased waist affected the women 
extensively and led to a dissociated body-subject.  
Particularly weight gain is observed to be a constant reminder of illness and a 
treatment without end (73) even though the women are considered cured after their 
cancer treatment. This paradox can induce a discrepancy between the women and 
their family and friends who may regard the women as cured (55), thus preventing 
the women from sharing their feelings with people in their social circle.  In addition, 
we found the paradox revealed in the women’s narratives as they interpreted their 
feelings as vanity when death could have been an option. Thus, connected to self-
perception and identity, changes in weight and body composition expand and go 
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beyond appearance and being cured, involving an existential level in a lifeworld 
context of concern for the unified body-subject.   
Interpreting the changes as vanity and downplaying them as normal ageing may be a 
sign of resignation or acceptance. This resignation and acceptance may contribute to 
reintegration with the world and life with new limits (12). However, in the effort to 
remove the traces of illness and return to the same body and self as before breast 
cancer treatment, a disciplinary course of action might also encompass 
fragmentation, dissociating the body into an object.  Without paying attention to 
these strategies there is a risk that changes in weight and body composition could 
prove just as long-term and persistent as the late side effect from cancer treatment 
found in other studies (73,75).   
8.1.2. THE UNIFIED BODY-SUBJECT IN THE PAST, PRESENT, AND 
FUTURE 
Visible weight gains are observed to affect self-worth and induce negative emotions 
long-term approx. 24 years after competed treatment (73) and up to 31 years from 
diagnosis (72).  The women in the present study are interviewed between 12 and 18 
months from diagnosis. From a time perspective, the present is always experienced 
on a horizon of the past and future (15,20). Integrating measured weight and body 
composition longitudinally with the women’s experiences created a clearer picture 
of how changes in fat, fat free mass, and total body water appeared to be in the 
foreground of the women’s lifeworld context in terms of past, present, and future. In 
illness this means that the habitual body acts as a reference point for the present 
body and highlights how the present body may be mutilated and obstructed in beings 
and doings (84).  
The biggest change in measured weight and body composition - except for the waist 
- was observed at six months among women receiving chemotherapy. This is in 
accordance with other studies that report increasing weight after completion of 
chemotherapy (35,62,66). During and immediately after chemotherapy, the women 
perceived a body with comprehensive changes, out of control, an object separate 
from their initial self-perception. Perceived as heavy, hurting, big, and fat, the body 
was an entity that had to be obeyed. Compared to the habitual body that used to be 
strong, enduring, and active, during chemotherapy the body turned into a sick and 
unknown body. The body-subject turned into ‘I’ and ‘it’.  
Although changes are found to level off at 12 months (30,62,66), other studies report 
increasing weight at that time (68,69), and some point at premenopausal status as a 
risk factor for weight gain (36,63,65). These different findings seem to be 
rediscovered in the joint displays as some women experienced a body on its way to 
becoming normal, while others experienced a body with remaining and increasing 
changes. In this context, the body could be perceived as unfriendly, fragile, and 
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sensitive. Aiming to reconcile with this transformed identity, the experience of the 
present reality and self-perception could be experienced as transitionally staying in 
the present body while longing for the habitual body.  
A healthy transition may be perceived as well-being and involves development and 
movement from one state to another (128). However, staying in between two states 
one can feel homeless and lost (129). Statements like ‘it was not my body’ indicate 
separation and could be a sign of feeling homeless, while the metaphor ‘being the 
master of one’s own life’ points at an attempt to not go into a homeless existence. 
Struggling to feel at home in one’s body may thus be associated with an unfinished 
transition and discomfort.  
At 18 months, waist circumference was significantly increased statistically in both 
women receiving chemotherapy and women receiving endocrine treatment alone. 
Contrary to the study of Francini et al. (58) which reported weight loss in 
postmenopausal women given aromatase inhibitors, the women from EG gained 0.4 
kg during 18 months, but waist circumference increased statistically significantly 
during the three measurements from baseline. This may indicate a changed 
distribution, and even though fat mass remained stable it is possible that the 
distribution has changed with increased fat mass in the trunk area.  Increased fat 
mass in the trunk area may be anticipated to impact general health and is a variable 
associated with metabolic syndrome (28,130).  
The increased weight in women from the CG now consisted of increased fat mass. 
Thus, the struggle to avoid exposure to estrogen from fat tissue (23) was not 
successfully accomplished by these women. However, in this study, the fat mass is 
measured for the whole body. Thus, the results cannot verify the possible changed 
fat distribution. The association between metabolic syndrome and breast cancer is 
particularly seen among postmenopausal women (130). As the waist increase was 
evident and statistically significant among those women in the EG who were 
exposed to hypertension, screening for metabolic syndrome may be relevant despite 
the minor weight gain in this group. 
Although the women seemed to move towards a unified body-subject at 18 months, 
the risk of dissociating in object and subject still persisted. Understanding the body 
as an inseparable unity (15,82,83) may contribute with additional understanding as it 
may be due to the inseparable body-subject that far-reaching changes in the sense of 
self appear (83). Talking about their experiences in dissociating terms might be the 
only way the women were able to express the intrusive changes and the impact on 
their self-perception and thus also their identity. Thus, an attempt to draw a map of 
the landscape of the essential meanings of changes in weight and body composition 
- ‘the world-in-itself-for the women’ - must be considered. 
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Independently of whether they belonged to the EG or the CG, the women were 
focused on their body appearance and weight, and it seemed that regaining a pre-
cancer weight and body - which had previously remained unnoticed and required no 
effort - was essential. Some wanted to regain former waist circumference or lose 
weight and others to keep their weight loss. Even if the present ties past and future 
together and always appears as ‘nows’ (20), the past and future appeared as figures 
in the foreground against their lifeworld experiences, i.e. the background. 
In accordance with other studies (72,75,76,131), the women were all increasingly 
focused on doing well for their bodies by being active and eating healthily. Long-
term survival served as an internal motivational factor (132), but returning to a pre-
cancer body also provided distance from the cancer illness and a feeling of being 
cured. However, body composition changed over time although the women aimed to 
find a new balance between demands, desires, and energy and to regain a friendly 
body, able to support everyday beings and doings.  
Talking about the future brought hope for a cured, unnoticed, and effortless pre-
cancer body aiming to be the master of one’s own life. The women struggled against 
capitulation to unpredictability and disorder, and with long-term survival as an 
internal motivational factor (132), the women increased their attention on doing well 
for their body by being active and eating well, thus disciplining the body.  
According to Frank (127), disciplining the body may be a way of fighting against 
bodily changes and maintaining control. Fearing disfigurement, the women 
attempted to discipline the body and avoid capitulation to unpredictability and 
disorder (127) in their efforts to remove the traces of illness and return to the same 
or a slimmer body. Their struggle to avoid exposure to estrogen from fat tissue (23) 
was, however, often not successful, as any weight gain at 18 months consisted of 
increased fat mass. In addition, a disciplinary way of action might encompass 
fragmentation and dissociation from the body as ‘it’. Thus, striving to find a new 
balance between demands, desire, and energy to regain a friendly body might be in 
contrast to regaining the feeling of a unified body.  
Our study demonstrated that changes in weight and body composition could 
promote disruption between body and self, and it is demonstrated that women short- 
and long-term may feel seriously transformed (55). Thus, the changes demand 
attention from the professionals. However, it is shown that health professionals may 
refrain from taking the women’s body perception seriously (71).  In the worst case 
this can prolong and aggravate illness and suffering as shown in the studies that 
included women for qualitative investigations at a long distance from diagnosis (71-
73,76).  
CHAPTER 8. DISCUSSION 
 
95 
8.1.3. THE MEANING OF THE DISSOCIATED BODY-SUBJECT 
Integrating qualitative and quantitative findings in this mixed methods study by 
taking a philosophical stance in existential phenomenology aimed at overcoming the 
gap between the body as an object and a subject, offering a unifying understanding 
of the lived body. Changes regarding the biological body (Körper) have been 
described, and the lived body (Leib) has been taken into account. Thus, a first 
person’s view has been integrated with a third person view. Understanding the body 
as an inseparable unity (15,82,83), essential for a healthcare practice and nursing in 
particular, provided embodied knowledge even though it may be difficult to put into 
words.  
According to Merleau-Ponty, the unified body-subject or the lived body is anchored 
in the world, unable to escape itself and intentionally directed towards things or 
events always perceiving and perceived. The women’s changed perception of body 
and self became visible when they communicated the intentional meaning of the 
changes as they appeared. The language contributed to rediscovering that ‘actual 
presence of myself to myself’ (20, p.xxix). Thus, the women’s embodied knowledge 
that normally is unreflective and hidden in a taken-for-granted everyday life was 
presented through the changed body, expressed as a dissociated body-subject and 
articulated in ‘I’ and ‘it’.  
‘Objectifying’ the body could be a way to manage the inescapably changed body, 
which entailed a loss of abilities, interrupted everyday life, and hindered ‘I can’. The 
new demanding and strange body gave rise to the taken-for-granted body being put 
out of play. Dissociating the body-subject in language may thus be an illustration of 
how changes in weight and body composition can contribute to feelings of 
discomfort and prolonging of illness. Attempts to discipline the body to regain 
former body can push towards alienation as well as comfort.  Conversely, if the 
women had had the power to control the changes we could question whether it had 
been easier for them to reconcile with the (new) habitual body and move towards 
reintegration or maintaining a unified body-subject.
CHAPTER 7. FINDINGS 
 
96 
 
 
CHAPTER 9. METHODOLOGICAL CONSIDERATIONS 
 
97 
CHAPTER 9. METHODOLOGICAL 
CONSIDERATIONS 
This chapter provides a critical reflection on how this mixed methods study, guided 
by existential phenomenology and reflective lifeworld research, meets various 
scientific criteria. 
9.1. ASSESSMENT OF QUANTITATIVE, QUALITATIVE AND 
MIXED METHODS RESEARCH 
For decades, researchers have discussed how we can assess the validity and rigor of 
quantitative and qualitative scientific work, and different types of vocabulary have 
been used in different traditions (87,133). Independently of tradition, every method 
must be used rigorously (4,95) and analysed in its own frame of logic (87,98). 
Dahlberg et al. (15) propose the criteria of objectivity, validity, and generalisation as 
useful in this assessment, as they may distinguish scientific research from everyday 
activities. In scientific investigations, a main conception is that it must be possible 
for the reader to follow the researcher’s reasoning. It is also important to maintain a 
certain distance to the studied phenomenon, at the same time acknowledging that the 
researcher is always part of the research process. Validity refers to the 
trustworthiness of findings which may guide health professionals in their clinical 
work in general and with the individual patient. Finally, it must be possible to 
generalise findings to people outside the specific study (15). Thus, Dahlberg et al. 
refer to both internal and external validity. 
Mixed methods aim to complement the strengths and overcome limitations 
regarding quantitative and qualitative methods.  In assessing a mixed methods study, 
the general validity is dependent on the validity of the individual studies. However, 
in mixed methods studies some additional issues must be considered. In the attempt 
to develop a vocabulary for scientific criteria of mixed methods research, 
Onwuegbuzie and Johnson (134) suggest to consider what they label as 
representation, legitimation, and integration. They argue that representing lived 
experiences using words and numbers may be difficult. Legitimations refer to 
acquiring findings and/or make inferences that are dependable, trustworthy, 
transferable, and/or confirmable. Finally, they stress that integration must be 
addressed. Dealing with representation and integration particularly legitimation 
issues must be addressed during the entire project. The following assessment of the 
validity of Studies I and II involves scientific criteria suggested by Dahlberg et al. 
(15) and Onwuegbuzie and Johnson (134). The latter will be addressed when 
assessing the mixed methods, specifically regarding legitimation that encompasses 
representation and integration issues. 
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9.1.1. STRENGHTS AND LIMITATIONS OF STUDY I  
Study I was a descriptive prospective cohort study that used a quantitative design. 
The study provided a third person perspective that focused on the biological body 
(Körper) and involved quantitative data collection and analysis. Thus, Study I 
provided data on factual changes and displayed a map of the ‘world-in-itself’. 
Disconnected from the experiences of the changes, the data were analysed in their 
own frame of logic as requested by mixed methods researchers (87,98) .  
During the research process, bias can occur e.g. at sample level, if the researcher 
deliberately includes participants who may respond in a certain way (135). 
Therefore, the objectivity of Study I is strengthened by relying on consecutive 
(random) inclusion. However, the groups of women who were deemed eligible, but 
were not included, were older and mainly postmenopausal. If these women had 
agreed to participate, the sample would presumably have been older with fewer 
women in the CG group and more in the EG group. Still, the included women were 
representative of the population of women treated for breast cancer. 
All the analyses were conducted in collaboration with a statistician and provided 
important knowledge of the actual sample. By chance, the two treatment groups 
turned out to be of equal size. As they displayed different characteristics, a direct 
comparison was not possible, but we were able to perform a subgroup analysis. This 
subgroup analysis showed that analysing data in a pooled sample delimited the 
knowledge of the individual women in need of intervention in order to maintain 
weight.  
Due to very few drops-outs, an almost complete dataset and a high response rate 
were secured. In addition, repeated measurements of the same sample (within 
subject) and just a few missing data supported the reliability of the data and thus 
their validity. To ensure the accuracy of the measurements, the weight device was 
calibrated regularly. In addition, the Tanita was compared with a BioScan 920-II 
that is used in other scientific investigations. This comparison showed no significant 
statistical difference between the two scales (Appendix G). However, the 
requirements for gaining valid data that minimised intra- and interday variations in 
body fluid relied on the women’s adherence to the recommendations and were not as 
controllable. As they were well informed about the requirements and asked to empty 
their bladder prior to the measurement, it may be reasonable to anticipate a valid 
measurement over time regarding the within subject measure. 
Regarding waist measurement, it was initially the plan that clinical nurses should 
perform this measure during the women’s visits to the outpatient clinic. As 
measurements of waist-hip circumference may be difficult, measurements at navel 
level were chosen as a variable for waist. To strengthen the validity of the 
measurements, possible changes were confirmed based on the women’s body feeling 
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and a note was made.  Due to organisational changes in the clinic, the majority of 
the measuring was undertaken by the PhD student with assistance from one nurse 
from the clinical research unit. A few measurements were undertaken by clinical 
nurses. Some of these referred to outliers in the analysis. Except for the few outliers, 
and on the basis of two persons measuring the majority of women, the data are 
considered robust although there is a big variation in waist values.  
The purpose of Study I was to describe the extent and patterns of changes in weight 
and body composition among women treated for breast cancer in a Danish context. 
The number of participants was discussed in the research group. In planning the 
present study, it was observed that prospective studies on changes in weight and 
body composition were conducted using samples consisting of 20-76 women 
(36,38,57,58) or as much as 272 women (69). Thus, 100 women were anticipated 
sufficient to describe the extent and pattern of these changes. However, dividing the 
cohort into the CG, the EG, and three weight groups - with small samples - limited 
the generalisability of the findings. This means that some results have to be 
interpreted with caution. For example, although the p-values for the odds ratios in 
weight loss and gain were statistically significant for women with stage III breast 
cancer compared to stage II, the risk of type 1 errors was high. The generalisability 
of findings from the sample to the entire population of women treated for breast 
cancer is thus questionable. Still, the findings may provide health professionals with 
knowledge that is relevant in their daily practice, particularly concerning women 
subjected to chemotherapy. 
9.1.2. STRENGHTS AND LIMITATIONS OF STUDY II 
Study II was a descriptive, phenomenological study that used a qualitative design. 
The study provided a first person perspective that focused on the lived body (Leib) 
and involved qualitative data collection and analysis. Thus, Study II provided data 
on the women’s lived experiences and displayed a map of the ‘world-for-them’. 
Although the women revealed how they experienced their factual changes, the focus 
of the analysis was on the essential meaning of the changes. Thus, these data were 
also analysed in their own frame of logic as requested by mixed methods researchers 
(87,98).  
In phenomenological investigations, data collection must involve a minimum of 
presumptions as well as an effort to avoid being guided by the literature, a priori 
framework, or theory (15,80,136). In this study, a focus group was conducted and 
analysed before the individual interviews were carried out. This analysis provided 
the thematic and dynamic dimensions of the interview guide and a reservoir of 
questions in everyday language (Paper 1). Although the analysis of the focus group 
formed a conscious part of the PhD student’s presumptions during the interviews 
and the subsequent analysis hereof, this may still have biased the final analysis. 
However, the open frame and explorative questions have taken this limitation into 
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consideration, as such questions allowed the women to narrate their experiences 
without restrictions.  
Furthermore, the threat against objectivity and validity may be minimised through 
transparency and by maintaining an open mind throughout the research process, 
while attempting to maintain a scientific, phenomenological approach (15,86,137). 
With regard to transparency, Norlyk and Harder (137) point at the importance of 
clarifying one’s philosophical stance. In accordance with central ideas and values in 
nursing, the overriding perspective of existential phenomenology and reflective 
lifeworld research has been explicated.  
The scientific phenomenological approach was supported by additional attempts to 
bridle my ‘natural’ attitude. Posing broad, open questions and open-ended follow-up 
questions, the participants were allowed to narrate their experiences from their 
natural attitude. Staying faithful and laying out the women’s experiences as 
illustrated by extracts of the analysis and quotes from the participants in Paper 2 
may provide the reader with an opportunity to follow reasoning throughout the 
analysis. 
Objectivity and internal validity may also be enhanced by member-checking and 
intercoder agreement (5,81). However, as member-checking is performed based on a 
natural attitude and not a scientific one, it is - according to Norlyk and Harder (137) 
- irrelevant. Instead, discussions in the research group were emphasised in order to 
challenge each other’s impressions and ideas, ‘keep wondering’, and prevent 
premature closure of the analysis (15,86). In addition, an intercoder agreement was 
applied, as six interviews were coded by co-authors and compared with the PhD 
student’s codes.   
To obtain external validity, the findings of a phenomenological investigation must 
direct the reader to her own experience (81,137) which means that the findings must 
be recognisable. Recognisable findings contribute to their generalisability, but the 
findings can only be said to be generalisable when new knowledge, if any, is 
transformed into practical actions (138). The generalisability of the findings beyond 
the context of the 12 women thus relies on how the findings are recognised and 
used.  
So far, the findings have solely been recognised by the research group and external 
reviewers and discussed with an international audience. However, the sample was 
included purposively and aimed to be heterogeneous with respect to age, treatment, 
and bodily changes. To obtain such heterogeneity, inclusion criteria were followed 
and the interviews were conducted between 12 and 18 months after breast cancer 
surgery and initiation of adjuvant antineoplastic treatment. Three women declined 
participation. Their measured changes were more extensive than those of the 12 
women who participated. Reasons for the decline were not sought, and it is unclear 
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whether interviews with these women would have influenced the findings. 
Nevertheless, the variation in the present sample has provided detailed descriptions 
of the women’s experiences which were in line with previous findings. In addition, 
the findings further expanded and elaborated our understanding of the women’s 
experiences. Thus, it can be argued that the findings may be transferred to women 
faced with similar conditions, while at the same time acknowledging that lifeworld 
phenomena can never be exhaustively explored (15).  
9.1.3. INTEGRATION – STRENGHTS AND LIMITATIONS 
The integrative mixed methods interpretation aimed to expand the understanding of 
the women as unified bodies and thus display a map showing ‘the-world-in-itself-
for-them’. Integration throughout the study - and particularly the integrative mixed 
methods interpretation - takes on the challenge of integration as recommended by 
Fetters and Freshwater (96). As the assessment of scientific quality should account 
for the entire research process, the strengths of using mixed methods depend on how 
the requirements for mixed methods studies are met, i.e. the combination of 
qualitative and quantitative methods, rigorous use of methods, integration of data 
collection, and/or data analysis and/or results (4,95). A salient point is the 
integration which must be part of the research process (91,97).  
In the present study, integration has taken place at: 1) the sample level, 2) by 
integrating findings from a focus group into an interview guide for individual 
interviews, and 3) by integrating the main findings of Studies I and II into joint 
displays, through the integrative mixed methods interpretation and the subsequent 
discussions and conclusion. This integration justifies the use of a mixed methods 
design and demonstrates how mixed methods may expand and elaborate the 
investigated phenomenon in a way that goes beyond the benefits of single methods 
studies (4,87,91,139). Although the benefits of conducting mixed methods studies 
on complex health-related issues are indubitable, this type of research takes time and 
a research team (139), and it can therefore be a challenging assignment for a PhD 
study.  
One of the supposed weaknesses of mixed methods research is that the researcher 
must be adept in both qualitative and quantitative research and numerous research 
methods (139). In addition, mixed methods which are considered a natural 
complement to traditional quantitative and qualitative research methods (139) 
require special attention.  Even though mixed methods are still under development 
and an expansive and creative form of research (93), some of the above-mentioned 
issues must be addressed. In the mixed methods community, a new vocabulary is 
suggested with regards to scientific criteria. In the following, legitimation is used as 
a term that replaces validity (134). 
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Integration of data on the sample level that aims to provide inferences and statistical 
generalisations from sample to population, constructing meta-inferences from the 
quantitative and qualitative inferences, may be problematic. Onwuegbuzie and 
Johnson point out a threat for sample integration legitimation, which may occur if 
the sample of the qualitative component is much smaller than or belongs to a 
different population than the quantitative sample (134). However, the aim of 
integration in this study was not to provide generalisation to the whole population of 
women treated for breast cancer. Instead, we wanted to expand the meaning of 
bodily changes and thus contribute to facilitating a mutual understanding among 
women as unified body-subjects and health professionals. 
In our case, integration was fulfilled on the sample level. The women in the 
interview study represented a small subsample from the entire cohort and were 
deemed representative at the inclusion. Thus, the sample of Study II was considered 
representative for Study I.  For feasibility reasons, the purposeful selection was 
based on preliminary quantitative data from Study I and not the final results. In a 
purely explanatory, sequential design, using final results from the quantitative 
component might have provided data on women with weight gain and decreased 
waist circumference and women with weight loss and increased waist. The interview 
further contributed with a wealth of rich data material, and the integrated mixed 
methods interpretation revealed new aspects with respect to stable weight, weight 
gain, and weight loss – giving rise to new questions.  However, from a sample 
integration legitimation point of view, it can be questioned whether integrating 
repeated, quantitative measurements with 12 individual interviews is sufficient.  
According to Creswell (4), the threat to the validity of a study related to sample 
integration particularly refers to convergent designs. As the present study follows a 
partly convergent, sequential design, measuring 95 women four times, it seems out 
of the question to interview the same amount of women as this would have required 
a lot of additional time and provided an unmanageable body of data for qualitative 
analysis. Moreover, this amount of qualitative data would be inconsistent with the 
fundamental assumption in phenomenological studies and thus inconsistent with the 
claim of conducting and analysing the individual studies in their own frame of logic 
by quotes, constituents, and meanings - and in numbers and percentages, 
respectively. With that said, the study might have benefitted from more interviews 
conducted over a longer period of time, comparing the women’s perception of the 
changed body with changes in body composition.  
Another threat to mixed methods studies relates to the researcher’s ability to 
systematically design a study that combines two or more methods in a way that 
accounts and compensates for weaknesses and strengths regarding the methods. In 
assessing this weakness minimisation legitimation (134), the applications of 
different methods and data analysis complemented each other as the quantitative 
data analysis provided breadth and the qualitative data analysis provided depth. The 
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added value of integrating the two datasets provided additional knowledge that was 
not obtainable with single studies alone.  
Assessing the requirements of combining qualitative and quantitative methods leads 
to reflections on the insider-outsider legitimation. This refers to the degree to which 
an insider and outsider view is presented. Applying a first person and third person 
perspective and assuming a phenomenological attitude during the entire process, 
while remaining faithful and faithless throughout the process (88), was a means not 
to remain ethnocentric or go native (134). In addition, skilled researchers were 
involved in analysing the qualitative and quantitative data and assessing the 
integrative mixed methods interpretation. As the two datasets were considered equal, 
the two viewpoints were deemed balanced. Likewise, taking a philosophical 
perspective in existential phenomenology contributed to keeping focus on the body 
as a unifying entity.  
According to Onwuegbuzie and Johnson, sequential legitimation must be considered 
as the study applied a partly explanatory, sequential design. However, questioning 
whether conducting an explorative, sequential mixed study would have provided 
different inferences is not relevant for this study as a main interest was to provide 
knowledge of the influence of changes in weight and body composition. 
Interviewing women before antineoplastic adjuvant treatment for breast cancer 
would have obstructed the purposeful selection of women for this study. 
Finally, Onwuegbuzie and Johnson point at paradigmatic, mixing legitimation and 
commensurability legitimation (134). In Chapter 4, the philosophical perspective for 
this study is described and arguments for the link to critical realism and thus mixed 
methods are provided. Taking a philosophical stance in existential phenomenology 
provided an understanding of the women as unified body-subjects that was in 
accordance with applying a mixed methods design for the study. The attempt to 
overcome the dualism regarding the biological body and the lived body and applying 
different methods that are normally considered incommensurable displayed a more 
moderate position as argued by several mixed methods researchers (4,5,89,134).  
In the nursing community, mixed methods and integration of qualitative and 
quantitative methods have met some resistance based on the argument that the 
methods belonged to incommensurable paradigms (9,140). Belonging to a 
humanistic tradition, the focus on nursing practice was claimed to be the experience 
of illness explored through qualitative enquiries. Investigation of diseases on the 
other hand was claimed to be the focus of medicine, using quantitative methods (9). 
From this perspective, integration or reconciliation seems to be out of question. 
Understanding nursing as an integrated part of health science, multiple theories and 
methods must be applied for the purpose of relieving suffering and promoting 
comfort in dealing with complex health-related issues, while conducting multi-
methods studies may maintain a dualistic perspective in research regarding human 
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beings. Instead, the moderate position in the present study is an example of a 
dialogue between mental models containing a set of assumptions, understandings, 
predispositions, values, and beliefs, including basic philosophical assumptions as 
suggested by Greene (89, p.53).  
The moderate position maintained both/and instead of either/or, recognising internal 
and external realities and the interaction between the two provided meta-inference 
greater than the sum of its parts. The integrative mixed methods interpretation 
expresses what Onwuegbuzie and Johnson call the Gestalt switch. This is a switch 
between figure and background and between quantitative results and qualitative 
findings in an iterative process in which a third viewpoint is created.  
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CHAPTER 10. CONCLUSION 
This chapter sums up the findings from Studies I and II and the integrative mixed 
methods interpretation with existential phenomenology as an overriding viewpoint.   
Combining research methods and applying existential phenomenology as an 
overriding viewpoint for the purpose of enhancing health and comfort is in 
accordance with central values in nursing and healthcare. From this perspective, 
patients are perceived not simply as bodies in need of care, but as persons who may 
need assistance in finding meaning in the face of illness and suffering. On this 
background, understanding the women as unified body-subjects aimed at expanding 
our knowledge of factual bodily changes and their influence on the women’s 
perception of body and self.   
In Study I, changes over 18 months were revealed to be modest, but statistically 
significant with respect to weight, fat mass, and waist circumference. Analysing 
subgroups and calculating odds ratios focussed attention on the group of women in 
adjuvant treatment with chemotherapy. These women seemed to be more exposed to 
bodily changes than women receiving endocrine therapy alone. Women in endocrine 
therapy increased their waist and remained stable in other body composition 
variables. In contrast, body composition variables fluctuated among the women 
receiving chemotherapy. These women had an increased risk of weight gain and 
statistically displayed significantly increased fat mass and waist circumference at 18 
months.  
Independent of treatment regimes, Study II revealed the ambiguous transforming 
body. Perceived as a demanding stranger, the women tried to dissociate themselves 
from the body, dividing the body-subject into ‘I’ and ‘it’, respectively. The women 
attempted to fight these changes by perceiving the body as an object that could be 
forced to cooperate. When they succeeded in forcing the body to maintain or gain 
normal weight and shape, the body-subject remained dissociated, but now the 
women perceived themselves as responsible agents on their way back to their pre-
cancer self and habitual state. Acknowledging that the changes could be out of 
control, the women had to cooperate with and listen to the body. Although they still 
longed for the habitual body, they accepted the present body. Consequently, they 
seemed to adapt to and increasingly accept another/new self, while maintaining 
responsibility and power. Coming to terms with a (new) habitual body, the body-
subject moved towards reintegration and away from illness. 
Independently of treatment regimens and across the three weight groups, the final 
integration of the two studies underscored that even small weight changes in 
association with increased waist circumference influence the women extensively. 
The integrative mixed methods interpretation demonstrated that changes analysed by 
means of statistical tools in a pooled sample neither account for nor correspond with 
CHANGES IN WEIGHT AND BODY COMPOSITION AMONG WOMEN IN ADJUVANT TREATMENT FOR BREAST 
CANCER 
106
 
the perceived changes. This challenges the quantitative findings, suggesting that 
weight changes in general are overestimated.  
Across the groups, even small changes can trigger fear of recurrence, shame, and 
self-blame and a dissociated body and self may be considered as the only way to 
cope with unmanageable changes. ‘Objectifying’ the body can be a way to manage 
the inescapably changed body, entailing a loss of abilities, interrupting everyday life, 
and hindering ‘I can’. On one hand, disciplining the body in an attempt to be master 
of one’s own life, to keep autonomy, personal agency, and capability to carry out 
certain actions may encompass fragmentation and dissociation of the body.   
On the other hand, interpreting the changes as vanity and downplaying them as 
normal ageing may be a sign of resignation or acceptance. This resignation or 
acceptance may contribute to reintegration with the world and life with new limits. 
Striving towards reconciliation and unifying the present body with a ‘new’ habitual 
body, health professionals need to acknowledge that the present body and self-
perception is determined by the former perception of body and self and wishes for 
the future. Lack of understanding of the women’s experiences may push towards 
bodily alienation and social changes, challenge self-identity and integrity, and 
contribute to prolonged and aggravated illness and suffering.  
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CHAPTER 11. IMPLICATIONS FOR 
PRACTICE AND FUTURE RESEARCH 
The overriding framework of existential phenomenology and various mental models 
and methods provided comprehensive insight into the women’s experiences of 
bodily changes. The present study has revealed that there is incomplete knowledge 
as to how weight and body composition measured in kilograms and centimetres 
affect these women, as even small changes may hold deeply existential meanings. 
Thus, without clarifying the women’s subjective experiences, the objective findings 
alone would be of limited value and inconsistent with a care-oriented nursing 
perspective (7,11). Instead this perspective stresses that the women are not physical 
bodies but persons who might need assistance in finding meaning in the experience 
of their illness and suffering (8,10). 
The findings showed that some women are at risk of developing an unhealthy 
weight and body composition with a wide range of relative weight changes, 
intertwined with a variety of conditions. Although rehabilitation for cancer patients, 
including women treated for breast cancer, has been established through the city 
councils, not all women choose or are able to utilise this offer. Furthermore, the 
encounter with and adaptation to a healthcare system that values effectiveness may 
prevent patients from expressing their needs and concerns (113). In addition, with 
respect to weight changes a question of vanity may prevent some women from 
asking for help. Thus, to decrease risk and prevent further health related side effects, 
nursing interventions may be considered on the organisational, population and 
individual level (6).  
To provide comfort and help for the women may be the responsibility of healthcare 
professionals (12,13). In order to identify women with increasing or decreasing 
weight during follow-up visits and to investigate the psycho-social and physical 
factors influencing their weight development, an assessment should be made at 12 – 
18 months. All women are potentially at risk of changes in weight and body 
composition and should receive attention. However, according to this study special 
attention should be given to younger, premenopausal women treated with 
chemotherapy.  
Implementation of individual interventions with respect to physical, psychological, 
and social concerns in the transition period from patient to survivor has proven to 
reduce cancer-specific distress (141). Clinic-based weight management programmes 
for breast cancer patients have proven to be effective (142). McCaughan et al. 
suggest that a nurse-led service during follow-up visits might be a relevant option 
for these women (51). In addition, to ensure future health and comfort for the 
women, it may be relevant to develop an assessment tool and interventions 
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focussing on nutrition and physical activity as a part of survivor care plans linked to 
rehabilitation initiatives across sectors. Concrete suggestions for women in this 
transition period might address how to minimise weight-related side effects.  
However, the question is whether ‘fixing or normalisation’ of the changed body 
contributes to a feeling of wholeness, a unified body-subject, as no direct correlation 
is found between the degree of changes and the women’s experiences.  
From a phenomenological and hermeneutical point of view, the Dutch philosopher 
Jenny Slatman suggests that body evaluation in oncology aftercare involves a 
narrative approach (143). Before deciding any interventions, the health practitioners 
must enter a joint, narrative work with the women. In collaboration with the 
professionals, the narrator may tell, build, and interpret her story aiming to deal with 
the present situation with special focus on how she values her physical appearance 
and sense of wholeness (143). From this stance, it may be possible to support the 
woman in the transition from one habitual body to a new one, while taking her body 
perception seriously, independently of how the changes are displayed quantitatively.  
Furthermore, it may provide health professionals with directions for interventions 
that may influence the women’s perception of body and self in a positive way and 
thus provide comprehensive care for these vulnerable women. Finally, this may be 
in accordance with a caring perspective and thus contribute to strengthen the life 
courage of the suffering women (11).  
Implementation of this joint orientation in a busy outpatient clinic may be a 
challenge. In line with a mixed methods approach, long-term follow-up regarding 
body composition may be manageable as data collection on a BIA is a cheap, easy, 
and non-invasive procedure. This will provide data on factual changes and 
knowledge of long-term changes. However, combining these measurements with 
breast cancer quality of life questionnaires is not sufficient to develop sensitivity to 
individual body experiences as they do not contain an adequate vocabulary for the 
experiences (143). Paying attention to how the women talk about their body, and 
developing and organising a vocabulary in a theme guide from the women’s 
expressions of body changes may provide the professionals with a tool for use in 
clinical settings. This may be an assignment for future research. 
Although this study has added to previous knowledge of the extent and influence of 
changes in weight and body composition on women’s body and self-perception, 
future research calls for several contemplations. 
As data collection with BIA is a cheap, easy, and non-invasive procedure, long-term 
follow-up may be manageable in a busy outpatient unit, combined with a 
questionnaire on body and self-perception. Applying these instruments may provide 
further understanding of the association between observed and experienced changes 
and consider the critique regarding unequal sample sizes as suggested by Creswell 
(4). In the present study, the serious changes in weight and body composition were 
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mainly found among women receiving chemotherapy, although some of these 
women were able to maintain or regain their pre-cancer body weight and shape 
during 18 months. Future exploration of psycho-social factors regarding these 
differences may provide health professionals with insight into critical mechanisms 
and coping strategies that may lead to extensive changes or support stable weight. 
Furthermore, it might be interesting to investigate the association between bodily 
changes and adherence to current recommendations for physical activity that aim to 
contribute to the general well-being and health, decrease fatigue, and prevent 
recurrence (28). Awareness of the women’s knowledge of the association between 
fat mass and breast cancer, adherence or lack of adherence to these 
recommendations may hold essential meaning of what can influence their spirit and 
life force during and after cancer treatment.  
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Appendix A. Literature search – 
quantitative phase 
Key words quantitative search phase 
 
 
Updated November 
2015 
 
PubMed (896 entries) 
 
Cinahl (226 entries  
 
Embase (1813 entries) 
 
Breast neoplasms 
 
MeSH 
Breast neoplasms 
Free text: 
Breast neoplasms 
Breast cancer 
 
CINAHL Headings 
Breast neoplasms 
Free text: 
Breast neoplasms 
Breast cancer 
 
Emtree 
Breast cancer 
Free text: 
Breast neoplasms 
Breast cancer 
 
Body weight 
 
MeSH 
Body weight 
Body weight changes 
Weight gain 
Weight loss 
Overweight 
Obesity 
Free text: 
Weight loss 
Weight reduction 
Weight gain 
Weight change* 
Overweight 
Obesity 
Obese 
 
CINAHL Headings 
Body weight 
Body weight Changes 
Weight gain 
Weight loss 
Obesity 
 
Free text: 
Weight loss 
Weight reduction 
Weight gain 
Weight change* 
Overweight 
Obesity 
Obese 
 
Emtree 
Body weight 
Weight change 
Weight gain 
Weight reduction 
Obesity 
 
Free text: 
Weight loss 
Weight reduction 
Weight gain 
Weight change* 
Overweight 
Obesity 
Obese 
 
Adjuvant treatment 
 
MeSH 
Chemotherapy, 
Adjuvant 
Antineoplastic agents 
Aromatase inhibitors 
Estrogen antagonists 
Free text: 
Chemotherapy 
Antineoplastic agent* 
Aromatase inhibitors 
Estrogen antagonists 
 
CINAHL Headings 
Chemotherapy, 
Adjuvant 
Antineoplastic agents 
Aromatase inhibitors 
Estrogen antagonists 
Free text: 
Chemotherapy 
Antineoplastic agent* 
Aromatase inhibitors 
Estrogen antagonists 
 
Emtree 
Adjuvant 
chemotherapy 
Antineoplastic agent 
Aromatase inhibitor 
Antiestrogen 
Free text: 
Chemotherapy 
Antineoplastic agent* 
Aromatase inhibitors 
Estrogen antagonists 
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Search strategy quantitative search phase. 
(("Breast Neoplasms"[Mesh] OR breast neoplasms[tw] OR breast cancer[tw]) AND 
((((((((((("Body Weight"[Mesh] OR "Body Weight Changes"[Mesh]) OR "Weight 
Gain"[Mesh]) OR "Weight Loss"[Mesh]) OR weight loss[tw]) OR weight reduction[tw]) 
OR weight gain[tw]) OR "Overweight"[Mesh]) OR "Obesity"[Mesh]) OR (weight 
change[tw] OR weight changes[tw])) OR overweight[tw]) OR (obesity[tw] OR 
obese[tw]))) AND ((((((("Chemotherapy, Adjuvant"[Mesh] OR "Antineoplastic 
Agents"[Mesh]) OR "Aromatase Inhibitors"[Mesh]) OR "Estrogen 
Antagonists"[Mesh]) OR chemotherapy[tw]) OR antineoplastic agent[tw]) OR 
aromatase inhibitors[tw]) OR Estrogen Antagonists[tw]) 
 
Selection process quantitative search phase 
 
Literature search updated November 
2015 
 
PubMed 896 
 
CINAHL  
226 
 
Embase 1831 
 
Sorted by language English or Nordic 
from 2004.   
Including titles with weight changes (loss 
and gain), chemotherapy, endocrine 
therapy, body composition, obesity. 
Excluding titles dealing with men, 
children, animals, biomedical research 
and other cancer forms than breast cancer 
 
 
 
91 
 
 
 
27 
 
 
 
91 
 
Reviews and papers without abstract 
deleted  
 
26 
 
27 
 
43 
 
 
Abstracts read and papers selected for full 
text readings 
 
 
 
23 
 
 
8 
 
 
34 
 
Assessed for relevancy and duplicates 
deleted from Cinahl and Embase 
 
 
 
 
3 
 
14 
 
Retrospective and prospective studies 
measuring weight across time displayed 
in kg, BMI, patterns or body composition 
terms, during and after current 
antineoplastic treatment selected for the 
final review from 2004 and ongoing  
 
 
16 
 
 
0 
 
 
3 
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Appendix B. Literature search 
qualitative phase 
Key words qualitative search phase  
 
Opdated November 2015 PubMed 1807 papers CINAHL 534 papers PsycINFO 378 papers 
 
 
Breast neoplasm 
Thesaurus: 
Breast Neoplasms 
Survivors 
 
Free text: Breast 
cancer 
Thesaurus: 
Body weight 
Weight gain 
Weight loss 
Free text: Breast 
cancer 
Thesaurus: 
Breast neoplasms 
Survivors 
 
 
 
 
 
Body weight 
MeSH: 
Body weight  
Weight gain 
Weight loss 
Free text: 
Weight changes 
Weight gain 
Weight loss 
Body weight 
Body image  
CINAHL Headings: 
Body weight 
Body weight changes 
Weight gain 
Weight loss 
Free text: 
Weight changes 
Weight gain 
Weight loss 
Body weight 
Body image 
Thesaurus: 
Body weight 
Weight gain 
Weight loss 
Free text: 
Weight changes 
Weight gain 
Weight loss 
Body weight 
Body image 
 
 
 
 
 
 
 
 
“Qualitative” 
MeSH: 
Quality of life 
Stress, Psychological 
adaptation, 
Psychological 
femininity 
Gender identity 
Self concept 
Free text: 
Coping 
Body perception 
Femininity 
Gender identity 
Quality of life 
Body experience 
Self concept 
Body image  
CINAHL Headings: 
Quality of life 
Stress, Psychological 
adaptation, 
Psychological 
coping 
Sex role 
Gender identity 
Self concept 
Free text: 
Coping 
Body perception 
Femininity 
Gender identity 
Quality of life 
Body experience  
Self concept 
Body image 
Thesaurus: 
Quality of life 
Psychological stress 
Coping behavior 
Adaptation 
Femininity 
Gender identity 
Self concept 
Self perception 
Free text: 
Coping 
Body perception 
Femininity 
Gender identity 
Quality of life 
Body experience 
Self concept 
Body image 
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Search strategy qualitative search phase. 
 (((("Breast Neoplasms"[Mesh] OR "Survivors"[Mesh]) OR ("breast 
neoplasms"[MeSH Terms] OR ("breast"[All Fields] AND "neoplasms"[All Fields]) OR 
"breast neoplasms"[All Fields] OR ("breast"[All Fields] AND "cancer"[All Fields]) 
OR "breast cancer"[All Fields])) AND ((((("Body Weight"[Mesh] OR ("body 
weight"[MeSH Terms] OR ("body"[All Fields] AND "weight"[All Fields]) OR "body 
weight"[All Fields])) OR ("weight gain"[MeSH Terms] OR ("weight"[All Fields] AND 
"gain"[All Fields]) OR "weight gain"[All Fields])) OR ("weight loss"[MeSH Terms] 
OR ("weight"[All Fields] AND "loss"[All Fields]) OR "weight loss"[All Fields])) OR 
("body weight changes"[MeSH Terms] OR ("body"[All Fields] AND "weight"[All 
Fields] AND "changes"[All Fields]) OR "body weight changes"[All Fields] OR 
("weight"[All Fields] AND "changes"[All Fields]) OR "weight changes"[All Fields])) 
OR ("body image"[MeSH Terms] OR ("body"[All Fields] AND "image"[All Fields]) 
OR "body image"[All Fields]))) AND ((((((((((("Quality of Life"[Mesh] OR "Stress, 
Psychological"[Mesh]) OR "Adaptation, Psychological"[Mesh]) OR 
"Femininity"[Mesh]) OR "Gender Identity"[Mesh]) OR ("adaptation, 
psychological"[MeSH Terms] OR ("adaptation"[All Fields] AND "psychological"[All 
Fields]) OR "psychological adaptation"[All Fields] OR "coping"[All Fields])) OR 
(("human body"[MeSH Terms] OR ("human"[All Fields] AND "body"[All Fields]) OR 
"human body"[All Fields] OR "body"[All Fields]) AND ("perception"[MeSH Terms] 
OR "perception"[All Fields]))) OR ("femininity"[MeSH Terms] OR "femininity"[All 
Fields])) OR ("gender identity"[MeSH Terms] OR ("gender"[All Fields] AND 
"identity"[All Fields]) OR "gender identity"[All Fields])) OR ("quality of life"[MeSH 
Terms] OR ("quality"[All Fields] AND "life"[All Fields]) OR "quality of life"[All 
Fields])) OR ("body image"[MeSH Terms] OR ("body"[All Fields] AND "image"[All 
Fields]) OR "body image"[All Fields])) OR ("self concept"[MeSH Terms] OR 
("self"[All Fields] AND "concept"[All Fields]) OR "self concept"[All Fields]))) AND 
"2014/09/24 15.00"[MHDA] : "2015/09/21 15.00"[MHDA] 
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Selection process qualitative search phase 
 
Literature search updated 
November 2015 
 
PubMed 1807 
 
CHINAL 
534 
 
PsycINFO 
378 
 
Sorted by language English or Nordic. 
Excluding titles dealing with men, 
children, animals, biomedical research 
and other cancer forms than breast 
cancer 
 
101 
 
57 
 
66 
 
Abstracts read carefully and all papers 
with breast cancer, body image, breast 
cancer survivors, quality of life,  weight 
changes, weight gain, weight loss in 
abstracts or key words were selected 
(overview, reviews, original research 
using qualitative and quantitative 
methods) 
 
 
34 
 
 
31 
 
 
3 
 
Papers read carefully to select original 
research using a qualitative approach to 
gain knowledge of the experience of 
changes in weight and body shape 
associated with current cancer treatment 
among women with breast cancer  
 
 
14 
 
 
7 
 
 
3 
 
Papers selected and described in the 
review of the literature. 
 
5 
 
0 
 
1 
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Appendix C. Participants information 
quantitative component  
Vægtændring hos kvinder med brystkræft under og efter 
behandling 
 
 
Deltagerinformation 
 
Kære 
 
 
Onkologisk Afdeling vil med denne information spørge, om du vil deltage i en videnskabelig 
undersøgelse. Vi vil sætte fokus på de vægtændringer, især vægtøgning, der kan være et 
problem i efterforløbet hos kvinder, der behandles medicinsk for brystkræft.  
 
Vægtøgningen måles ofte i kilo. Det betyder, at vi ikke ved, hvordan vægtøgningen er fordelt 
på fedt og fedtfri masse. Dét vil vi gerne have mere viden om, så vi kan forbedre vores 
vejledning i forbindelse med vægtændringer.  
 
Hvis du vil deltage i undersøgelsen betyder det, at du vil blive målt omkring taljen og vejet på 
en speciel vægt ca. hvert halve år i forbindelse med din behandling eller kontrolbesøg – i alt 4 
gange. Vejningen vil blive foretaget af en sygeplejerske. For at vejningen bliver foretaget så 
nøjagtig som mulig, bliver du vejet med bare fødder. Desuden er det hensigtsmæssigt, at du: 
- er udhvilet og ikke har trænet 24 timer før målingen 
- at du har tømt din blære 
- ikke har indtaget alkohol inklusiv vin 24 timer inden vejningen, da det kan påvirke 
din væskebalance 
 
Din deltagelse i undersøgelsen vil ikke medføre ekstra besøg i afdelingen. 
 
Deltagelse i undersøgelsen er frivillig. Du kan, på et hvilket som helst tidspunkt, trække dit 
tilsagn tilbage, uden at det vil få konsekvenser for din nuværende eller evt. fremtidige pleje og 
behandling.  
 
Undersøgelsen er anmeldt til Datatilsynet og drøftet med Videnskabsetisk Komité Region 
Nordjylland, og hvis du ønsker at deltage i undersøgelsen, skal du underskrive og datere en 
samtykkeerklæring. De oplysninger, vi registrerer, vil blive behandlet fortroligt. Det vil blandt 
andet sige, at det ikke vil være muligt at genkende dig, når resultaterne af undersøgelsen 
bliver offentliggjort eksempelvis i et videnskabeligt tidsskrift. 
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Har du spørgsmål til denne undersøgelse, er du velkommen til at ringe på nedenstående 
telefonnumre. 
 
Venlig hilsen  
Ansvarlig for undersøgelsen 
Udviklingssygeplejerske Birgith Pedersen, ph.d. studerende  
Onkologisk Afdeling  
Aalborg Sygehus   
Tlf. 99322925/99328047  
birgith.pedersen@rn.dk 
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Appendix D. Comparison of included 
and eligible, not included participants 
 
 
  
Included 
N = 95 
Eligible, not included 
N = 30 
Age     
   Mean years (range) 
 
58 (28-82) 64 (45-84) 
Menopausal status   
   Premenopausal  38 (40 %) 5 (16.1 %) 
   Postmenopausal 
 
57 (60 %) 25 (83.3 %) 
Tumour Stage   
I 59 (62.2 %) 14 (46.7 %) 
II 27 (28.4 %) 14 (46.7 %) 
III 9 (9.4 %) 2 (6.6 %) 
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Appendix E. Comparison Tanita and 
BioScan 
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Appendix F. Participants information 
focus group  
Vægtændring hos kvinder med brystkræft under og efter 
behandling  
Deltagerinformation fokus gruppe 
Kære  
Tusind tak fordi du vil deltage i en uformel samtale om dine oplevelser af ændringer 
i vægt og kroppens facon under og efter din behandling for brystkræft.  Samtalen vil 
finde sted i et møderum i onkologisk afdeling og der vil være mellem 5 -7 andre 
deltagere. 
Samtalen vil blive optaget på diktafon og efterfølgende udskrevet og analyseret. I 
denne proces vil der ske en anonymisering. Det vil sige, at dine beskrivelser ikke 
kan henføres til dig. Analysen vil blive brugt til at udarbejde en interviewguide, der 
skal bruges til individuelle interview i et ph.d - projekt.  
Ph.d- projektet omhandler vægtforandringer under og efter behandling for brystkræft 
og indeholder to dele. 
Første del består i registrering af ca. 100 kvinders vægt på en ”Body composition 
analyzer” gennem 18 måneder. Det vil sige, at kvinderne bliver vejet på en vægt, der 
kan udskille forskellige parametre som fedtmasse, fedtfri masse, måle BMI m.m. 
Desuden registreres maveomfang.   
Anden del består af interview med ca. 15 kvinder, der har oplevet vægtforandringer. 
Interviewet foretages ca. et år efter behandlingens start.   Det er til dette interview, 
jeg skal udarbejde en guide med spørgsmål. Interviewet forventes at bidrage til at 
skabe mere viden om, hvilken betydning kropslige forandringer i forbindelse med 
vægtændringer kan have for disse kvinder. 
Nedenstående spørgsmål kan overvejes inden vi mødes, men det er væsentligt at få 
drøftet det, der er betydningsfuldt for dig: 
- Hvilke tanker du har gjort dig om vægtforandringer 
- Hvilken betydning har de haft for dig 
- Hvilke sammenhænge ser du i forhold til eventuelle vægtændringer 
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- Hvordan du har taklet evt. vægtændringer 
Deltagelse i undersøgelsen er frivillig. Du kan, på et hvilket som helst tidspunkt, 
trække dit tilsagn tilbage, uden at det vil få konsekvenser for din nuværende eller 
evt. fremtidige pleje og behandling. Hvis du ønsker at deltage i undersøgelsen, skal 
du underskrive og datere en samtykkeerklæring. De oplysninger, vi registrerer, vil 
blive behandlet fortroligt.  
 
Undersøgelsen er anmeldt til Datatilsynet og drøftet med Videnskabsetisk Komité 
Region Nordjylland. 
 
 
Mange hilsner 
Birgith Pedersen 
Udviklingssygeplejerske og ph.d. studerende 
Onkologisk Afdeling,  
Aalborg Universitetshospital 
Tlf.:  9932 2925 
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Appendix G. Participants information 
qualitative component 
 
Vægtændring hos kvinder med brystkræft under og efter behandling 
 
Deltagerinformation – individuelle interviews 
 
Onkologisk Afdeling/Speciale for kræftbehandling  
Aalborg Universitetshospital 
 
 
Kære 
 
Tak fordi du har sagt ja til at deltage i undersøgelsen vedrørende vægtændringer og 
vægtens fordeling mellem muskler og fedt i forbindelse med behandling for 
brystkræft. Du er nu blevet vejet og blevet målt omkring livet flere gange. Disse data 
indgår i kvantitative beregninger og vi forventer at få mere viden om 
sammenhængen mellem behandling, udvikling af vægtændringer samt hvorledes 
ændringerne fordeler sig.  
  
Vi vil også gerne have mere viden om, hvad eventuelle kropslige forandringer i 
forbindelse med vægtændringer kan betyde for den enkelte kvinde. Til dette ønsker 
vi at foretage interviews med ca. 15 kvinder.  
 
Derfor vil jeg spørge, om du kunne være interesseret i at lade dig interviewe om, 
hvad eventuelle vægtforandringer har betydet for dig. Interviewet vil foregå, hvor du 
ønsker det. Dvs. hjemme hos dig eller på hospitalet og vil vare ca. en time. 
Interviewet vil blive optaget på diktafon og efterfølgende udskrevet og analyseret. I 
denne proces vil der ske en anonymisering. Det vil sige, at dine beskrivelser ikke 
kan henføres til dig.  
 
I interviewet vil jeg være inspireret af en interviewguide, som jeg har udarbejdet på 
baggrund af et fokusgruppeinterview, men da det handler om at få så mange nuancer 
frem som muligt, har du mulighed for at fortælle netop det der er vigtigt for dig. 
  
Nedenstående spørgsmål kan overvejes inden interviewet, men alt relateret til din 
oplevelse af vægtændringer er væsentligt for undersøgelsen at få frem: 
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- Hvordan oplever du forandringerne og hvordan bliver du opmærksom på 
dem? 
- Hvilken betydning har forandringerne for din opfattelse af dig selv og din 
krop? 
- I hvilke situationer bliver du opmærksom på dine vægtforandringer? 
- Hvad tænkte/følte du da du oplevede forandringerne? 
- Hvilke sammenhænge ser du i forhold til eventuelle vægtændringer? 
- Hvordan du har håndteret evt. vægtændringer? 
 
Undersøgelsen er anmeldt til Datatilsynet og drøftet med Videnskabsetisk Komité 
Region Nordjylland. Deltagelse i undersøgelsen er frivillig.  
Du kan, på et hvilket som helst tidspunkt, trække dit tilsagn tilbage, uden at det vil 
få konsekvenser for din nuværende eller evt. fremtidige pleje og behandling.  
Hvis du ønsker at deltage i undersøgelsen, skal du underskrive og datere en 
samtykkeerklæring.  
 
De oplysninger, vi registrerer, vil blive behandlet fortroligt. Det vil blandt andet 
sige, at det ikke vil være muligt at genkende dig, når resultaterne af undersøgelsen 
bliver offentliggjort eksempelvis i et videnskabeligt tidsskrift. 
 
Har du spørgsmål til denne undersøgelse, er du velkommen til at ringe på 
nedenstående telefonnumre. 
 
Venlig hilsen  
Udviklingssygeplejerske Birgith Pedersen, ph.d. studerende,  
Onkologisk Afdeling/Speciale for kræftbehandling,  
Aalborg Universitetshospital.  
Tlf. 97661558  
Mail: birgith.pedersen@rn.dk 
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Appendix H. Estimated patterns of 
changes in weight and body 
composition 
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Appendix I. Estimated odds ratio for 
weight groups 
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